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Abstract 
 
The Tn916-like family of conjugative transposons are broad host range mobile 
genetic elements and are clinically important as they are one of the major vectors 
responsible for the spread of antibiotic resistance among bacterial pathogens. This 
study was designed to investigate the behaviour of the conjugative transposons 
Tn916 and Tn5397, focusing on the transcriptional regulation and transfer. The 
proposed regulatory system of Tn916 involves transcriptional attenuation upstream 
of tet(M) and is regulated by tetracycline. The translation of orf12 is central to this 
regulatory mechanism as it is the translating ribosome upon orf12 RNA that is 
hypothesised to destroy, or prevent the formation of the transcriptional 
terminators. This hypothesis was tested using a Bacillus subtilis construct, with a 2 
bp mutation disrupting the start codon of orf12. This construct is expected to result 
in the transcriptional terminators being permanently formed as the ribosome will 
no longer translate the orf12 and destroy them. Results indicate a lower 
transcription of tet(M) and downstream genes which was supported by the slower 
growth rate of the B. subtilis mutant compared to the wild type upon challenged 
with tetracycline. When tetracycline is present, a reduced fitness of this mutant was 
observed compared to the wild type. However, the transfer frequency of the B. 
subtilis mutant was similar to that of the wild type.  
 
The transcription of Tn916 and Tn5397 was investigated by quantifying the 
expression level using reporter assays, where the Ptet(M) promoter and the open 
iv 
reading frames upstream of tet(M) were cloned upstream of a -glucuronidase 
gene. In the presence of tetracycline, Tn916 wild type construct was upregulated 
whereas the Tn5397 wild type construct showed a constant expression level. 
Disruption of the start codon of orf12 (Tn916) and orf26 (Tn5397) has also led to a 
constant expression level of -glucuronidase.  
 
The termination efficiency of the Tn916 terminators was estimated using promoter 
assays and a published algorithm. Results suggest that the large terminator is more 
efficient [47% ( 18)] than the small terminator [23% ( 15)], which was supported 
by the algorithm analysis for Tn916.  
 
Finally, reciprocal gene transfer of Tn5397 between Clostridium difficile and 
Enterococcus faecalis was demonstrated. The transfer frequency [ standard 
deviation (SD)] detected was 8.85 x 10-8 ( 2.14 x 10-7) per recipient. Tn5397 
integrates into the genome of E. faecalis at a single site that is within an orf 
encoding the phosphotransferase (PTS) IIA component. Comparative growth curves 
showed that the acquisition of Tn5397 has a very small effect on the growth of E. 
faecalis.  
 
This work has extended the current knowledge of the regulation and transfer of 
conjugative transposons of the Tn916-like family. It has provided a better 
understanding about the mechanism of transcriptional regulation of these 
elements.  
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2 
1 General introduction 
1.1 Antibiotic resistance  
 
Antibiotics are chemical substances that work to either inhibit bacterial growth 
(bacteriostatic agents) or kill them (bactericidal agents) (Russell and Chopra, 1996). 
Since the first discovery and clinical application of antibiotics, there has been a 
major improvement of the treatment of infectious diseases, which has resulted in a 
reduction in the morbidity and mortality associated with these illnesses (Alanis, 
2005). However, continuous exposure to antibiotics has accelerated the emergence 
of antibiotic resistance (Heinemann et al., 2000), predominantly among pathogens 
causing nosocomial infections (Emori and Gaynes, 1993; Hsueh et al., 2002). The 
increased prevalence of antibiotic resistance in bacterial pathogens has become a 
formidable public health concern and this phenomenon has led to collaborative 
efforts from various sectors to combat the rising antibiotic resistance. To date, a 
number of strategies have been implemented and these include the most recent 
antibiotic re-engineering approach (Xie et al., 2011), surveillance of antibiotics use 
and resistance as well as educating the health practitioners on the proper use of 
antibiotics during treatment (Hadley, 2004).  
 
 
 
 
3 
1.2 Nosocomial infections 
 
Nosocomial infections, also called hospital-acquired or health-care associated 
infections are those acquired in, or associated with, hospitals or because of 
healthcare interventions (Jamieson, 2008; Breathnach, 2009). Infections are 
considered nosocomial if they appear 48-72 h after hospitalisation or within 30 days 
after discharge. The frequency of nosocomial infections amongst patients in British 
and Irish hospitals has been estimated to be 5-10% (Smyth et al., 2008), with the 
highest in surgical wards and intensive care units (ICU) (Majumdar and Padiglione, 
2012). Nosocomial infections include surgical, wound, catheter-associated urinary 
tract, respiratory tract and gastrointestinal infections. These infections can be 
caused by any pathogen found in hospitals or healthcare units via direct contact 
with patients as well as the contaminated environmental surfaces (Eckstein et al., 
2006). In recent years, nosocomial infections and antibiotic-resistance have become 
the subjects of considerable media, public and political interests (Breathnach, 
2009). Antibiotic-resistant nosocomial infections have been linked to a substantial 
increase in morbidity, mortality and the financial burden associated with patient 
management and implementation of infection control measures (Jamieson, 2008; 
Woodford and Livermore, 2009). Among the predominant antibiotic-resistant 
bacteria causing nosocomial infections are the Gram-positive Clostridium difficile 
and vancomycin-resistant enterococci (VRE) (Pituch, 2009; Cartman et al., 2010; 
Majumdar and Padiglione, 2012). 
4 
1.2.1 Clostridium difficile 
 
C. difficile is an anaerobic, spore-forming and toxin-producing bacillus and the 
leading cause of antibiotic-associated disease which can range from mild, self-
limiting diarrhoea to severe pseudomembranous colitis (Huang et al., 2009). C. 
difficile strains have been classified and grouped using various molecular typing 
methods. One such method is ribotyping which is a typing method based on the 
sequence of the 16S – 23S region of the genome. In the UK up to 2003, it was 
reported that ribotype 001 contributed approximately 60% of C. difficile-associated 
diarrhoea (CDAD) cases. Molecular surveillance in 2006 however showed that 40% 
of isolated C. difficile was PCR-ribotype 027 which is a highly transmissible and 
virulent strain (Barbut et al., 2007; Sundram et al., 2009). The genome sequence of 
the virulent and multidrug-resistant C. difficile 630 reveals the presence of 
numerous mobile genetic elements, particularly conjugative transposon (CTn); 
CTn1, CTn2, CTn4-7 (Brouwer et al., 2011).  Some of this CTns are related to the 
vancomycin resistance transposons of Enterococcus sp. e.g CTn2, CTn4 and CTn5 
which share homology to Tn1549 (Sebaihia et al., 2006). Resistance to 
antimicrobials among C. difficile varies widely, however, all isolates remain 
susceptible to metronidazole and vancomycin, which is the treatment of choice for 
C. difficile infection (CDI). However, recently fidaxomicin, which has been shown to 
be as effective as vancomycin, has been approved in the USA (since May 2011) and 
Europe (since December 2011) as an alternative medication for CDI patients 
(Cornely et al., 2012).  
5 
1.2.2 Enterococcus faecalis 
 
Enterococcus spp. are commensal bacteria which usually reside in the 
gastrointestinal tract and are occasionally associated with urinary tract infections 
(Rice, 2006; Amyes, 2007). However, in the late 1980s, Enterococcus spp. has 
emerged as one of the most important nosocomial pathogens due to the outbreaks 
of VRE (Bensoussan et al., 1998). The emergence of VRE is associated with the 
distribution of the mobile elements Tn1546, which contains vanA, and Tn1549 and 
Tn5382, which contain vanB (Bonten et al., 2001; Launay et al., 2006). The 
emergence of VRE has been linked to the higher use of vancomycin (Kirst et al., 
1998) which, as mentioned above, remains as the conventional antimicrobial 
treatment, along with metronidazole, of CDI in the UK (Pepin, 2008; Baines et al., 
2009; Leffler and Lamont, 2009).  
 
1.3 Horizontal gene transfer 
 
One of the mechanisms for the spread of antibiotic resistance genes among 
bacteria is the acquisition of mobile genetic elements, transferred via horizontal 
gene transfer (HGT). During HGT the genetic material can be transferred without 
the requisite reproduction associated with vertical inheritance (Poole, 2009). The 
three fundamentally distinct mechanisms involved are transformation, transduction 
and conjugation. 
6 
1.3.1 Transformation 
 
Transformation was the first mechanism of HGT to be discovered and is a process of 
DNA uptake by bacteria from the environment (Frost et al., 2005). Transformation 
was first observed when avirulent strains of Streptococcus pneumoniae acquired 
virulence by incubation with an extract from killed virulent cells (Griffith, 1928). 
Transformation occurs when the bacterial cells enter a competence state, 
commonly in late logarithmic phase (Dale and Park, 2010). Competence of bacteria 
can be either natural or artificially induced (Mandel and Higa, 1970). In some 
bacteria, transformation is selective, where a short species-specific sequence is 
required for efficient uptake of extracellular DNA. For example, the transformation 
of the piliated Neisseria meningitidis is mediated by the presence of a specific 10 bp 
sequence (GCCGTCTGAA) known as the uptake signal sequence (USS), that appears 
nearly 2000 times in its genome (Elkins et al., 1991). In contrast, Bacillus subtilis and 
S. pneumoniae have been shown to take up virtually any DNA molecule. 
Transformation is one of the main mechanisms mediating transfers of genetic 
material encoding antibiotic resistance determinants amongst clinically important 
bacteria (Woegerbauer et al., 2002; Kim et al., 2006; Domingues et al., 2012). 
Hannan et al. (2010) have demonstrated the transfer of conjugative transposon 
Tn916 which encodes for tetracycline resistance from Veillonella dispar to 
Streptococcus spp. in biofilms via transformation. Additionally, development of 
tetracycline and kanamycin resistance in Campylobacter jejuni has also been 
demonstrated by the same mechanism (Jeon et al., 2008).  
7 
1.3.2 Transduction 
 
Transduction is the process by which DNA is acquired following a phage infection. 
Transduction has often been classified into two categories; generalised and 
specialised (or restricted) transduction (Ozeki and Ikeda, 1968). In generalised 
transduction, any region of the bacterial chromosome has an equal chance of being 
transduced whereas in specialised transduction, the DNA transferred is limited to a 
very small region of the host chromosome (Dale and Park, 2010) as it is packaged 
with the bacteriophage genome. Generalised transduction was first identified by 
Zinder and Lederberg (1952) where the phage P22 was shown to transfer 
chromosomal DNA from one strain of Salmonella to another. Phages that mediate 
generalised transduction generally breakdown host DNA into a suitable sized 
fragments thus allowing it to be incorporated into the phage head. In some cases, 
the bacterial plasmid or host chromosomal DNA is taken up into the phage head in 
place of the phage DNA. The transducing particles then have the ability to infect 
susceptible hosts and the DNA becomes incorporated into the recipient genome by 
homologous recombination (Fineran et al., 2009).  
 
Whereas in typical generalised transduction, the bacterial DNA is packaged without 
the phage DNA, specialised transduction can packaged the host DNA along with 
some, or all of the phage DNA (Fineran et al., 2009). The mechanism of specialised 
transduction was first observed using E. coli and phage lambda (λ) (Morse et al., 
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1956). Specialised transduction relies on temperate phages (e.g. phage λ and phage 
Mu) that are able to form prophage during lysogenic cycle (Fineran et al., 2009). In 
specialised transduction, the excision of phage DNA from the host genome is 
imprecise, which leads to the formation of the hybrid circular DNA containing phage 
and bacterial DNA. Once the transducing particles have been packaged, they are 
then capable of infecting a new host. Upon injection, the transducing phage 
lysogenises the host, resulting in the stable integration of the genes into the new 
host genome as part of the prophage (Hendrix, 2002). If this lysogeny breaks down, 
and the phage enters the lytic cycle, all of the progeny will then harbour the 
bacterial DNA.  
 
1.3.3 Conjugation 
 
Conjugation is a process of DNA transfer via a proteinaceous cell-to-cell junctions or 
a bridge-like tunnel between bacterial cells, although the nature of some of these 
structures remains unclear. In general, the mechanism of conjugation involves 
three main steps: mating formation, signaling event for transfer to occur and 
transfer of DNA (Frost et al., 2005). In most cases, this involves self-transmissible 
conjugative elements, which include plasmids and integrative conjugative elements 
(ICEs) (e.g. conjugative transposons). The two mechanisms of conjugation show 
differences between these two types of element and are detailed below.  
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1.3.3.1 Conjugative plasmids 
 
Conjugative plasmids are self-replicating, double-stranded closed circular units of 
DNA that are capable of horizontal transmission. For many years, the conjugative 
plasmids have been associated with the dissemination of antibiotic resistance 
amongst bacterial pathogens (Palmer et al., 2010). The conjugative mechanisms of 
plasmids are different between those of Gram-negative and Gram-positive bacteria. 
The Gram-negative bacteria use a type IV secretion system (T4SS), also known as 
the mating pair formation (Mpf) apparatus to form a pilus (Lawley et al., 2003; 
Thomas and Nielsen, 2005). Conjugation is initiated by contact between pili and a 
suitable recipient resulting in a pore or channel formation (Lawley et al., 2003). 
Once contact is established, a mating signal is generated and a protein called 
relaxase nicks the plasmid DNA at a specific site known as the origin of transfer 
(oriT) to give a single-stranded substrate that is suitable for transfer (Grohmann et 
al., 2003). In the recipient cell, DNA synthesis converts the single-strand DNA into a 
double-stranded molecule (Dale and Park, 2010).  
 
Some Gram-positive bacteria can stimulate mating by producing a pheromone-like 
peptide as observed in many enterococcal strains (Hirt et al., 2002; Chandler and 
Dunny, 2004). This peptide which is a chemical signal for interbacterial 
communications is transmitted from the recipient cells to the donor cells (Chandler 
and Dunny, 2004). Activation of this signal leads to the production of two proteins; 
aggregation substance (AS) and binding substance (BS) that appear on the surface 
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of both the donor and the recipient cells (Clewell and Weaver, 1989). Synthesis of 
these proteins is responsible for the cell-to-cell contact and thus initiates the 
transfer of the plasmid (Waters and Dunny, 2001). Plasmid DNA is transferred to 
the recipient cells through the same mechanisms as observed in Gram negative 
bacteria.  
 
1.3.3.2 Conjugative transposons  
 
Conjugative transposons, or integrative conjugative elements (ICEs) are genetic 
elements that encode enzymes which can catalyse their own integration, excision, 
transposition and conjugation (Franke and Clewell, 1981). Conjugative transposons 
were first identified in the early 1980s (Buu-Hoi and Horodniceanu, 1980) where 
the transfers of chromosome-borne multiple antibiotic resistance markers were 
observed in beta-hemolytic groups streptococci (Horodniceanu et al., 1981). There 
are many distinct families of conjugative transposons as illustrated in Table 1.1. The 
two most extensively studied conjugative transposons are Tn916 and Tn1545, 
which have a broad host range and are clinically important, as they are one of the 
major vectors responsible for the spread of antibiotic resistance among bacterial 
pathogens (Clewell et al., 1995; Scott and Churchward, 1995). Conjugative 
transposons are capable of being transferred via conjugative transposition from 
genomes of donor cells to those of recipients, sometimes across large phylogenetic 
distances (Roberts et al., 2001a). The steps involve in the transposition and transfer 
of conjugative transposons was proposed by Salyers et al. (1995) and is illustrated 
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in Figure 1.1. The mechanism of integration and excision of conjugative transposons 
is mediated by either tyrosine recombinases (Landy, 1989), serine recombinases 
(Stark et al., 1992) or DDE transposase (Brochet et al., 2009), which were classified 
based on their evolutionary and mechanistic relatedness (Smith and Thorpe, 2002).  
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Table 1.1 Conjugative transposons family  
 
Conjugative transposons 
 
Original host 
 
Size (kb) 
 
Characteristics 
 
Reference 
 
Tn916 family 
Tn916 Enterococcus faecalis 18.3 Confers tetracycline resistance 
 
Franke and Clewell, 1981 
Tn925 Bacillus firmus 18.0 Confers tetracycline resistance Christie et al. 1987 
Tn1545 Streptococcus pneumoniae 25.3 Confers tetracycline, kanamycin and 
chloramphenicol resistance 
Courvalin and Carlier, 
1986 
Tn2009 Streptococcus pneumoniae 23.5 Confers tetracycline, erythromycin and macrolide 
resistance 
Del Grosso et al. 2004 
Tn2010 Streptococcus pneumoniae 26.3 Confers tetracycline, erythromycin and macrolide 
resistance 
Del Grosso et al. 2006 
Tn2017 Streptococcus pneumoniae 28.5 Confers tetracycline, erythromycin and macrolide 
resistance 
Del Grosso et al. 2009 
Tn3872 Streptococcus pneumoniae 23.3 Confers tetracycline and erythromycin resistance McDougal et al. 1998 
Tn5386 Enterococcus faecium 29.5 Confers immunity to subtilisin Rice et al. 2007 
Tn5251 Streptococcus pneumoniae 18.0 Confers tetracycline resistance Ayoubi et al. 1991 
Tn5397 Clostridium difficile 20.6 Confers tetracycline resistance Mullany et al. 1990 
Tn6000 Enterococcus casseliflavus 33.2 Confers tetracycline resistance Brouwer et al. 2010 
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Conjugative transposons 
 
Original host 
 
Size (kb) 
 
Characteristics 
 
Reference 
 
Tn916 family 
    
Tn6003 Streptococcus pneumoniae 25.1 Confers tetracycline, erythromycin, kanamycin 
and MLS (macrolide, lincosamide and 
streptogramin B) resistance 
Cochetti et al. 2008 
Tn6009 Klebsiella pneumoniae 17.8 Confers tetracycline and mercury resistance Soge et al. 2008 
Tn6087 Streptococcus oralis 21.2 Confers tetracycline and CTAB 
(cetyltrimethylammonium bromide) resistance 
Ciric et al. 2011 
 
Composite conjugative transposon 
Tn3701 Streptococcus pyogenes >50.0 Confers tetracycline and erythromycin resistance Le Bouguènec et al. 1988 
Tn5252 Streptococcus pneumoniae 47.5 Confers chloramphenicol resistance Ayoubi et al. 1991 
Tn5253 Streptococcus pneumoniae 65.5 Tn5251 inserted into Tn5252 Ayoubi et al. 1991 
Tn5385 Enterococcus faecalis 65.0 Confers tetracycline, erythromycin, gentamicin, 
mercuric chloride, streptomycin and penicillin 
resistance. Conjugation of this element may be 
due to a smaller conjugative element, Tn5381 
located within this element 
Rice and Carias, 1998 
Tn5276 Lactococcus lactis 70.0 Confers production and immunity to nisin and a 
sucrose metabolic pathway 
Rauch and De Vos, 1992 
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Conjugative transposons 
 
Original host 
 
Size (kb) 
 
Characteristics 
 
Reference 
 
Conjugative transposons from Bacteroides 
 
XBU4422 Bacteroides 65.0 Cryptic element Bedzyk et al. 1992 
Tcr Emr 7853 Bacteroides 70.0-
80.0 
A distinct class of Bacteroides conjugative 
transposons. Confers resistance to tetracycline 
and erythromycin 
Nikolich et al. 1994 
Tcr Emr DOT Bacteroides 70.0-
80.0 
A distinct class of Bacteroides conjugative 
transposons. Confers resistance to tetracycline 
and erythromycin 
Shoemaker et al. 1989 
 
Other conjugative transposon 
Tn4371 Ralstonia eutropha 55.0 Confers biphenyl catabolism. Conjugative 
transfers has not been demonstrated although 
conjugative genes are present 
Merlin et al. 1999 
Tn5301 Lactococcus lactis 70.0 A distinct class of conjugative transposons. 
Confers nisin production and sucrose metabolism 
Horn et al. 1991 
CTnscr94 Salmonella seftenberg 100.0 Encodes a sucrose fermentation pathway Hochhut et al. 1997 
R391 Proteus rettgeri 93.9 Confers resistance to kanamycin and mercury Murphy and Pembroke, 
1995 
SXT Vibrio cholerae 62.0 Confers resistance to sulfamethoxazole, 
trimethoprim and streptomycin 
Waldor et al. 1996 
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A. Intracellular transposition 
 
 
 
 
 
 
B. Intercellular transposition 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Intracellular and intercellular transposition of a conjugative transposon. (A) The 
integrated form of the conjugative transposon excises from the chromosome to form a 
covalently closed double-stranded and non-replicative DNA circular which is the 
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transposition intermediate. Filled boxes indicate the two ends of the conjugative 
transposon. Integration can occur into a chromosome or a plasmid. (B) The integrated form 
excises to form the transposition intermediate circle. The circular form is nicked at an oriT 
(filled circle) and a single strand is transferred by a similar process to plasmid transfer. The 
double-stranded form (dashed arrows) of the circular intermediate is regenerated in both 
donor and recipient cells, followed by integration. (Copied from Salyers et al., 1995) 
 
 
1.4 Genetic organisation of Tn916 
 
 
Tn916 is an 18 kb conjugative transposon that was originally discovered in the 
chromosome of the hemolytic multidrug-resistant Enterococcus faecalis DS16 
(Franke and Clewell, 1981; Flannagan et al., 1994). This element is the paradigm of 
a large family of conjugative elements, which are found in an extremely broad 
range of bacteria. Tn916 has 24 open reading frames (orfs), which encode putative 
proteins ranging from 2.9 to 93.7 kDa in molecular mass (Clewell et al., 1995). 
Almost all known conjugative transposons from Tn916 family confer tetracycline 
resistance via tet(M), either alone or associated with other resistance genes as 
reported in Tn1545 (Courvalin and Carlier, 1986). However, an exception to this was 
observed for Tn5386 from E. faecium which contains a series of ORFs with 
homology to lantibiotic immunity genes inserted into the same location where 
tet(M) is found in Tn916 (Rice et al., 2007). Similarly, CTn1  from C. difficile contains 
an ABC transporter inserted into the same location. Genes on Tn916-like elements 
are organized in modules, involved in the recombination, conjugation, regulation 
and accessory functions (Figure 1.2).  
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Figure 1.2  A schematic representation of Tn916 showing the four functional modules: 
conjugation (blue); recombination (red); regulation (green) and the accessory gene tet(M) 
(grey). Arrow boxes represent the open reading frames (orfs) and the orientation of the 
genes. Filled triangle represents the position of the oriT (origin of transfer), which is the 
conjugation-nicked-site. (Adapted from Roberts and Mullany, 2009) 
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1.4.1 Recombination of Tn916 
 
The first step in the conjugative transposition of Tn916 involves the staggered 
endonucleolytic cleavages at each ends of the transposon. These cleavages 
generate a 6 bp protruding 5’-hydroxyl ends termed coupling sequences (Rudy and 
Scott, 1994; Manganelli et al., 1996; Marra and Scott, 1999). The non-
complementary sequences are then joined, resulting in a circular intermediate 
molecule with a heteroduplex at the circle joint (Caparon and Scott, 1989). The 
double stranded circular intermediate is nicked at the origin of transfer (oriT) site 
(represented by black triangle in Figure 1.2) (Jaworski and Clewell, 1995) and a 
single strand of the circularised transposon is transferred to the recipient, where 
the complementary strand is synthesised. Scott et al. (1994) has postulated that 
this transfer process is somewhat similar to the process that occurs during transfer 
of plasmids. Integration of Tn916 into a target site can be visualised as a reversal of 
the excision process with an AT rich region becoming the preferred target site 
(Clewell et al., 1995; Lu and Churchward, 1995).  
 
Studies by Scott et al. (1994) and Nelson et al. (1997) have postulated that a 
conserved sequence of Tn916 target sites in multiple mutants examined is 
TTTTTnnnnnnAAAAA, with the 6 “N’s” can  be any of the four bases. Further to this, 
study by Cookson et al. (2011) has shown that the consensus sequence 
TTTTTTATATAAAAAA (the italicised hexanucleotides is variable and forms the 
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coupling sequence) is used by Tn916 for integration in 123 insertion sites in 
Butyrivibrio proteoclasticus strain B316T. More recently, Mullany et al. (2012) 
indicates that Tn916 has preferentially inserted the genome of C. difficile strains 
630 and R20291 at an intergenic regions, with a consensus sequence of 5’- 
TTTTTA[AT][AT][AT][AT]AAAAA. Integration of Tn916 into the target site involves a 
formation of heteroduplex regions on either side of the conjugative transposon. 
These mismatched bases are either resolved during replication or corrected by DNA 
repair (Manganelli et al., 1997).  
 
Ultimately, the ability of Tn916 to transpose inter- and intracellularly is mediated by 
two transposon-encoded proteins; integrase (Int) and excisionase (Xis) (Jaworski et 
al., 1996; Rudy et al., 1997). In Tn916, the genes that encode for these proteins are 
located at one end of the element (Figure 1.2). Int and Xis are required for excision 
and integration, whereas only Int is required for integration (Storrs et al., 1991). Int 
is a member of tyrosine recombinases family and belongs to a distinct subgroup of 
heterobivalent recombinases which perform highly directional recombination 
reactions (Abani et al., 2005).  Xis is a small and highly basic (pI=9) protein of 67 
amino acids (Rudy et al., 1997) and modulates the recombination by either 
facilitating or preventing the binding of Int to sites required for recombination 
(Abbani et al., 2005).  
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1.4.2 Conjugation of Tn916 
 
Conjugation of Tn916/Tn916-like elements contributes to the dissemination of 
antibiotic resistant genes among various Gram-positive and Gram-negative 
bacteria. Despite the fact that the specific mechanism of conjugation of these 
elements is somewhat limited, a study by Senghas and co-workers (1988) using Tn5 
(a non-conjugative transposon) mutagenesis has suggested that orf24 to orf13 are 
involved in this process (Figure 1.2). This study however, did not complement the 
Tn5 insertions to exclude the polar effects. The orfs spanning the conjugation 
region of Tn916 has been studied widely, and thus the specific functions of these 
proteins or homologs of these proteins are shown in Table 1.2. 
 
The initial step in conjugation of Tn916 requires Orf20 to nick a sequence known as 
oriT. Orf20 is the Tn916 relaxase protein and the gene is situated downstream of its 
cognate oriT (Rocco and Churchward, 2006). The oriT sequence of Tn916 is a 466 bp 
in length, containing 6 sets of inverted repeats and lies within the intercistronic 
space that separates orf21 and orf20 (Jaworski and Clewell, 1995). Interaction 
between the oriT and the Tn916 tyrosine recombinase has also been 
demonstrated,. This interaction has been postulated to prevent premature transfer 
of the element (Rocco and Churchward, 2006). 
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Table 1.2 Known (experimentally proven) functions of orfs within Tn916 conjugation module (Adapted from Ciric et al. 2011) 
Coding 
region 
 
Closest Homolog 
 
Accession number 
 
Function 
 
Reference 
orf21 Streptococcus agalactiae 2603V/R Tn916, 
FtsK/SpoIIIE family protein 
NP_687949 FtsK/SpoIIIE family protein required 
for DNA segregation during cell 
division 
Wu and Errington, 
1994 
orf20 Streptococcus pneumoniae putative 
conjugative transposon initiation factor 
CBW39427 Endonuclease which cleaves Tn916 
at oriT 
Rocco and 
Churchward, 2006 
orf18 Ureaplasma urealyticum serovar 9 str. 
ATCC 33175 conjugative transposon 
protein 
ZP_03079519 Anti-restriction protein responsible 
for DNA restriction immunity (Ard) 
Serfiotis-Mitsa et al. 
2008 
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1.4.3 Regulation of Tn916 
 
Knowledge about the regulation of Tn916/Tn916-like elements is almost completely 
limited to Tn916. The regulatory model of Tn916 has never been experimentally 
proven, although it is fundamentally important. The proposed regulatory region of 
Tn916 consists of orf12, orf9, orf7 and orf8 (Figure 1.2). The regulatory region of 
Tn916 is conserved in nearly all Tn916-like elements, suggestive of the important of 
this region in the transcriptional regulation of these elements (Roberts and 
Mullany, 2009; Ciric et al., 2011).  
 
The orf12 located upstream of tet(M) is an 86 bp open reading frame corresponding 
to a 28 kDa protein. It encodes rare amino acids and several inverted repeat 
sequences that would form hairpins in mRNA followed by uridine residues. The run 
of uridines has been proposed to be a rho factor-independent transcriptional 
terminator (Su et al., 1992). Regulation of Tn916 involves an interaction between 
the ribosomes with tetracycline, which results in the destruction of the 
transcriptional terminator. This regulatory mechanism is known as transcriptional 
attenuation (described in Section 1.8.1.2.3) (Su et al., 1992).  
 
In the presence of tetracycline, most ribosomes are inactivated by the reversible 
binding of tetracycline. This event retards the protein synthesis, thus results in the 
build-up of charged tRNA molecules. At this stage, a few ribosomes remain active
23 
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Figure 1.3 Structure of various members of the Tn916/Tn916-like elements. Functional modules are represented as shown in the key. The 
organisms from which the elements were isolated are shown at the left end. Mobility of the elements is denoted by a capital M on the right. 
(Taken from Roberts and Mullany, 2009). 
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due to the protection by the low and basal level of Tet(M). The increased 
availability of the charged tRNA molecules enables a more rapid translation of orf12 
by these protected ribosomes. Additionally, this event increases the rate of protein 
translation, which is normally slow due to the presence of rare codons in orf12. The 
ribosomes are predicted to catch up the RNA polymerase (RNAP) and prevent the 
formation of or destroy the terminator structures (designated 5S:6S and 7:8 in 
Figure 1.4. Transcription therefore proceeds from the promoter upstream of orf12 
and extends into, and through, tet(M) and into the downstream genes. 
 
However, under normal growth conditions, where the tetracycline is absent, the 
ribosomes pauses on the leader sequences of orf12.  This is due to the shortage of 
tRNA molecules for the rare codons within orf12 (Figure 3.1). As a result, the 
ribosome lags behind the extending RNAP allowing the formation of the predicted 
strong 5S:6S terminator and/or the weaker 7:8 terminator. At this stage, the 
majority of transcripts are terminated. This event results in a limited expression of 
Tet(M), due to a basal level of read-through transcription of the termination site. 
These terminators are not likely to be 100% efficient as in some instances, the 
RNAP escapes the termination site (Du and Babitzke, 1998) and leads to the 
transcriptional read-through into tet(M). As it has been postulated that the 
synthesis of Tet(M) could still occur without the translation of the leader peptide 
(since free ribosomes are able to bind to tet(M) Shine-Dalgarno site) (Su et al., 
1992), therefore this event might be of important particularly in maintaining the 
basal level of Tet(M) under drug-free conditions. 
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Figure 1.4 The alternative secondary structures that are predicted to form in mRNA of 
Tn916. The stem-loops 1:2, 3:4 and 5S:6S are mutually exclusive of structure 5L:6L. The 
free-energy values of each structure are shown in kcal mol-1. The red-shaded area 
represents the orf12. The Shine-Dalgarno sequences are underlined and labeled. The start 
codon of tet(M) is shaded yellow. The structures which include the terminators are labeled 
(T). (Copied from Roberts and Mullany, 2009) 
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Transcriptional analysis by Celli and Trieu-Cout (1998) revealed that other than 
Ptet(M), Tn916 also contains another three promoters, namely Porf7, Porf9 and 
Pxis. In the absence of tetracycline, transcription through orf9 is proposed to 
produce an antisense RNA, which results in the downregulation of Porf7. This will 
have an effect of reducing the transcription of orf7, orf8 and downstream genes. 
However, when tetracycline is present, orf9 is transcribed at a lower level as 
antisense orf9 RNA is produced from the transcription initiating at the promoter 
upstream of tet(M) leading to an upregulation of Porf7. This led to an increased 
transcription of orf7, orf8 and downstream genes as Orf7 is predicted to upregulate 
its own promoter. (Figure 1.5).  
 
The translation rate will return to the previous level once the majority of the 
ribosomes are protected by Tet(M). At this stage, the level of charged tRNAs is 
smaller as most of them are being used by the protected ribosomes, which in turn 
leads to a slower translation rate. The ribosomes translating the orf12 will once 
again lag behind the transcribing RNAP, enabling the formation of the terminator 
structures, thus reducing the transcription of tet(M). This regulatory system allows 
the cell to sense the presence or absence of tetracycline, and react either by 
downregulating or upregulating the transcription and translation of Tn916 (Su et al., 
1992; Celli and Trieu-Cout (1998).  
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Figure 1.5 Regulation of expression of the transfer genes within Tn916. ORFs are 
represented by block arrows, pointing towards the probable direction of transcription. The 
transcription level was presented by the thick and thin arrows, which denoted the higher 
and lower transcription, respectively. In the absence of tetracycline (-Tc), most of the 
transcripts initiated at Ptet terminate at Palorf12. Porf9 transcribes the orf9 gene 
efficiently, while Porf7 directs a low level of transcription through orf7 and orf8. In these 
conditions, Porf7 and Pxis direct a low level of transcription through the transposition and 
downstream genes. In the presence of tetracycline (+Tc), the transcripts initiated at the 
Ptet read-through the Palorf12, Palorf10, Palorf7and Palorf8. This condition decreased the 
transcription of orf9 genes from the Porf9 and increased transcription of orf7 and orf8 from 
the Porf7. The resulting overexpression of ORF7 and ORF8 stimulated the activity of Porf7, 
thus leads to an increased transcription of downstream genes. Orf9 could repress the 
activity of Porf7. (Copied from Celli and Trieu-Cuot, 1998) 
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Regulation of Tn916 is not necessarily dependent on the presence or absence of 
tetracycline but the key event to this mechanism is the change in the translation 
rate, which is associated with the level of charged tRNA (Roberts and Mullany, 
2009). An increased amount of charged tRNA is likely to result in the upregulation 
of the majority of Tn916 genes. Based on this fact, any malfunction in the cell’s 
translational apparatus will lead to a drop in the translational rate, and thus 
increase the tRNA concentration. This event is expected to be deleterious to the 
cell. Upon sensing this cellular distress, Tn916 will then activate its own 
transcription and movement.  
 
1.4.4 Accessory genes of Tn916 
 
Accessory genes that include antibiotic resistance determinants have been 
demonstrated to confer evolutionary advantages on the host cells. In Tn916, an 
antibiotic resistance gene, tet(M) which encodes for tetracycline resistance 
determinant is present (Flannagan et al., 1994). This gene is replaced by a variety of 
other accessory genes in other elements as shown in Figure 1.3. The tet(M) gene 
was identified as a coding sequence corresponding to a 72 kDa protein (Su et al., 
1992). Other accessory genes such as erm(B) (encodes for erythromycin resistance), 
mef(E) (encodes for macrolide efflux pump protein) and ABC transporters are also 
present in Tn916-like elements, sometimes replacing tet(M) (Figure 1.3).  
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1.5 Genetic organisation of Tn5397 
 
Tn5397 is a 21 kb conjugative transposon originally identified in the Gram-positive 
pathogen C. difficile 630 (Mullany et al., 1996). Tn5397 which was first named Tc-CD 
confers tetracycline resistance via tet(M) (Mullany et al., 1990). This element is 
closely related to Tn916 in the central regions that are involved in conjugation, 
however the regions required for transposition are completely different. In Tn5397, 
the excision and integration mechanism are dependent on a large resolvase 
subgroup of site-specific recombinases, termed TndX which was encoded by tndX 
located at one end of this element (Figure 1.6). Another characteristic that 
distinguishes Tn5397 from Tn916 is the presence of a group II intron, inserted 
within orf14 of Tn916 (Mullany et al., 1996). 
 
1.5.1 Recombination of Tn5397 
 
Sequence analysis of the ends of Tn5397 has shown that this element contains a 
gene, tndX that encodes for a large serine recombinase TndX, which is a member of 
the resolvase family of site-specific recombinases (Wang et al., 2000). TndX is a 61.5 
kDa protein and is closely related to TnpX resolvase from Tn4451 of C. perfringens 
(Bannam et al., 1995) with 37% identity and 61% similarity (Wang et al., 2000). 
TndX mediates recombination via a concerted cleavage and rejoining mechanism, 
as described for the resolvase/invertases (Stark et al., 1992).  
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Figure 1.6 A schematic representation of Tn5397 showing the four functional modules: 
conjugation (blue); recombination (red); regulation (green) and the accessory gene tet(M) 
(grey). Arrow boxes represent the open reading frames (orfs) and the orientation of the 
genes. Filled triangle represents the position of the oriT (origin of transfer), which is the 
conjugation-nicked-site. A group II intron is inserted into orf14. (Adapted from Roberts and 
Mullany, 2009) 
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TndX promotes the excision of Tn5397 by introducing 2 bp staggered cuts at the 3’ 
ends of the directly repeated GA dinucleotides at each end of the transposon. 
Excision of the transposon as a circular intermediate and regeneration of the 
original target site occurs during strand exchange. A circular intermediate of the 
transposon is formed by ligation of the two ends. A single strand of the circular 
intermediate can then be transferred to a new host by conjugation. Integration of 
Tn5397 into the new genome occurs when TndX promotes a site-specific 
recombination with the joint of the circular intermediate. This event extended upon  
recognition of a suitable target site that contains a central GA dinucleotide at the 
crossover site within the target genome (Wang et al., 2000; Wang et al., 2006). 
Strand exchange and ligation result in the site-specific integration of Tn5397 to the 
target genome flanked by directly repeated GA dinucleotides. 
 
1.5.2 Conjugation of Tn5397 
  
As previously described, Tn5397 and Tn916 are closely related despite several 
insertions and deletions in Tn5397. The left end of Tn5397 showed an absence of 
the first 201 bp of Tn916 sequence and was replaced by 180 bp of unrelated DNA 
sequence. This has result in the deletion of orf24. Since no studies have been 
carried out confirming the functional role of this open reading frame, the specific 
effect of this deletion to the transfer of Tn5397 is undetermined. The other major 
difference between Tn916 and Tn5397 is the presence of a group II intron in the 
reading frame analogous to orf14 of Tn916 (Figure 1.6) (Roberts et al., 2001b). 
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Group II introns are a class of genetic element, categorised by their secondary 
structure which is essential for splicing via RNA-catalysed pathways (Michel and 
Ferat, 1995). Group II introns are also capable of moving from an intron-containing 
allele to an intronless allele (a process called homing) at high frequency and to 
ectopic sites at a much lower frequency (Belfort and Perlman, 1995; Michel and 
Ferat, 1995). The intron within Tn5397 has been postulated to encode a 
multifunctional protein; maturase, reverse transcriptase and endonuclease which 
are required for splicing, homing and transposition activities (Mullany et al., 1996).  
 
1.5.3 Regulation of Tn5397 
 
The regulatory region of Tn5397 has an 84 bp deletion effectively removing the 
leader peptide orf12 (Roberts et al., 2001b). This deletion disrupts one of the 
predicted terminators (5S:6S) (Figure 1.4) that is predicted to be crucial for 
regulation of tet(M) in Tn916 (Su et al., 1992). This deletion also results in the 
formation of two alternatives orfs; orf25 and orf26 (Roberts et al., 2001b). Although 
knowledge about the regulatory mechanism of Tn5397 is somewhat limited, studies 
have shown that despite the differences between the regulatory region of Tn5397 
and Tn916, the expression of tetracycline resistance determinant, Tet(M) is still 
inducible, as determined by comparative growth curve analysis and reverse 
transcriptase PCR (Roberts, 2001). 
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1.6 Ribosomal protection proteins 
 
Ribosomal protection-mediated tetracycline resistance was first discovered in 
streptococci (Burdett, 1986). There are 11 ribosomal protection proteins (RPPs) 
identified to date with Tet(O) and Tet(M) being the best studied of these 
determinants (Connell et al., 2003). RPPs confer resistance to tetracycline through 
interactions with the ribosome, thus prevent the antibiotic from binding to the 
ribosome (Burdett, 1990). These proteins are hypothesised to interact with the 
base of h34 protein within the ribosome and initiate an allosteric disruption of the 
primary tetracycline binding sites, thereby freeing the ribosomes from the 
inhibitory effects of tetracycline (Connell et al., 2003). Protein synthesis resumes as 
the ribosomes return to its normal conformation. However, it is unknown whether 
the ribosomal proteins actively prevent reattachment of the tetracycline after they 
have been released.  
 
A new class of tetracycline resistant determinant primarily encodes for RPPs has 
been discovered. These genes arise by recombination between the wild type 
resistant determinants, predominantly the tet(M), tet(W) and tet(O) genes. 
Although these hybrid genes demonstrated different mosaicism, the final size of the 
genes remains the same. The best example is tet(O/32/O), which has tet(32) 
sequence in the central region and flanked by tet(O) sequence. Some mosaic genes 
confer higher resistant level than the  wild type as seen in tet(O/W/O), with 
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resistance level of 128 to >256 µg ml-1 as compared to 64 µg ml-1 conferred by 
tet(O) or tet(W) genes (Stanton et al., 2004). Recently, two mosaics tet(S/M) were 
identified in Streptococcus bovis and S. intermedius (Barile et al., 2012; Novais et al., 
2012). In S. bovis, this hybrid was mainly composed of Tet(M) whereas Tet(S) 
dominated the sequence in S. intermedius (Novais et al., 2012). Although the role of 
mosaic genes remains unclear, they have been shown to be widespread and 
abundant (Patterson et al., 2007) which suggested that their presence in the 
environment are prevalent and significant, thus should be considered in future 
surveillance programs (Thaker et al., 2010).  
 
1.7 Bacterial gene expression 
 
Gene expression involves two consecutive steps; transcription and translation in 
which the information is converted from one form to another. Transcription 
produces a complementary RNA copy of one strand of a DNA duplex, which is 
catalysed by RNA polymerase (RNAP). RNAP is the key enzyme of gene expression 
and regulation not only in bacteria, but also in eukaryotes and archaea (Borukhov 
and Nudler, 2008). The complete RNAP or holoenzyme consists of six subunits 
(α2’) and can be separated into two components, the core enzyme (α2’) 
and the sigma factor (the  polypeptide), which is devoted to direct the core RNAP 
to specific initiation sites called promoters (Wigneshweraraj et al., 2008; Krebs et 
al., 2010). The transcription reaction is divided into three stages; initiation, 
elongation and termination as illustrated in Figure 1.7. Initiation of transcription
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Figure 1.7 Main features of bacterial transcription. Transcription involves three stages; the 
RNA polymerase binds to the promoter and unwound the DNA to form an open complex, 
moves along the DNA template during elongation and dissociates at terminator site. 
(Adapted from Dale and Park, 2010) 
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involves the binding of an RNAP to the double-stranded DNA at promoters. The 
start point of transcription is assigned as +1 and the value increases as they go 
downstream. The elongation step occurs in a 5’ to 3’ direction as the RNAP 
covalently adds ribonucleotides to the 3’-end of the growing single-stranded RNA 
chain. As the enzyme moves, it unwinds the duplex DNA, separating the DNA 
strands thus exposing the template strand for ribonucleotide base pairing. The DNA 
duplex is reformed behind the RNAP. The termination of transcription involves 
recognition of a specific DNA sequence known as terminator. At this point, no 
further bases should be added to the RNA chain, thus the enzyme and the 
synthesised RNA dissociate from the DNA template strand allowing reformation of 
DNA duplex. The synthesised RNA is called a transcription unit, and encodes either 
protein coding RNA (mRNA) or non-coding RNAs (rRNA and tRNA).  
 
In translation, the messenger RNA (mRNA) which carries the information for a 
specific amino acid sequence in the form of genetic code is decoded by the 
ribosome. The mRNA is read in a group of 3 nucleotides (Crick et al., 1961) or 
codons, deriving a specific amino acid chain or polypeptide that will later fold into 
an active protein. The protein translation involves four stages; initiation, 
elongation, translocation and termination. In the initiation step, the 30S subunit of 
the ribosome binds to a specific sequence on the mRNA, known as the ribosome 
binding site (RBS) followed by association of the charged-initiation tRNA with the 
start codon (AUG, GUG or CUG). The 50S subunit then attaches to this complex and 
initiates the translation. The initiation step is modulated by the activation of non-
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ribosomal proteins known as initiation factors that regulate the binding of mRNA to 
the ribosomal complex. The assembled ribosome has two tRNA-binding sites called 
A- and P-sites. The aminoacylated tRNA normally binds to the A-site, while their
anticodon region pairs with the mRNA. The tRNA moves to the P-site once the 
peptide bond is formed. Movements of tRNA from A-site to P-site are called 
translocation. The ribosomes move along the mRNA, translating it into amino acids 
until one of the three termination codons (UAA, UAG or UGA) appears in the A-site. 
At this point, the polypeptide chain is released and the ribosome dissociates from 
the mRNA, with the aid of the protein factors called release factors. 
 
1.8 Regulation of gene expression 
 
Regulation of gene expression in bacteria is essential to control the way that the 
information in genes is turned into gene products in response to environmental 
changes. Bacterial cells have evolved many different complex mechanisms to 
regulate the transcription and translation of genes (Gollnick and Babitzke, 2002). A 
number of studies have shown that the principal in the regulatory event in most 
organisms is at the level of transcription initiation (Gollnick and Babitzke, 2002; 
Henkin and Yanofsky, 2002; Naville and Gautheret, 2009) although there are 
numerous essential regulatory factors that are also involved such as gene copy 
number, stability of the mRNA and post-translational modification (Dale and Park, 
2010). 
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1.8.1 Transcriptional control 
 
Transcriptional regulation is one of the major mechanisms used by bacteria to 
control the gene expression. The regulation of gene expression has been identified 
for all three stages of transcription; initiation, elongation and termination. At the 
transcription initiation level, the efficiency of genes being transcribed is determined 
by the affinity of RNAP for the promoter (Busby and Savery, 2007). This regulatory 
mechanism involves a number of regulatory factors, of which promoters are 
particularly important. Once transcription is initiated  the nascent transcripts may 
fold into specific secondary structures that signal the transcribing RNAP to pause or 
terminate transcription. This post-initiation regulatory mechanism is categorised as 
transcription termination. 
 
1.8.1.1 Transcription initiation 
1.8.1.1.1 Promoter activity 
 
 
Earlier work on gene regulation focused interest on promoters involves in the 
transcription initiation (Cheng et al., 1991), which is the primary stage in the 
regulation of gene expression in bacteria. Bacterial promoters have a conserved 
sequence that constitutes a recognisable signal for RNAP to bind and form an open 
complex. There are four conserved features in bacterial promoters that specify the 
initial binding of RNAP; the -35 and -10 hexamers, the distance between -35 and -10 
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hexamers, and the AT rich region located upstream of the -35 hexamer (UP 
element)  (Hawley and McClure, 1983; Ross et al., 1993; Krebs et al., 2010). The -35 
and -10 hexamers are named for their locations that are centred at 35 and 10 bp 
upstream of the +1 transcription start site (TSS) (Harley and Reynolds, 1987). The 
consensus sequences of -10 and -35 are TTGACA and TATAAT, with a few 
exceptions. It has been postulated that the strong promoters tend to have a 
sequence close to this consensus, and function more efficiently (Browning and 
Busby, 2004). The distance separating the -35 and -10 hexamers is crucial as it holds 
the two motifs at the appropriate separation for an efficient contact with the RNAP. 
The optimal distance is between 16-18 bp, and spacing outside this range leads to 
the inefficient contact between the RNAP and the promoters as the contact points 
would not lie on the same side of the DNA helix (Figure 1.8) (Harley and Reynolds, 
1987). UP element interacts with the α subunit of RNAP and facilitate the initial 
binding of RNAP to the promoter (Rao et al., 1994; Strainic et al., 1998). In fact, the 
presence of UP element in some promoters (e.g. rrnB P1 of E. coli) has been shown 
to increase the frequency of transcription 30-90 fold (Estrem et al., 1998; Dale and 
Park, 2010). 
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Figure 1.8 Importance of the distance separating the -35 and -10 regions of a promoter. A. 
An optimal distance (16-18 bp) between -35 and -10 is crucial for an efficient contact 
with the RNAP. B. An increase in the spacing leads to inefficient contact between 
the RNAP and the promoter. (Adapted from Dale and Park, 2010) 
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1.8.1.1.2 Alternative promoters and   factors 
 
During transcription initiation, the  factor binds to the core RNAP to form a 
holoenzyme, which recognises the hexameric promoter elements by the consensus 
sequences, thus determines the specificity of RNAP (Dombroski et al., 1992). The 
promoter consensus described above is recognised by the primary  factor, 70 
helps the RNA polymerase transcribe most genes required in exponentially growing 
cells (Saitoh and Ishihama, 1977). However, most bacterial species possess several 
different  factors, which in turn results in recognition of distinct promoter 
sequences by the RNAP (Table 1.3). These alternative  factors control the 
expression of genes in bacteria as a response to the environmental conditions and 
stresses.  
 
The initial binding of the holoenzyme to the promoter leads to the formation of the 
closed binary complex in which the promoter DNA remains duplex. The closed 
complex is converted into an open complex via isomerisation process, which 
separate the DNA duplex from position -11 to +4, overlapping the -10 hexamer 
(Paget and Helmann, 2003). After a nascent RNA of 8-10 nucleotides has been 
synthesised, the  factor is no longer necessary, thus released to allow elongation 
to proceed and RNAP to escape the promoter (Paget and Helmann, 2003). In some 
cases, however, the  factor remains associated with the RNAP throughout the 
elongation process, which suggested that this factor does not need to be released
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Table 1.3 Alternative promoters and  factor sequences.  
-35 region Spacer (bp) -10 region Sigma 
factor 
Regulated genes Reference 
 
TTGACA 
 
16-18 
 
TATAAT 
 
70 
 
General 
housekeeping genes 
 
 
Gruber and 
Gross, 2003 
CTTGAAA 13-15 CCCATNT* 32 Heat-shock genes Arsene et al. 
2000 
 
CTGGNA 6 TTGCA 54 Nitrogen-
assimilation genes 
 
Studholme 
and Buck, 
2000 
 
  CTACACT 38 Stationary-
phase/general 
stress genes 
 
Tanaka et al. 
1995 
GTTTAA 12-14 GGGTAT B General stress 
genes* 
 
Hecker and 
Volker, 2001 
TAAA 15 GCCGATAA 28 Flagellum genes Liu and 
Matsumura, 
1995 
*Present in B. subtilis. All others are in E. coli 
*N=A, T, C or G 
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from the core RNAP upon the transition from initiation to elongation process 
(Mukhopadhyay et al., 2001). 
 
1.8.1.2 Transcription termination 
 
Bacteria use two different strategies to regulate the gene expression at the level of 
transcription termination; rho-independent or intrinsic termination and rho-
dependent termination (Henkin and Yanofsky, 2002).  
 
1.8.1.2.1 Rho-independent termination 
 
Intrinsic terminators, which are hypothesized to play a major role in the 
transcriptional attenuation mechanism described above, are encoded in the 
genome of most prokaryotes and are used to signal transcription termination at the 
end of a gene and as control elements in the attenuators that are found just 
downstream of the promoters (Greenblatt, 2008). These terminators consist of a 
GC rich hairpin in the secondary structure followed by a series of uridine residues 
(d’ Aubenton Carafa et al., 1990). In intrinsic termination, the RNA transcribed from 
the inverted palindrome DNA template folds into a stable hairpin, thus favouring 
the RNA-RNA interaction over the RNA-DNA interaction that normally occurs during 
transcription elongation (Figure 1.9). The hairpin is thought to interact with the 
transcribing RNAP, causing it to pause at the terminator site. The elongation factor,
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Figure 1.9 Intrinsic or rho-independent termination. Dashed arrows show inverted repeat 
sequences, that when transcribed into RNA, fold into a stable hairpin structure with a stem 
and a  loop. This structure is normally followed by a series of uridine (U) residues. 
Interaction between the hairpin structure and the transcribing RNAP leads to pausing of 
the RNAP. The U residues downstream of the structure destabilises the RNA-DNA hybrid 
during the pausing time, allowing the transcription complex to disassemble and terminates 
the transcription.  
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NusA that bound to the RNAP stabilises this interaction, thus increases the pausing 
time and creates an opportunity for termination to occur. The downstream uridine 
residues destabilise the RNA-DNA hybrid when RNAP pauses at the hairpin. The rU-
dA interactions are extremely unstable and less energy is required for dissociation 
of this RNA-DNA hybrid. When the RNAP pauses at the hairpin structure, the weak 
rU-dA terminal region unwind hence terminates the transcription completely (Krebs 
et al., 2010).  
 
1.8.1.2.2 Rho-dependent termination 
 
 
In rho-dependent termination, a protein called rho factor is required to terminate 
the RNA synthesis at the termination sites. Rho factor is a hexameric ATP-
dependent helicase (Platt and Richardson, 1992) that binds to the specific 
recognition sequences in RNA called rho utilization (rut) site and tracks along the 
RNA in a 3’ direction until it catches up the RNAP. The rut site is identified as a 
cytosine-rich sequence, approximately 70-80 bp in length and has no secondary 
structure (Guérin et al., 1998). Once the RNAP reaches the termination site, it 
pauses and allows time for the rho protein to translocate to the RNA-DNA hybrid 
region and starts to unwind the hybrid at the active site of RNAP, causing 
dissociation of the RNA transcript. Figure 1.10 illustrates the mechanism of rho-
dependent termination. 
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Figure 1.10 Mechanisms of rho-dependent termination. Rho factor binds to the rho-
utilization site (rut) on mRNA and moved along the transcript in a 3’ direction. At the 
terminator stem loop structure, the Rho factor is able to catch up the paused RNAP. 
Rho then unwinds the RNA-DNA hybrid in the transcription bubble which results in 
the disassociation of all components hence terminate the transcription.  
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1.8.1.2.3  Transcription attenuation 
 
Other mechanism used by bacteria to control the gene expression is attenuation. 
Attenuation causes premature termination of RNA transcription at the beginning of 
a transcription unit (Naville and Gautheret, 2009). This mechanism which is 
controlled by external events are responsible in regulating the formation of the 
hairpin needed for transcription termination. At present, a number of attenuation 
mechanisms have been identified and these include the attenuation-based RNA 
thermometers, riboswitches, T-boxes, amino acid operon leaders and by RNA-
protein interactions (Figure 1.11) (Naville and Gautheret, 2009). 
 
In the attenuation-based RNA thermometers system, bacteria regulate gene 
expression using RNA sequences that change their conformation in response to 
temperature. The three major temperature-responsive genes classes that have 
been identified are virulence genes, heat shock genes and cold shock genes (Naville 
and Gautheret, 2009; Kortmann and Narberhaus, 2012). At low temperature, the 
RNA thermometers fold into a structure that entirely or partially includes the 5’ 
untranslated region (5’ UTR) of an mRNA, thus control the accessibility of ribosomes 
for the Shine-Dalgarno sequence. As the temperature gradually shifts, the 
terminator structure melts, and permits ribosome access thereby increasing the 
efficiency of translation initiation.  
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Figure 1.11 Mechanisms of transcription attenuation in bacteria. (A) Riboswitch. Small 
ligands bind directly to the RNA aptamer. The concentration of ligand decides whether the 
riboswitch should fold into a terminator (red) or and antiterminator structure (dashed 
arrow). (B) T-box. The specific uncharged tRNA interacts with the T-box and leads to the 
formation of antiterminator structure (dashed arrow). The charged tRNA is unable to bind 
to the T-box, thus the terminator (red) forms. (C) Amino acid operon leaders. The 
alternative folding into a terminator (red) or an antiterminator (dashed arrow) is 
determined by the translation rate of the ORF (short arrow) which in turn depends on the 
concentration of the corresponding charged tRNAs available. (D) RNA-protein interactions. 
The alternative terminator/antiterminator folding is controlled by  interaction with and 
RNA-binding protein. (Adapted from Naville and Gautheret, 2009)  
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Riboswitches are complex folded RNA domains that undergo allosteric structural 
changes in response to particular metabolites, leading to premature transcription 
termination. Riboswitches can detect a variety of metabolites which include amino 
acids and derivatives, nucleotides and derivatives (Sudarsan et al., 2008), sugars, 
vitamin cofactors (Regulski et al., 2008) and metal ions (Dann et al., 2007). These 
regulatory elements comprise of a receptor (aptamer) which is the metabolite-
binding domain and an expression platform that undergo conformational switch in 
response to the changes in the aptamer (Narberhaus et al., 2005). Most 
riboswitches have an inhibitory effect in the bound state, although in certain 
instances, metabolites binding leads to the formation of a structure that interferes 
with the terminator (Mandal and Breaker, 2004).  
 
T-boxes regulate gene expression using uncharged tRNA as the signal molecule for 
structural shift. T-boxes are normally found in the 5’ UTR of genes concerned with 
aminoacyl-tRNA synthetases, or related amino acid metabolism in Gram-positive 
bacteria, especially Firmicutes (Vitreschak et al., 2008). These elements can fold 
into two alternative hairpin structures, an intrinsic transcription terminator that 
results in a premature termination or an antiterminator that allows continued 
transcription into the downstream genes. The specific pairing of T-box and an 
uncharged tRNA stabilises the alternate antiterminator structure, thereby 
preventing transcription termination (Gutiérrez-Preciado et al., 2009). 
Antitermination forms when there is high level of uncharged tRNA, which leads to 
an increase in the concentrations of charged tRNA for protein synthesis.  
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Transcription attenuation by the amino acid operon leaders involves the leader 
peptide as the sensor element which can fold to form two alternative hairpin 
structures, a terminator or an antiterminator (Henkin and Yanofsky, 2005). This 
leader peptide contains codons for a specific amino acid and is located between the 
TSS and the start of the first structural gene. The terminator is formed when there 
is excess amino acids and therefore of the charged cognate tRNAs in the cell. This 
leads to ribosomal read-through and an efficient translation of the leader peptide, 
which prevent the formation of antitermination. Alternatively, a shortage of 
charged tRNA in the cell causes ribosome to pause on the leader peptide, thus 
lagging behind the transcribing RNAP. This leads to the formation of a terminator 
and subsequent transcription termination (Naville and Gautheret, 2009). As this 
system exploits the ribosome as a mediator to sense the charged tRNA, it is 
therefore known as ribosome-mediated transcription attenuation (Lyubetskaya et 
al., 2003; Merino and Yanofsky, 2005) and examples of resistance genes that are  
regulated by this mechanism are the chloramphenicol (cat) (Lovett, 1990; Moffat et 
al., 1994) and erythromycin (erm) (Gryczan et al., 1980; Min et al., 2008) genes. 
 
The transcription attenuation mediated by the RNA-protein interactions is differ 
from the previous attenuation mechanism in such a way that the decision to 
terminate transcription or to read-through into the structural genes is determined 
by the sequence specific RNA-binding proteins. An excess of amino acid activates 
the RNA-binding protein, leading to its binding to the 5’ antiterminator hairpin. The 
free 3’ segment concurrently paired with the adjacent RNA segment and form a 
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terminator and so the transcription halts in the leader region. Instead, under 
conditions of limiting amino acid, the RNA-binding protein does not bind to the 
nascent RNA transcript, therefore an antiterminator is formed, allowing 
transcription of the downstream structural genes (Gollnick and Babitzke, 2002).  
 
1.8.1.2.4 Tryptophan (trp) operon 
 
The tryptophan (trp) operon, was first described by Yanofksy (1981) is a group of 
structural genes that regulate the biosynthesis of tryptophan in the cell. This 
operon contains a 162 bp leader sequence that lies between the transcription start 
site (TSS) and the start of the structural gene, trpE (Figure 1.12 A). The leader 
sequence is able to form several alternative base-paired conformations under 
different conditions as illustrated in Figure 1.12 B. In between the leader peptide, 
they are two tryptophan codons that require the presence of tryptophan within the 
cell to be incorporated into the peptide.  
 
When tryptophan is absent or limited, the ribosomes stall at the trp codons which is 
part of region 1. The presence of ribosomes at this point sequesteres region 1, thus 
preventing it from base-pairing with region 2. This means that region 2 is able to 
form a stem-loop structure by base-pairing with region 3. As this structure is not a 
terminator, the transcription is continues to express the trp operon.  
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In the presence of sufficient tryptophan, ribosomes are able to proceed through the 
leader peptide until they reach the stop codon, which lies between regions 1 and 2. 
As the ribosomes occupy this position, region 2 is therefore prevented from 
forming a stem-loop structure with region 3. This allows regions 3 and 4 to form a 
termination stem-loop and leads to transcriptional termination. The presence of 
tryptophan therefore prevents the expression of the trp operon. 
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Figure 1.12 Transcriptional attenuation in the trp operon. A. Organisation of the trp operon 
of E. coli. The trp operon consists of structural genes preceded by a control region including 
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attenuator. The leader peptide of trp operon consists of 14 amino acids, with two 
successive codons for tryptophan (single letter codes: M: methionine; K: lysine; A: alanine; 
I: isoleucine; P: proline; V: valine; L: leucine; G: glycine; W: tryptophan; R: arginine; T: 
threonine and S: serine. B. Attenuation of trp operon. The four regions can base pair. 
Region 1 complementary to region 2, which is complementary to region 3, which is 
complementary to region 4.  (I) In the absence of protein synthesis, conformations 1:2 and 
3:4 are able to form, thus lead to transcriptional termination. (II) When tryptophan is 
limited, ribosome stalls at the Trp codons, and thus region 1 cannot base pair with region 2. 
This allows region 2 and region 3 to base pair, preventing the terminator hairpin from 
forming, allowing RNA polymerase to read through the attenuator and continues the 
transcription. (III) When tryptophan is abundant, ribosomes are able to synthesise the 
leader peptide, and proceed to the UGA codon within region 1 and region 2, thus 
preventing it from base pairing with region 3. The terminator hairpin forms via base pairing 
between the free-region 3 and region 4. Under this condition, the RNA polymerase 
terminated at the attenuator. (Copied from Dale and Park, 2010) 
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1.9 Aims of the study 
 
The aim of this study was to investigate the behaviour of the conjugative 
transposons Tn916 and Tn5397, focusing on the transcriptional regulation and 
transfer. Specific aims are to: 
 
1. investigate the role of orf12 in the regulation of Tn916 
2. investigate the activity of the promoter Ptet(M) in Tn916 and Tn5397 
3. determine the termination efficiency of terminators in Tn916  
4. investigate the transfer of Tn5397 between Clostridium difficile and 
Enterococcus faecalis 
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2 Materials and Methods 
 
This chapter outlined the materials and methods that are used throughout the 
project. The specific materials and methods are outlined at the beginning of the 
relevant chapter. 
 
2.1 Sources of media, enzymes and reagents 
 
Luria-Bertani (LB) agar and broth were obtained from Difco (Oxford, UK). Brain 
heart infusion (BHI) agar and broth and the Clostridium difficile selective 
supplement (CDSS) (D-cycloserine and cefoxitin) were obtained from Oxoid Ltd 
(Basingstoke, UK). All antibiotics were obtained from Sigma-Aldrich (Poole, UK) and 
were used at a concentration of 5 µg ml-1 (fusidic acid, Fa), 10 µg ml-1 (tetracycline, 
Tc; chloramphenicol, Cm; and erythromycin, Em), 25 µg ml-1 (rifampicin, Rif) and 
100 µg ml-1 (ampicillin, Amp), unless stated otherwise. All restriction enzymes were 
obtained from New England Biolabs (NEB) Ltd (Hertfordshire, UK). Defibrinated 
horse blood was obtained from E & O Laboratories (Scotland, UK).  
 
2.2 Bacterial strains, plasmids and transposons 
 
All bacterial strains, plasmids and transposons used in this study are listed in Table 
2.1 and Table 2.2. Bacterial strains, plasmids and transposons were obtained from 
UCL Eastman Dental Institute.  
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Table 2.1 Bacterial strains used in this study 
Bacterial strains Characteristics Resistance 
marker 
Reference/source 
C. difficile 630 Contains Tn5397 and Tn5398, 
donor strain 
Emr, Tcr Hachler  et al. 1987 
 
C. difficile R20291 
 
Ribotype 027, recipient strain 
 
Emr 
 
Anaerobe Reference 
Laboratory, Cardiff, UK 
 
C. difficile CD37 
 
Recipient strain 
 
Rifr 
 
Wust and Hardegger, 
1983 
 
E. faecalis JH2-2 
 
Recipient strain 
 
Far, Rifr 
 
Jacob and Hobbs, 1974 
 
E. faecalis EF20A 
 
Transconjugant  
(CD 630 x EF JH2-2) 
 
Tcr, Far, 
Rifr 
 
This study 
 
E. coli (α-select 
bronze efficiency) 
 
Competent cells 
 
Ampr 
 
Bioline (London, UK) 
 
B. subtilis BS34A 
 
Contains Tn916 
 
Tcr 
 
Roberts et al. 2003 
 
B. subtilis BS59A 
 
Contains Tn916ΔE 
 
Emr 
 
Hussain et al. 2005 
 
B. subtilis BS79A 
 
Contains Tn916Δorf12 
 
Tcr 
 
This study 
 
B. subtilis BS80A 
 
Contains Tn916 and 
pHCMCO5/Tn916 Ptet(M) WT 
 
Tcr, Cmr 
 
This study 
 
B. subtilis BS81A 
 
Contains Tn916 and 
pHCMCO5/Tn916 Ptet(M) PO 
 
Tcr, Cmr 
 
This study 
 
B. subtilis BS82A 
 
Contains Tn916 and 
pHCMCO5/Tn916 Ptet(M) ST 
 
Tcr, Cmr 
 
This study 
 
B. subtilis BS83A 
 
Contains Tn916 and 
pHCMCO5/(-)Ptet(M)  
 
Tcr, Cmr 
 
This study 
 
B. subtilis BS84A 
 
Contains Tn916 and 
pHCMCO5/Tn5397 Ptet(M) WT 
 
 
 
Tcr, Cmr 
 
This study 
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Bacterial strains Characteristics Resistance 
marker 
Reference/source 
B. subtilis BS85A Contains Tn916 and 
pHCMCO5/Tn5397 Ptet(M) PO 
Tcr, Cmr This study 
 
B. subtilis BS86A 
 
Contains Tn916 and 
pHCMCO5/Tn5397 Ptet(M) ST 
 
Tcr, Cmr 
 
This study 
 
B. subtilis BS87A 
 
Contains Tn916 and pHCMCO5/ 
Ptet(M) ST I 
 
Tcr, Cmr 
 
This study 
 
B. subtilis BS88A 
 
Contains Tn916 and pHCMCO5/ 
Ptet(M) LT I 
 
Tcr, Cmr 
 
This study 
 
B. subtilis BS89A 
 
Contains Tn916 and pHCMCO5/ 
Ptet(M) ST II 
 
Tcr, Cmr 
 
This study 
 
B. subtilis BS90A 
 
Contains Tn916 and pHCMCO5/ 
Ptet(M) LT II 
 
Tcr, Cmr 
 
This study 
 
B. subtilis BS91A 
 
Contains Tn916 and pHCMCO5/ 
Ptet(M) LTST II 
 
Tcr, Cmr 
 
This study 
 
B. subtilis BS92A 
 
BS34AΔamyE, contains Tn916  
 
Tcr, Cmr 
 
This study 
 
 
Abbreviations: Emr, Erythromycin-resistant; Tcr, tetracycline-resistant; Rifr, rifampicin-resistant; 
Far, fusidic acid-resistant; Ampr, ampicillin-resistant, Cmr, chloramphenicol-resistant; Ptet(M) 
WT, wild type promoter construct; Ptet(M) ST, start codon promoter construct; Ptet(M) PO, 
promoter only construct; (-) Ptet(M), promoter-less construct; Ptet(M) LT, large terminator 
construct; Ptet(M) ST, small terminator construct; Ptet(M) LTST, large and small terminators 
construct. 
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Table 2.2 Plasmids and conjugative transposons used in this study 
Plasmids/transposons Characteristics Resistance 
marker 
Reference/source 
 
pUC19 
 
Cloning vector 
 
Ampr 
 
Yanisch-Perron et al. 
1985 
 
pGEM-T Easy 
 
Cloning vector 
 
Ampr 
 
Promega 
(Southampton, UK) 
 
pAPR108 
 
pGEM-T Easy/Tn916 
fragment 
 
Ampr, Tcr 
 
This study 
 
pAPR109 
 
pGEM-T Easy/ 
Tn916Δorf12 fragment 
 
Ampr, Tcr 
 
This study 
 
pHCMCO5 
 
Shuttle vector 
 
Ampr,Cmr 
 
Bacillus Genetic Stock 
Center, Ohio, USA 
 
pHCMCO5-lacO/Pspac 
 
Shuttle vector 
 
Ampr,Cmr 
 
This study 
 
pHCMCO5-Ptet(M) 
 
Shuttle vector 
 
Ampr,Cmr 
 
This study 
 
pHCMCO5/Tn916 
Ptet(M) WT 
 
Expression vector 
 
Ampr,Cmr 
 
This study 
 
pHCMCO5/Tn916 
Ptet(M) PO 
 
Expression vector 
 
Ampr,Cmr 
 
This study 
 
pHCMCO5/Tn916 
Ptet(M) ST 
 
Expression vector 
 
Ampr,Cmr 
 
This study 
 
pHCMCO5/(-)Ptet(M) 
 
Expression vector 
 
Ampr,Cmr 
 
This study 
 
pHCMCO5/Tn5397 
Ptet(M) WT 
 
Expression vector 
 
Ampr,Cmr 
 
This study 
 
pHCMCO5/Tn5397 
Ptet(M) PO 
 
Expression vector 
 
Ampr,Cmr 
 
This study 
 
pHCMCO5/Tn5397 
Ptet(M) ST 
 
Expression vector 
 
Ampr,Cmr 
 
This study 
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Plasmids/transposons Characteristics Resistance 
marker 
Reference/source 
 
pHCMCO5/ Ptet(M) ST I 
 
Expression vector 
 
Ampr,Cmr 
 
This study 
 
pHCMCO5/ Ptet(M) LT I 
 
Expression vector 
 
Ampr,Cmr 
 
This study 
 
pHCMCO5/ Ptet(M) ST II 
 
Expression vector 
 
Ampr,Cmr 
 
This study 
 
pHCMCO5/ Ptet(M) LT II 
 
Expression vector 
 
Ampr,Cmr 
 
This study 
 
pHCMCO5/ Ptet(M) LTST 
II 
 
Expression vector 
 
Ampr,Cmr 
 
This study 
 
pDL 
 
Integration  vector 
 
 
Ampr,Cmr 
 
Bacillus Genetic Stock 
Center, Ohio, USA 
 
pDLΔbgaB 
 
Integration vector 
 
Ampr, Cmr 
 
This study 
 
pUC19-Pcwp2-GusA 
 
Cloning vector 
 
Ampr 
 
Emerson et al. 2009 
 
pUC19-GusA 
 
Cloning vector 
 
Ampr 
 
This study 
 
pUC19-Ptet(M)-GusA 
 
Cloning vector 
 
Ampr 
 
This study 
 
Tn916 
 
Conjugative transposon 
 
Tcr   
 
Franke and Clewell, 
1981 
 
Tn916ΔE 
 
Conjugative transposon, 
Tn916 containing ermB 
gene 
 
Emr   
 
Rubens and Heggen, 
1988 
 
Tn5397 
 
Conjugative transposon 
 
Tcr 
 
Mullany et al. 1990; 
Mullany et al. 1996 
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2.3 Growth conditions 
 
All bacteria were grown at 37oC unless stated otherwise. Escherichia coli was grown 
on LB agar or in LB broth. Bacillus subtilis strains and Enterococcus faecalis were 
grown on BHI agar or in BHI broth. All bacterial cultures were incubated under 
shaking condition (200 rpm). C. difficile was grown on BHI agar supplemented with 
5% (v/v) defibrinated horse blood and in pre-reduced BHI broth. C. difficile was 
incubated in an anaerobic chamber (Don Whitley Scientific Ltd, Shipley, UK) with an 
atmosphere of 80% nitrogen, 10% hydrogen and 10% carbon dioxide. All media 
were supplemented with appropriate antibiotics unless stated otherwise. Media 
components are listed in Appendix B. 
 
2.4 Storage of bacterial strains 
 
All bacterial stocks were maintained in 1 ml aliquots of 10% (v/v) sterilised glycerol 
at -80oC (Sambrook et al., 1989). 
 
2.5 Molecular biology techniques 
 
2.5.1 Plasmid DNA purification 
 
Plasmid DNA purification was carried out using QIAprep Spin Miniprep Kit (Qiagen, 
Crawley, UK). This protocol was designed for purification of up to 20 µg of high copy 
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plasmid DNA from 1-5 ml overnight cultures of E. coli in LB medium. All 
centrifugation steps were carried out at 17,900 x g (13,000 rpm) in a table-top 
microcentrifuge. The bacterial cells were pelleted and the supernatant discarded. 
The pelleted cells were resuspended in 250 µl of Buffer P1 and transferred to a 
microcentrifuge tube. Buffer P2 (250 µl) was then added and the tube was inverted 
gently for 4-6 times. 350 µl of Buffer N3 was added to the mixture, and again the 
tube was immediately inverted 4-6 times. The tube was centrifuged for 10 min and 
the supernatants were applied to the QIAprep spin column by decanting or 
pipetting. The spin column was centrifuged for 1 min and the flow-through 
discarded. The spin column was washed by adding 750 µl of Buffer PE and 
centrifuging for 1 min. The flow-through was discarded and the spin column was 
centrifuged for an additional minute to remove residual wash buffer. The QIAprep 
spin column was then placed in a clean 1.5 ml microcentrifuge tube. The DNA was 
eluted by adding 30-50 µl of Buffer EB (10 mM Tris-Cl, pH 8.5) or distilled water to 
the centre of the spin column membrane, left to stand for 1 min at room 
temperature (25oC) and centrifuged for 1 min. The plasmid DNA was ready for 
further applications. 
 
2.5.2 Genomic DNA purification 
 
Genomic DNA purification was carried out using the PUREGENE DNA Purification 
Kit (Gentra Systems, Minneapolis, USA) with slight modifications. This protocol was 
designed for DNA purification of 0.5 ml bacterial culture, with an expected yield of 
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3-30 µg DNA. All centrifugation steps were carried out at 17,900 x g (13,000 rpm) in 
a table-top microcentrifuge. The overnight culture was briefly placed on ice prior 
centrifugation for 1 min. The supernatant was removed as much as possible using 
pipet. The pelleted cell was resuspended in 300 µl of Cell Suspension Solution. 1.5 
µl of Lytic Enzyme Solution was added and the tubes were inverted 25 times. The 
tubes were incubated at 37oC for 30 min to digest the cell walls. Samples were 
inverted occasionally during the incubation. The cells were centrifuged for 1 min 
and the supernatant discarded. The cell pellet was resuspended in 300 µl of Cell 
Lysis Solution and heated at 80oC for 5 min to complete cell lysis. This was followed 
by RNase treatment, where 1.5 µl of RNase A Solution was added to the cell lysate. 
Sample was mixed by inverting the tube 25 times and incubating at 37oC for 15-60 
min. Subsequently, sample was cooled to room temperature (approximately 10-15 
min) prior to addition of 100 µl of Protein Precipitation Solution. Sample was 
vortexed vigorously at high speed for 20 sec to ensure even mixing and centrifuged 
for 3 min. After this step, the precipitated proteins should be visible as a tight white 
pellet. The supernatant containing the DNA was poured into a clean 1.5 ml 
microcentrifuge tube containing 300 µl 100% isopropanol. Sample was mixed by 
inverting the tube 50 times and centrifuged for 1 min. The DNA should be visible as 
a small white pellet after centrifugation. Supernatant was poured off and the tube 
was briefly drained on a clean absorbent paper. 300 µl of 70% ethanol was added 
and the tube was inverted several times to wash the DNA pellet. The tube was 
centrifuged for 1 min and supernatant discarded. The DNA pellet was air dried for 
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10-15 min and re-dissolved overnight at room temperature (25oC) in 100 µl of DNA 
Hydration Solution or sterile distilled water.  
 
2.5.3 DNA extraction from agarose gel 
 
DNA extraction from agarose gel was carried out using QIAquick Gel Extraction Kit 
from Qiagen, Crawley, UK. This protocol was designed for DNA extraction of up to 
10 µg. All centrifugation steps were carried out at 17,900 x g (13,000 rpm) in a 
table-top microcentrifuge. The DNA fragment was excised from the agarose gel 
with a clean and sharp scalpel. The gel slice was weighed in a colourless tube. 3 
volumes of Buffer QG was added to 1 volume gel (100 mg ~ 100 µl) and incubated 
at 50oC until the gel slice completely dissolved. Mixture was vortexed occasionally 
during this incubation to help dissolve the gel slice. 1 volume of isopropanol was 
then added and mixed by inverting the tube several times. A QIAquick spin column 
was placed into a provided 2 ml collection tube. Sample was applied to the spin 
column and centrifuged for 1 min to bind the DNA. The flow-through was discarded 
and the spin column was placed back into the same tube. 0.75 ml of Buffer PE was 
added to the spin column and centrifuged for 1 min to wash the DNA. The flow-
through was discarded and once more, the spin column was placed back into the 2 
ml collection tube and centrifuged for an additional 1 min to remove the residual 
wash buffer. The spin column was placed into a clean 1.5 ml microcentrifuge tube. 
The DNA was eluted by adding 30 µl of Buffer EB (10 mM Tris-Cl, pH 8.5) or sterile 
distilled water to the centre of the QIAquick membrane, left to stand for 1 min at 
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room temperature (25oC) and centrifuged for 1 min. The DNA was ready for further 
applications. 
 
2.5.4 PCR purification 
 
PCR purification was carried out using QIAquick PCR Purification Kit (Qiagen, 
Crawley, UK). This protocol was designed to purify single or double stranded DNA 
fragments from PCR and other enzymatic reactions. All centrifugation steps were 
carried out at 17,900 x g (13,000 rpm) in a table-top microcentrifuge. 5 volumes of 
Buffer PB was added to 1 volume of the PCR sample and mixed. The QIAquick spin 
column was placed into a provided 2 ml collection tube. Sample was applied to the 
spin column and centrifuged for 1 min to bind the DNA. The flow-through was 
discarded and the spin column was placed back into the same collection tube. 0.75 
ml of Buffer PE was added and centrifuged for 1 min. The flow-through was 
discarded and once more, the spin column was placed back into the 2 ml collection 
tube and centrifuged for an additional 1 min to remove the residual wash buffer. 
The spin column was placed into a clean 1.5 ml microcentrifuge tube. The DNA was 
eluted by adding 30 µl of Buffer EB (10 mM Tris-Cl, pH 8.5) or sterile distilled water 
to the centre of the QIAquick membrane, left to stand for 1 min at room 
temperature (25oC) and centrifuged for 1 min. The DNA was ready for further 
applications. 
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2.5.5 Agarose gel electrophoresis 
 
DNA fragments were mixed with 0.1 volume of loading buffer (Appendix A) and 
were separated on 1-2% (w/v) agarose (Bioline, London, UK) gel electrophoresis. 
Gels were prepared to the relevant percentage in 1X TAE (tris-acetate-EDTA) buffer. 
The electrophoresis was run for 30-45 min at 50-100 V. The HyperLadder I (Bioline, 
London, UK) and 1 kb marker (NEB,UK) were used as a size reference. Nucleic acid 
was stained either with GelRed (Biotium Inc, Cambridge, UK) or ethidium bromide 
(Promega, Southampton, UK), both at a concentration of 0.5 µg ml-1. The nucleic 
acid was visualised using a UV transilluminator (320 nm). Gel images were produced 
using AlphaImager equipment and computer software (Innotech Corporation, UK).  
 
2.5.6 Restriction endonuclease reactions 
 
DNA was digested using restriction enzymes (NEB, Hertfordshire, UK) according to 
the manufacturer’s instructions. All restriction endonuclease reactions were carried 
out at 37oC unless stated otherwise.  
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2.5.7 DNA ligation reactions 
 
Ligation of DNA was carried out using either T4 DNA ligase or Quick T4 DNA ligase 
(NEB, Hertfordshire, UK) according to the manufacturer’s instructions. Ligation was 
carried out using a molar ratio of 1:3 vector to insert. The ligation mixture was 
incubated overnight at 4oC with regular T4 DNA ligase or incubated for 10 min at 
room temperature (25oC) with Quick T4 DNA ligase, dependent on the requirement 
of the experiment.  
 
2.5.8 Dephosphorylation reactions 
 
Dephosphorylation was carried out to remove the 5’-phosphate groups from each 
end of the linearised vector to minimize the self-ligation of the vector during 
cloning. The linearised vector (1 µg) was incubated with 0.01 U pmol-1 of Calf 
Intestinal Alkaline Phosphatase (CIAP) and 5 µl of CIAP 10X Reaction Buffer for 30 
min at 37oC. Dephosphorylation mixture was set up in 50 µl reaction. After 30 min 
incubation, an equivalent amount of CIAP previously used was added to the 
reaction mixture and incubation continued for an additional 30 min. 
Dephosphorylation was stopped with the addition of 0.5 mM 
ethylenediaminetetraacetic acid (EDTA) and incubated at 75oC for 10 min. 
Subsequently, the dephosphorylated vector was purified using QIAquick PCR 
Purification Kit (Qiagen, Crawley, UK) and ready for further applications. 
70 
2.5.9 Preparation of B. subtilis competent cells 
 
The B. subtilis competent cells were prepared according to the protocol described 
by Hardy (1985).  A single colony from a fresh overnight plate was inoculated into 
10 ml SPI broth (Appendix A) in a 200 ml conical flask. The culture was incubated 
overnight with shaking (200 rpm) at 30oC. A 10 ml of the overnight culture was then 
transferred to the 100 ml fresh pre-warmed SPI medium in a 1 L flask and grown at 
37oC with shaking (200 rpm) until the rate of increase in the OD600 decreased. At 
the end of the logarithmic growth, a 10 ml of this culture was transferred to the 90 
ml SPII broth (Appendix A) and the culture was incubated for 1.5 h at 37oC under 
shaking condition (200 rpm). Cells were harvested by centrifugation at 3,000 x g 
(5,000 rpm) for 10 min at 20oC. The cells were resuspended in 10 ml supernatant, to 
which sterile glycerol had been added to 10% (v/v). Aliquots of 500 µl were 
dispensed on ice and the cells frozen and stored at -80oC until required.  
 
2.5.10 Transformation of B. subtilis 
 
The aliquots of B. subtilis competent cells were quickly thawed at 37oC and were 
added to a 50 ml conical tube containing 0.5 µg DNA. The tube was incubated at 
37oC for 1 h under gentle agitation (50 rpm). 5 ml of LB broth was then added 
followed by a further 1.5 h incubation at 37oC with shaking (200 rpm). Aliquots of 
100 µl was spread onto BHI agar supplemented with appropriate antibiotics. The 
remaining cells were spun down at 3,000 x g (5,000 rpm) for 10 min and 
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supernatant discarded. The pelleted cells were resuspended in 100 µl of fresh LB 
medium and spread onto BHI agar supplemented with appropriate antibiotics. All 
plates were incubated overnight at 37oC for 24-48 h.  
 
2.5.11 Transformation of E. coli  
 
E. coli transformation was carried out using competent cells “α-select bronze 
efficiency” (Bioline, London, UK). 100-1000 pg of DNA was added to a 100 µl aliquot 
of cells and mixed gently by tapping the tube. The cells were incubated on ice for 30 
min prior heat shock treatment by placing them in a 42oC water bath for 45 sec. The 
cells were placed back on ice for 2 min. 900 µl of SOC medium (Appendix A) was 
added to the cells and incubated at 37oC for 1 h with shaking condition (200 rpm). 
Aliquots of 100 µl was spread onto LB agar supplemented with appropriate 
antibiotics. The remaining cells were spun down at 3,000 x g (5,000 rpm) in a table-
top microcentrifuge for 10 min and supernatant discarded. The pelleted cells were 
resuspended in 100 µl of fresh LB medium and spread onto LB agar supplemented 
with appropriate antibiotics. All plates were incubated overnight at 37oC.  
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2.5.12 Blue/white colour screening 
 
Ligated DNA was transformed into E. coli α-select bronze efficiency. Transformants 
containing recombinant plasmids were selected for on LB agar containing 100 µg 
ml-1 ampicillin, 40 µg ml-1 chromogenic substrate 5-bromo-4-chloro-indolyl-β-D-
galactopyranoside (X-Gal) and 0.1 M non-metabolisable lacZ inducer isopropyl--D-
thiogalactoside (IPTG). Plates were incubated overnight at 37oC. White colonies, 
which indicate the presence of recombinant plasmids were selected for further 
investigation.  
 
2.5.13 Oligonucleotides synthesis 
 
All oligonucleotides were synthesised by Sigma-Aldrich (Poole, UK). Sequences of all 
primers used throughout this study were listed in Table 2.3.  
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Table 2.3 Primers used throughout this study 
Primers Sequence (5’→ 3’) Amplicon 
AJ1 CTGGCAACAGCATTTAGTGG 4.1 kb Tn916 fragment 
AJ4 TTTTTATTGGCGTTTAGTAGTG 4.1 kb Tn916 fragment 
AJ15 GAATATCTGTGCGCTTTGTATGCC 4.0 kb Tn916 fragment 
(Δorf12) 
AJ16 TCCGGATACTTTAGAATCACATGAT 4.0 kb Tn916 fragment 
(Δorf12) 
CTn9824F GAAAACTTTAGTGATTGGTGG orf14 junction in Tn916 
CTn13562 GGGATACGCTATGGTTGTG orf9 junction in Tn916 
O10R CCCGTCATTCACATAGTAGG orf14 junction in Tn916 
O14R GATGTACTTCATGGCCGACG orf9 junction in Tn916 
catF GAGTTTTATGATTTATACCTTTCTG cat : amyE junction 
catR AGGTATAAATCATAAAACTCTTTGA cat : amyE junction 
ycgB TTCTTCTTTTTATCGTCTGCGGCGG cat : amyE junction 
ldh CCGTAAGATGTTTTGACCGGTTGTG cat : amyE junction 
tetM F GCTCAATGTTGATGCAGGAA tet(M) fragment 
tetM R TATATATGCAAGACGCTGTCT tet(M) fragment 
Ptet(M) For GGCGGCGGGTACCCAAAGCAACGCAGGTATCTC Ptet(M) Tn916 fragment 
Ptet(M) Rev GGCGGCGGAATTCGTGATTTTCCTCCAT Ptet(M) Tn916 fragment 
Ptet(M) 
For5397 
GGCGGCGGGTACCCAAAGCAACGCAAGTATCTC Ptet(M) Tn5397 fragment 
Ptet(M) 
Rev5397 
GGCGGCGGAATTCTCAGGTGATTTTCCTCCAT Ptet(M) Tn5397 fragment 
For916 ST GAATATCTGTGCGCTTTGTATGCC Tn916 start codon 
promoter construct 
Rev916 ST TCCGGATACTTTAGAATCACATGAT Tn916 start codon 
promoter construct 
For916 PO ATGGAGGAAAATCACGAATTCCTGC Tn916 promoter only 
construct 
Rev916 PO ACAGATATTCTCCGGATACTTTAGA Tn916 promoter only 
construct 
For5397 ST GGTTAGTTTTGGCGTACCCAGTGAT Tn5397 start codon 
promoter construct 
Rev5397 ST CCTCCTAAAAAGGGACATCTAATT Tn5397 start codon 
promoter construct 
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Primers Sequence (5’→ 3’) Amplicon 
For5397 PO ATGGAGGAAAATCACGAATTCCTGC Tn5397 promoter only 
construct 
Rev5397 PO GGCGGCGGAATTCTAATTATTTGTTCCCACTATC Tn5397 promoter only 
construct 
LT For ATCCCAGTGATAAGAGTATTTATCACTGGGATTTT 
TATGGAGGAAAATC 
Tn916 large terminator 
construct (set I) 
LT Rev AAAAATCCCAGTGATAAATACTCTTATCACTGGG 
ATACAGATATTCTCCG 
Tn916 large terminator 
construct (set I) 
LT II For TTATCACTGGGACGGTCATGCCCTTTTGGG Tn916 large terminator 
construct (set II) 
LT II Rev ATACTCTTATCACTGGGATTTTTATGCATA Tn916 large terminator 
construct (set II) 
ST For GCCCTTTTGGGCTTTTATGGAGGAAAATCA Tn916 small terminator 
construct (set I) 
ST Rev AAAAGCCCAAAAGGGCACAGATATTCTCCG Tn916 small terminator 
construct (set I) 
ST II For TGCCCTTTTGGGCCGGCGAATGGAGGAAAA Tn916 small terminator 
construct (set II) 
ST II Rev TAAAAATCCCAGTGATAAATACTCTTATCA Tn916 small terminator 
construct (set II) 
LTST Rev TGACCGTCCCAGTGATAAATACTCTTATCA Tn916 small and large 
terminator construct (set 
II) 
LEO CCACTTGATATGAAAAATCAAATGGCTC sspPCR, CI*, left end 
transposon:genome 
junction 
REO     ACGTGTATCAAGCAGAGGGAATCGGTAAA 
 
sspPCR, CI*, right end 
transposon:genome 
junction 
TndX  (F300) 
 
CTTTAGGGAAAATAACTGAT 
 
1.6 kb fragment of tndX 
TndX (F30)         CTTACAATGTTAAAACAGCAAGC 1.6 kb fragment of tndX 
PTS  (For) 
 
GTGTCAATGACCGCAGAAGA Chromosomal target site, 
left end 
transposon:genome 
junction 
*Circular intermediate 
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Primers Sequence (5’→ 3’) Amplicon 
PTS (Rev) 
 
TCGCTAGAATGACCTGTAGAAGAA Chromosomal target site, 
left end 
transposon:genome 
junction 
M13 For GTAAAACGACGGCCAGT SSPPCR 
M13 Rev CAGGAAACAGCTATGAC SSPPCR 
RT1 TTCAAGCTCTATCCTACAGCGACAGC Tn916 fragment 
RT2 ATATACGAGTTTGTGCTTGT Tn916 fragment 
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2.5.14 Standard PCR protocol 
 
PCR amplification was carried out using GeneAmp 2400 PCR system (Perkin-Elmer 
Cetus, USA) with the following standard conditions: initial denaturation step at 94oC 
for 4 min, 30-35 PCR cycles [94oC, 1 min; 53-60oC, 1 min (dependent on primer 
annealing temperature); 72oC, 1-4 min (dependent on expected amplicon size, 
usually 1 min for each 1 kb is allowed]; 1 cycle of 4 min at 72oC and preservation at 
4oC until the sample were analysed. All of the temperature and times are variable. 
The melting temperatures (Tm) of the primers were calculated by the following 
equation; 
Equation 2.1 Tm = 67.5 + [0.34 x % (G+C)] - (395/n), where n is the length of the primers 
The annealing temperature was derived as 5oC below the Tm of the primer with the 
lowest Tm. The PCR reaction mixture contains 5 µl of 10X Taq polymerase buffer 
(NEB, Hertfordshire, UK), 1 µl of 10 pmol µl-1 of each forward and reverse primers 
(Sigma-Aldrich, Poole, UK),  1 µl of 10 mM dNTP mix (NEB, Hertfordshire, UK), 0.5 U 
µl-1 of Taq polymerase (NEB, Hertfordshire, UK) and 1 µl of DNA template 
(approximately 0.2 ng µl-1). The total volume of PCR mixture was made up to 50 µl 
using distilled water. All PCR products were purified using QIAquick PCR Purification 
Kit (Qiagen, Crawley, UK) as described previously.  
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2.5.15 Site-directed mutagenesis 
 
Site-directed mutagenesis reaction was carried out using the Phusion Site-Directed 
Mutagenesis Kit from NEB (Hertfordshire, UK). The entire plasmid (pGEM-T Easy) 
was amplified using phosphorylated primers that introduce the desired mutations. 
The amplified, linear PCR product containing the mutations is then circularised in a 
10 min ligation reaction with Quick T4 DNA Ligase. The resulting plasmid was then 
transformed into E. coli α-select bronze efficiency using a standard transformation 
protocol. The site-directed mutagenesis protocol was illustrated in Figure 2.1. 
 
2.5.15.1 5’-Phosphorylation of oligonucleotides 
 
The following components were added to a microcentrifuge tube; 300 pmol 
oligonucleotides, 5 µl 10X T4 Polynucleotide Kinase Reaction Buffer, 1 µl T4 
Polynucleotide Kinase 10 U µl-1, 5 µl 10 mM ATP and distilled water to a final 
volume of 50 µl. The reaction mixture was incubated at 37oC for 30 min. The T4 
Polynucleotide Kinase was inactivated at 65oC for 20 min. The reaction products 
were stored at -20oC until required.  
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Figure 2.1 Schematic diagram of the site-directed mutagenesis protocol. There are four 
types of mutations that can be introduced using this protocol; point mutation, deletion, 
and 2 types of insertion which involves 3 main steps. Phosphorylated primers are used for 
the PCR amplification.  
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2.5.15.2 PCR amplification 
 
All tubes were carefully mixed and centrifuged before opening to improve recovery. 
PCR reaction mixture was prepared as follows: distilled water to a final volume of 
50 µl, 10 µl of 5X Phusion HF Buffer, 1 µl 10 mM dNTPs, 1 µl of phosphorylated 
forward and reverse primers, 1 µl of DNA template (approximately 0.2 ng µl-1), 0.5 
µl Phusion Hot Start II DNA Polymerase (0.02 U µl-1). The PCR amplification was 
carried out using the following conditions: initial denaturation step at 98oC for 30 
sec; 25 PCR cycles (98oC, 5-10 sec; 65-72oC, 10-30 sec; 72oC, 15-30 sec kbp-1); final 
extension at 72oC, 5-10 min and preservation at 4oC until the sample were analysed. 
 
2.5.15.3 Ligation 
 
The volume of 25 ng PCR product was adjusted (usually equivalent to 1-5 µl of PCR 
reaction) to 5 µl with distilled water. 5 µl of 2X Quick Ligation Reaction Buffer was 
added and mixed. 0.5 µl of Quick T4 DNA Ligase was then added and mixed 
followed by a brief centrifugation. The ligation mixture was incubated at room 
temperature (25oC) for 10 min and chilled on ice prior to E. coli transformation. 
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2.5.15.4 E. coli transformation 
 
Transformation of the ligated products was carried out using a standard E. coli 
transformation protocols as described previously. 1-10 µl of the reaction mixture 
was transformed into 50 µl chemically competent E. coli cells.  
 
2.5.15.5 Analysis of transformants 
 
Successful transformants harbouring the recombinant plasmid were screened 
through blue/white selection using standard protocol as described in Section 
2.5.12. The mutants were analysed by DNA sequencing. 
 
2.5.16 DNA sequencing reactions 
 
Sequencing reactions were carried out at the Department of Biochemistry, 
University of Cambridge and the Wolfson Institute for Biomedical Research, 
University College London. The concentrations used for DNA sequencing were 100 
ng µl-1 for plasmids and 1 ng µl-1 per 100 bp for PCR products and was determined 
either by agarose gel electrophoresis or the NanoDrop 1000 Spectrophotometer 
(Thermo Scientific, Surrey, UK). 
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2.5.17 DNA sequence analysis 
 
Analysis of DNA sequence was carried out using a web-based tool Biology 
Workbench (http://workbench.sdsc.edu/) and the Basic Local Alignment Search 
Tool (BLAST) (http://blast.ncbi.nlm.nih.gov/).   
 
2.6 Filter mating 
 
The filter mating experiments were conducted as described by Roberts et al. (2000). 
The donor and recipient strains were grown overnight on BHI agar supplemented 
with appropriate antibiotics. The colonies were inoculated into 20 ml of antibiotic-
free BHI broth (pre-reduced broth for C. difficile) and grown overnight at 37oC in the 
relevant atmospheric environments. The cultures were diluted to OD600 ~ 0.1 and 
were left to grow at 37oC until mid-exponential phase (OD600 = 0.5-0.6). The cells 
were harvested by centrifugation at 3,000 x g (5,000 rpm) for 10 min and 
supernatant discarded. The pelleted cells were resuspended in 1 ml pre-reduced 
BHI broth. Both the donor and recipient were mixed gently but thoroughly and 200 
µl aliquots were spread on 0.45 µm-pore-size sterilised nitrocellulose filters 
(Sartorius, UK) which had previously been placed on antibiotic-free BHI agar. Plates 
were anaerobically incubated overnight at 37oC. Filters were immersed in 1 ml pre-
reduced BHI broth and vortexed for 10-20 sec prior to plating on BHI agar 
supplemented with appropriate antibiotics. The plates were incubated 
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anaerobically at 37oC for 24-48 h. The transfer frequency  was calculated using the 
following formula: number of colonies x dilution factor = number of CFUs per filter.  
 
2.7 Southern blot and hybridisation 
 
Southern blot hybridisation and labelling of the probe was carried out using ECL 
Direct Nucleic Acid Labelling and Detection Systems (Amersham, Little Chalfont, UK) 
according to the manufacturer’s instructions.  
 
2.7.1 Gel processing 
 
After running the agarose gel for the appropriate length of time, the gel was placed 
in a suitable plastic box, covered with depurination solution (Appendix B) and 
agitated on an orbital shaker, ensuring that the gel moves freely. Treatment was 
stopped immediately once the bromophenol blue-dye has turned completely 
yellow (approximately 10-12 min). The depurination solution was discarded and the 
gel was rinsed with distilled water. The gel was then submerged with denaturation 
solution (Appendix B) and agitated for 25 min after the bromophenol dye has 
returned to its blue colour. This solution was discarded and the gel was rinsed with 
distilled water. The gel was subsequently covered with neutralisation solution 
(Appendix B) and agitated for 30 min.   
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2.7.2 Capillary blotting 
 
The gel was blotted by capillary transfer using 20X SSC in the following set up 
(Figure 2.2).  A raised platform was made in a suitable container filled with 20X SSC 
(Appendix A). This platform was covered with 3 sheets of 3 MM Whatman filter 
paper saturated with 20X SSC to act as a wick. The gel was placed onto the 3MM 
paper, making sure no air bubbles were present. A sheet of Hybond N+ nylon 
membrane (Amersham, Little Chalfont, UK) was cut to the size of the gel and placed 
on top of the gel without trapping air bubbles. Another 3 sheets of 3 MM paper 
were cut to the size of the gel and soaked with 10X SSC. These wetted papers were 
placed on top of the membrane, again avoiding trapping air bubbles. A 5-7 cm stack 
of absorbent paper towels were placed on top of the 3 MM paper. A glass plate and 
a 500 g weight were placed on top of the paper towels. This blotting stack was left 
overnight at room temperature (25oC). 
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Figure 2.2 Set up of the gel blotting procedure through capillary transfer.  
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2.7.3 Processing the blot 
 
The blotting stack was dismantled and the membrane and the gel were removed 
together. The membrane was peeled from the gel and placed side up on a clean 
piece of 3 MM paper. The DNA side was marked with a pencil. The membrane was 
placed in 6X SSC and rinsed for 1 min with gentle agitation to remove the agarose. 
The DNA was fixed to the membrane by UV cross-linking in a UV Stratalinker 1800 
(Stratagene, Amsterdam, Netherlands) according to the manufacturer’s 
instructions.   
 
2.7.4 Labelling the DNA probes 
 
Labelling of the DNA probes was carried out according to the manufacturer’s 
instructions. The DNA to be labelled was diluted to a concentration of 10 ng µl-1 
using sterile distilled water.  The DNA (100 ng in 10 µl) was denatured by heating 
for 5 min in a boiling water bath and cooled immediately by incubation for 5 min on 
ice. The tube containing the DNA was spun briefly prior to addition of an equivalent 
volume (10 µl) of DNA labelling reagent. The glutaraldehyde solution (10 µl) was 
then added and mixed gently but thoroughly. The tube was again spun to collect 
the contents at the bottom of the tube. The tube was incubated for 10 min at 37oC 
and if not used immediately was held on ice for 10-15 min.  
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2.7.5 Hybridisation and stringency washes 
 
The hybridisation buffer was prepared as follows: solid sodium chloride (analytical 
grade) was added to 50 ml of hybridisation buffer to a final concentration of 0.5 M. 
The blocking agent was subsequently added [final concentration of 5% (w/v)] and 
immediately mixed until the blocking agent was present as a free suspension. 
Mixing was continued with stirring for 1 h at room temperature followed by 
incubation at 42oC for 30 min with occasional mixing. If not used immediately, the 
buffer could be stored at -20oC in a sterile plastic container for up to 3 months. 
 
The pre-hybridisation procedure was performed by pre-heating the hybridisation 
buffer at 42oC. In a suitable container, the blot was pre-wet with 5X SSC, loosely 
rolled up and placed in a glass hybridisation tube. The 5X SSC was poured off and 
the appropriate volume of hybridisation buffer (0.0625-0.125 ml cm-2) was added 
followed by a pre-hybridisation in a rotisserie oven at 42oC for at least 15 min. The 
labelled probe was added to the buffer, making sure not to place it directly on to 
the membrane. Hybridisation was carried out overnight in the rotisserie oven at 
42oC.  
 
The hybridisation buffer was discarded and 50-100 ml of 5X SSC was added to the 
tube and replaced in the rotisserie oven for 5 min at 42oC. The 5X SSC was 
discarded and replaced with a pre-warmed primary wash buffer (Appendix B) so 
that the hybridisation tube was one-third full. The tube was returned to the 
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rotisserie oven and the blot was washed for 20 min at 42oC. The primary wash 
buffer was discarded and replaced with an equal volume of a fresh buffer and 
continued washing for 10 min. This washing step was repeated for a second time. 
The blot was then removed from the hybridisation tube and placed in a plastic tray 
soaked with an excess of secondary wash buffer (Appendix B). Incubation was done 
with gentle agitation on a rotary shaker for 5 min at room temperature (25oC).  
 
2.7.6 Signal generation and detection 
 
An equal volume of detection reagent 1 and detection reagent 2 were mixed in a 
volume that is sufficient to cover the blot. The excess secondary wash buffer was 
drained, and the blot was placed onto a clean piece of Saran Wrap. The detection 
reagents were added directly onto the blot and incubated for 1 min at room 
temperature (25oC). The excess detection reagents were drained and the blot was 
wrapped in Saran Wrap without trapping air bubbles. The blot was placed DNA side 
up in a film cassette and the autoradiography film was placed over the blot. The 
film cassette was closed and the film was exposed for 30 sec - 1 min. The film was 
removed under safe light conditions and developed. A second film was exposed for 
an appropriate length of time if required.  
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2.8 Statistical analysis 
 
All data are presented as mean ± standard deviation (SD). Analysis of variance, one-
way ANOVA was carried out to compare the differences between two or more 
means. A mean difference is considered significant when P<0.05. Statistical analysis 
was performed using Statistical Package of Social Science (SPSS) version 20.0 (SPSS 
Inc., Chicago, IL, USA). 
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3 Investigation into the role of orf12 in the regulation of 
Tn916 
 
3.1 Introduction 
 
Tn916 is the paradigm of a large family of conjugative transposons commonly found 
in enterococci and streptococci (Franke and Clewell, 1981; Clewell and Gawron-
Burke, 1986). In 1992, Su and co-workers (Su et al., 1992) have described a model 
of how transcriptional attenuation, associated with tetracycline, regulates the 
expression of tet(M) in Tn916 (Figure 3.1). Central to this hypothesis is the 
transcription of the small leader peptide (orf12) upstream of tet(M). The 
involvement of orf12 has never been experimentally proven in vivo, although it is 
fundamentally important. 
 
In this chapter, we investigated the involvement of orf12 using B. subtilis::Tn916 
with a 2 bp mutation replacing the start codon of orf12 (ATG) with GCG which 
would prevent any initiation of translation of orf12. The translation of orf12 is 
central in the proposed regulatory mechanism as it is the translating ribosome that 
is hypothesised to destroy, or prevent the formation of the transcriptional 
terminators. The mutant B. subtilis::Tn916Δorf12 was subjected to experiments to 
test for any differences in transcriptional activity, fitness cost and mobility 
compared to the wild type strain.  
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Figure 3.1 The transcriptional regulation of Tn916. Panel A shows the conjugative transposon Tn916 , the inverted repeat sequences (black arrows) 
within the orf12 and the amino acid sequence corresponding to the peptide product (single letter codes: M: methionine; L: leucine; C: cysteine; P: 
proline; V: valine; H: histidine; K: lysine; N: asparagine; S: serine; D: aspartic acid; I: isoleucine; Y: tyrosine; W: tryptophan; F: phenylalanine; A: 
alanine; G: glycine). The rare codons within the leader peptide are shown in blue font. Panel B shows the putative secondary structure that is 
predicted to form in the mRNA of Tn916. The red-shaded area represents orf12. The terminator structures are presented by the capital ‘T’. The 
ribosome binding sites for orf12 and tet(M) are underlined. The start codon of the tet(M) is highlighted in yellow. The free energy changes in kcal 
mol-1 for each stem loop structure are indicated as ΔG. In the absence of tetracycline, the amount of charged aminoacyl tRNA is proposed to be 
limited. As a result, the ribosome pauses at the codons that call for rare amino acids (cysteine, methionine and histidine), thus lags behind the 
extending RNA polymerase and does not interfere with the formation of the terminator structures. At this stage, most of the transcription is 
terminated. Conversely, in the presence of tetracycline, the reversible binding of tetracycline-ribosome leads to an increased amount of charged 
aminoacyl tRNA, including the rare ones (cysteine, methionine and histidine). The build up of charged aminoacyl tRNA allows the rapid translation 
of orf12 by the Tet(M) protected ribosomes, the rapid translation is proposed to allow the ribosome to catch up with the RNA polymerase thus 
preventing the formation of, or destroying the terminator structures. These result in a long transcript that extends through the terminators into 
the tet(M) and the downstream genes (Su et al., 1992).  
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3.2 Materials and methods 
 
 
3.2.1  Bacterial strains and plasmids 
 
E. coli α-select (bronze efficiency) was used for transformation of pGEM-T Easy 
harbouring the Tn916 fragment and pDL. B. subtilis BS59A (contains Tn916ΔE) was 
used as a host for construction of Tn916Δorf12 mutant. The B. subtilis mutant 
carrying the cat gene for competitive fitness assays was constructed using B. subtilis 
BS34A (contains wild typeTn916). C. difficile CD37 was used as a recipient in filter-
mating experiments. All strains were grown under the conditions described in 
Section 2.3. 
 
3.2.2  Bacterial transformation 
 
B. subtilis and E. coli transformation was carried out according to the protocol in 
Section 2.5.10 and Section 2.5.11, respectively. Selection of B. subtilis 
transformants was carried out on BHI agar after 24-48 h incubation at 37oC. 
Conversely, the E. coli transformants were selected on LB agar after 18-24 h 
incubation at 37oC. 
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3.2.3  Construction of mutation in the regulatory region of 
Tn916 
 
The region from the end of orf14 to orf9 was amplified (Figure 3.2). The PCR 
product (4.1 kb) was purified prior to cloning into pGEM-T Easy vector and 
transformed into E. coli. Transformants were selected on LB agar supplemented 
with ampicillin (100 µg ml-1), tetracycline (10 µg ml-1), IPTG (0.1 M) and X-gal (40 µg 
ml-1). After 18-24 h incubation at 37oC, white colonies were randomly picked and 
grown in LB broth supplemented with ampicillin (100 µg ml-1). Plasmid extraction 
was then carried out. One plasmid designated pAPR108 was subjected to site 
directed mutagenesis (Section 2.5.15) to introduce a 2 bp mutation disrupting the 
start codon of orf12. Two phosphorylated primers were designed, with the desired 
mutation located in the middle of the mutagenic primer. The PCR product was 
ligated according to the manufacturer’s instructions and designated pAPR109. This 
plasmid was transformed into E. coli and after 18-24 h incubation at 37oC, the 
transformants were selected for plasmid purification. The purified plasmids were 
subsequently sequenced.  
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Figure 3.2 Amplification of Tn916 regulatory fragment. Primers AJ1 and AJ4 (Table 2.3) 
were designed to amplify the Tn916 from the end of orf14 to orf9. The expected PCR 
product is 4.1 kb. The amplified PCR product was cloned into pGEM-T Easy and 
subsequently transformed into E. coli. 
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3.2.4  Construction of B. subtilis mutant 
 
 
The pAPR109 vector was used as template for PCR to amplify the Tn916Δorf12 
fragment, so that it can be used for transformation in B. subtilis BS59A (contains 
Tn916ΔE). BS59A was the result of a filter-mating with C. difficile::Tn916ΔE with B. 
subtilis CU2189 (Hussain et al., 2005). Primers AJ1 and AJ4 (Table 2.3) were used for 
the PCR amplification. A large flanking region of the Tn916Δorf12 fragment is crucial 
in the homologous recombination as it is expected to efficiently replace erm(B)  in 
Tn916ΔE by allelic exchange. The allelic exchange allows selection of transformants 
on tetracycline. The constructed B. subtilis mutant was used for downstream 
analysis and designated BS79A (contains Tn916Δorf12). This mutant strain is in an 
isogenic background to BS34A (contains wild type Tn916) however the exact 
location of the conjugative transposon in BS59A has not been determined. 
 
3.2.5 Constructions of a B. subtilis mutant with a different 
antibiotic resistance gene 
 
B. subtilis mutant carrying a cat gene marker was constructed to allow selection 
during competitive fitness assay. The integration vector pDL harbouring the cat 
gene, which confers resistance to chloramphenicol was used for integration within 
the coding sequence of the non-essential amyE gene of B. subtilis BS34A (contains 
wild type Tn916). In the first instance, the bgaB gene was removed from the vector 
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using restriction enzymes SacI and SnaBI (Figure 3.3). The bgaB gene was removed 
from the vector to avoid any background effect from this gene. The vector was re-
ligated and transformed into E. coli. After 18-24 h incubation at 37oC, plasmid 
extraction was carried out followed by restriction digest of the pDLΔbgaB vector 
using PstI. The linearised fragment was subsequently transformed into B. subtilis 
BS34A. The homologous amyE sequence that flanked the cat gene is expected to 
integrate into the amyE locus in B. subtilis chromosome via double recombination. 
Transformants were selected on BHI agar supplemented with tetracycline (10 µg ml-
1) and chloramphenicol (5 µg ml-1) after 24-48 h incubation. The constructed 
mutant was designated BS92A (BS34AΔamyE, contains Tn916). 
 
3.2.6  Validation of the integrated cat gene into amyE locus 
 
Integration of the cat gene into the amyE locus in B. subtilis was confirmed using 
starch hydrolysis. The wild type [BS34A (contains wild type Tn916)] and the mutant 
[BS92A (BS34AΔamyE, contains Tn916)] strains were streaked on BHI agar 
supplemented with starch (1%). After 24 h of incubation at 37oC, the plate was 
flooded with Gram’s iodine. A clear zone around the grown colonies indicates 
hydrolysis of starch. BS92A with the interrupted amyE gene will not be able to 
hydrolyse the starch, hence no clearing zone is expected.  
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Figure 3.3 Construction of pDLΔbgaB integration vector. bgaB gene was removed from pDL using restriction enzymes SacI and SnaBI (red boxes). 
The linearised fragment was ligated prior to transformation into E. coli.  
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3.2.7 Comparative growth curves  
 
 
The growth curve assay was carried out by cultivating B. subtilis BS34A (contains 
wild type Tn916) and BS79A (contains Tn916Δorf12) separately in 100 ml BHI broth 
in 250 ml Erlenmeyer flasks. The cultures were grown in a shaking incubator (200 
rpm) at 37oC. The growth was monitored by measuring the optical densities (OD) at 
600 nm every 30 min up to 5 h. Tetracycline is added to two of the cultures in the 
overnight growth of the starter cultures and two of the cultures (one previously 
grown in tetracycline and one in antibiotic free media) at the start of the 5 h growth 
period following the overnight growth. Therefore one culture was grown in 
antibiotics media and then subcultured into antibiotic free (Tc-abf on Figures 3.4 
and 3.5) and antibiotic containing media (Tc-Tc on Figures 3.4 and 3.5) and the 
other was initially grown in the absence of antibiotics and then similarly 
subcultured into antibiotic free (abf-abf on Figures 3.4 and 3.5) and antibiotic 
containing media (abf-Tc on Figure 3.4 and 3.5). 
 
3.2.8 Competitive fitness assay 
 
The relative fitness was assayed by cultivating the B. subtilis strains separately in 
BHI broth (free antibiotic) for 18 h to a density of 1 x 109 cfu ml-1. This is a 
preconditioning step ensuring both competitors were in comparable physiological 
states and cell densities prior to competition experiments. The two competitors 
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(0.1 ml of each strain) were then mixed in a 250 ml Erlenmeyer flask containing 100 
ml BHI broth (free antibiotic or supplemented with tetracycline). Prior to 
incubation, 0.1 ml of the mixed culture was diluted to 1 x 10-4 and 1 x 10-5 in 1 ml 
BHI broth and plated on BHI agar supplemented with tetracycline (10 µg ml-1) to 
select for B. subtilis strains BS34A (contains wild type Tn916) and BS79A (contains 
Tn916Δorf12) and tetracycline plus chloramphenicol (5 µg ml-1) to select for B. 
subtilis BS92A (BS34AΔamyE, contains Tn916). The initial cell densities are 
calculated by subtracting the number of colonies on BHI agar supplemented with 
tetracycline and chloramphenicol from the BHI agar plus tetracycline. Incubation 
was carried out for 5 h in a shaking incubator (200 rpm) at 37oC. At the end of the 
culture period, 0.1 ml of the mixed culture was diluted to 1 x 10-5 and 1 x 10-6, 
followed by plating on BHI agar supplemented with the same antibiotics as 
mentioned previously. The final cell densities was then determined. 
 
The fitness of one genotype relative to the other was elucidated, first by calculating 
the realised Malthusian parameter for each competitor and then by computing the 
ratio of their Malthusian parameters (Lenski et al., 1991). The following equations 
was used to determined the relative fitness of the competitors; (i) m = ln (N1/N0) (ii) 
w = m1/m2 and (iii) s = 1-w, where m is the Malthusian parameter, N1 and N0 are 
the final and initial densities during the pairwise, w is the relative fitness of each 
genotype and s is the selection coefficient or fitness effect. 
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3.2.9  Transfer experiment and transconjugants selection 
  
Transfer of Tn916 between B. subtilis strains [BS34A (contains wild type Tn916) and 
BS79A (contains Tn916Δorf12)] and C. difficile CD37 was carried out using filter 
mating (Section 2.6). The nontoxinogenic C. difficile CD37 was used as a recipient in 
this experiment as it has been previously shown to be a good recipient for Tn916 
from B. subtilis strains (Mullany et al., 1990).  The donor strains were grown in BHI 
broth supplemented with tetracycline whereas the recipient strain was grown in a 
pre-reduced BHI broth supplemented with rifampicin. The transconjugants were 
selected on BHI agar supplemented with tetracycline (10 µg ml-1) and rifampicin (25 
µg ml-1) after 24-48 h incubation at 37oC under anaerobic condition (Section 2.3). 
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3.3 Results 
 
3.3.1  Construction of Tn916Δorf12 fragment 
 
The involvement of orf12 in the regulation of tet(M) in Tn916 was investigated by 
constructing a 2 bp mutation in the start codon of orf12. Constructions of the 
mutated start codon was carried out by first, amplifying the Tn916 fragment (from 
the end of orf14 to orf9) using primers AJ1 and AJ4 (Figure 3.4 A). The amplified PCR 
product was cloned into pGEM-T Easy and subsequently transformed into E. coli α-
select (bronze efficiency). The plasmid harbouring the correct sized insert (4.1 kb), 
designated pAPR108 (Figure 3.4 B) was used as the template in site directed 
mutagenesis, where a 2 bp mutation was introduced in the start codon of the orf12 
using primers AJ15 and AJ16. Amplification of the regulatory region and the entire 
plasmid gave rise to a 7.1 kb fragment as shown in Figure 3.4C. The mutated 
regulatory region was ligated and transformed into E. coli. Plasmid extraction was 
then carried out and sequenced. Figure 3.5 shows a multiple sequence alignment of 
Tn916Δorf12 and Tn916 fragments. These data confirmed the mutation made in the 
start codon of orf12 of Tn916 (ATG→GCG).  
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Figure 3.4 Analysis of Tn916 and Tn916Δorf12 fragments. Panel A shows the amplified 
Tn916 fragment. Lane 1: HyperLadder I; Lane 2: The 4.1 kb PCR product. Panel B shows the 
undigested and EcoRI-digested pGEM-T Easy. Lane 1: HyperLadder I; Lanes 2, 4, 5 and 6: 
Undigested plasmids; Lane 3: Digested plasmid with no insert; Lane 7: Digested plasmid 
with the correct sized insert. Arrows represent the 4.1 kb insert. Panel C shows the PCR 
product of Tn916Δorf12 fragment. Lane 1: HyperLadder I; Lane 2: The PCR product (7.1 kb). 
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Figure 3.5 Multiple sequence alignment of Tn916 and Tn916Δorf12 fragments. The 2 bp 
start codon mutation of orf12 is shown in the red box. The promoter Ptet(M) is indicated by 
-35 and -10 underlined sequences. The dashed arrows represent the inverted repeats 5, 6, 
7 and 8. The ribosome binding site (RBS) and the start codon of tet(M) are underlined. 
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3.3.2  Integration of Tn916Δorf12 fragment into B. subtilis 
BS59A 
 
In B. subtilis BS59A (contains Tn916ΔE), the Tn916Δorf12 fragment is expected to 
replace erm(B) via allelic replacement as illustrated in Figure 3.6. The integration of 
Tn916Δorf12 fragment and an allelic replacement of erm(B) gene by the tet(M) 
gene will allow selection of B. subtilis transformants using tetracycline. The 
replaced gene [erm(B) to tet(M)] was confirmed by PCR. Two sets of primers 
(CTn9824F and O10R; CTn13562F and O14R) (Table 2.3) were used to amplify the 
integrated junctions as shown in Figure 3.7 A. The PCR products (Figure 3.7 B) were 
sent for sequencing. Another PCR amplification was carried out to confirm the 
presence of tet(M) in B. subtilis BS79A (contains Tn916Δorf12) (Figure 3.7 C). The 
presence of tet(M) was further confirmed by the sequencing results. 
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Figure 3.6 Double cross over recombination that is expected to occur in B. subtilis BS59A 
(contains Tn916ΔE). The black triangle represents the mutation in the start codon of orf12. 
The blue boxes represent the homologous region of Tn916. The tet(M) and erm(B) genes 
are represented by the red and black arrowed boxes, respectively. 
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Figure 3.7 The amplified Tn916 junctions in B. subtilis BS79A (contains Tn916Δorf12). Panel 
A: Arrows represent the primers and direction of priming. Junction 1 (J1) is expected to be 
1.7 kb in size whereas junction 2 (J2) is 1.4 kb in size. Panel B: The PCR products of J1 and 
J2. Panel C: The PCR products of tet(M) genes. Lane 1: HyperLadder I; Lane 2: Genomic DNA 
of B. subtilis BS34A (positive control); Lanes 3-8: Genomic DNA of B. subtilis BS79A (from 6 
isolated colonies); Lane 9: Genomic DNA of B. subtilis BS59A (negative control); Lane 10: No 
DNA.  
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3.3.3  Confirmation of the removal of bgaB gene from pDL 
vector and construction of B. subtilis mutant carrying cat 
gene 
 
The integration vector pDLΔbgaB was successfully constructed by removing the 
bgaB gene from pDL. The bgaB was removed from the vector to avoid any 
background effect from this gene. Both pDL and pDLΔbgaB were digested with PstI 
and a reduction in the size of pDLΔbgaB compared to pDL indicates the absence of 
bgaB gene (Figure 3.8). Integration of pDLΔbgaB into the amyE locus of B. subtilis 
BS34A (contains wild type Tn916) was carried out via transformation. In B. subtilis 
BS34A, the plasmid is expected to integrate into the genome via allelic exchange, 
causing disruption to the amyE gene (Figure 3.9). The constructed B. subtilis mutant 
was designated BS92A. pDLΔbgaB contains the cat gene that encodes for 
chloramphenicol resistant hence allows selection during competitive fitness assays.    
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Figure 3.8 Confirmation of the removal of bgaB gene from pDL. The gel photo visualises the 
undigested and PstI-digested pDL and pDLΔbgaB.  Lane 1: HyperLadder I; Lane 2: 
Undigested pDL; Lane 3: Digested pDL; Lane 4: Undigested pDLΔbgaB; Lane 5: PstI-digested 
pDLΔbgaB. A reduction in the size of pDLΔbgaB observed in Lane 5 compared to pDL on 
Lane 3 suggests the absence of bgaB gene.  
 
 
Figure 3.9 The expected double recombination of the integration vector in B. subtilis 
BS34A. Linearisation of the plasmid should lead to integration only by a double cross over 
mechanism.  
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3.3.4 Confirmation of double recombination and validation of 
the interrupted amyE gene in B. subtilis BS92A 
 
The double recombination of the linearised pDLΔbgaB in B. subtilis BS34A (contains 
wild type Tn916) was confirmed using PCR amplification. Two sets of primers were 
designed upstream and downstream of the integrated junctions, and overlapping 
the cat gene (Figure 3.10 A). The genomic DNA of one transformant designated B. 
subtilis BS92A (BS34AΔamyE, contains Tn916) was used as template for the PCR 
reaction (Figure 3.10 B).  In addition, the interruption of the amyE gene was 
confirmed phenotypically using starch agar. Upon interaction with the Gram’s 
iodine, a clear zone was observed around the streaked BS34A (control) indicated 
the hydrolysis of starch by the extracellular amylase. Conversely, the absence of 
clear zone around the BS92A confirmed the interruption of amyE gene (Figure 
3.11).  
 
The constructed BS92A was subjected to a comparative growth curve against the 
wild type strain (BS34A) to ensure that the marker (cat gene) is stably maintained 
and its presence does not interfere with the growth rate of BS92A. In this 
experiment, BS34A and BS92A were grown separately for 5 h, and an OD600 was 
measured periodically every 0.5 h. Based on the results, BS92A displayed the same 
rate of growth as BS34A, hence is considered appropriate marker strain for 
competitive experiments (Figure 3.12). 
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Figure 3.10 PCR amplification of the integrated junctions in B. subtilis BS34A (contains wild 
type Tn916). Panel A: Arrows represent the primers and direction of priming. Two sets of 
primers that overlapped the cat gene were used for the PCR amplification. Panel B: The 
PCR products of the integrated junctions. Four different colonies were used as template for 
the PCR amplification. Lane 1: HyperLadder I; Lanes 2-5: Amplified PCR products using 
primers ycgB and catR (Junction 1); Lane 7-10: Amplified PCR products  using primers catF 
and ldh (Junction 2). Lanes 6 and 11: Negative control (genomic DNA of B. subtilis BS34A). 
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Figure 3.11 Observations on starch agar. The clearing zone indicates the hydrolysis of 
starch by the extracellular amylase whereas the absence of clearing zone indicated there is 
no hydrolysis of starch, presumably due to the interruption of amyE gene. 
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Figure 3.12 Comparative growth curve of B. subtilis strains BS34A (contains wild type 
Tn916) and BS92A (BS34AΔamyE). Both strains demonstrated the same growth profile 
(P>0.05). Error bars represent standard deviation of three independent experiments. 
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3.3.5 Comparative growth curves of B. subtilis strains BS34A 
and BS79A  
 
In this experiment, the effect of tetracycline to the growth of B. subtilis BS34A 
(contains wild type Tn916) and BS79A (contains Tn916Δorf12) was investigated. 
Figure 3.13 and Figure 3.14 illustrate the growth profile of BS34A and BS79A, 
respectively, which were monitored under four different conditions; from overnight 
antibiotic free media to tetracycline (abf-Tc) and antibiotic free (abf-abf) media, and 
from overnight tetracycline containing media to antibiotic (Tc-Tc) and antibiotic 
free (Tc-abf) media. As shown in Figure 3.13, the abf-abf and Tc-abf cultures of 
BS34A showed a similar growth profile (p>0.05). A slightly delayed growth was 
observed for Tc-Tc culture, whereas the slowest growth rate was observed for abf-
Tc culture. Towards the end of the logarithmic phase and the start of stationary 
phase, all cultures seemed to grow at the same rate. BS79A demonstrated a similar 
growth profile to BS34A (Figure 3.14). Despite the BS34A and BS79A being almost 
isogenic (the element may be in a different location) the growth kinetics are the 
same (Figure 3.15). Interestingly, when the abf-Tc cultures of both strains were 
compared, it was noted that BS79A had a significantly slower growth rate than 
BS34A (Figure 3.16) (p<0.05), particularly during the mid-exponential phase (2 h). 
However, both strains grow at the same rate after 4 h. 
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Figure 3.13 Comparative growth curve of BS34A. Colors indicate different treatments of 
each sample from the overnight culture to the tested culture. Black: antibiotic free to 
tetracycline; blue: antibiotic free; red: tetracycline and green: tetracycline to antibiotic free. 
Error bars represent standard deviation from three independent experiments. 
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Figure 3.14 Comparative growth curve of BS79A. Colors indicate different treatments of 
each sample from the overnight culture to the tested culture. Black: antibiotic free to 
tetracycline; blue: antibiotic free; red: tetracycline and green: tetracycline to antibiotic free. 
Error bars represent standard deviation from three independent experiments. 
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Figure 3.15 Comparative growth curve of B. subtilis strains BS34A and BS79A in antibiotic 
free medium (abf-abf). BS34A (■) and BS79A (●) demonstrate a similar growth rate 
(P>0.05). Error bars represent standard deviation from three independent experiments. 
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Figure 3.16 Comparative growth curve of B. subtilis strains BS34A and BS79A, challenged 
with tetracycline (abf-Tc). BS79A (●) exhibited a delayed growth relative to BS34A (■) 
(P<0.05) during the mid-exponential phase (2 h). Error bars represent standard deviation 
from three independent experiments.  
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3.3.6  Competitive fitness of B. subtilis BS34A, BS92A and 
BS79A 
 
Estimation of the relative fitness between B. subtilis strains BS34A (contains wild 
type Tn916), BS92A (BS34AΔamyE) and BS79A (contains Tn916Δorf12) was carried 
out by competition experiments. In this experiment, BS92A carrying the cat gene 
was used as the marked competitor to distinguish between BS34A and BS79A (both 
strains carry tet(M) gene hence not directly competed). The relative fitness of the 
competitors was calculated using the equations described in Section 3.2.8. Results 
indicate that BS92A is 3% more fit than BS34A (Table 3.1). In contrast, BS79A is 4% 
more fit than BS92A (Table 3.2). The transitive fitness relation between these three 
strains is BS79A>BS92A>BS34A, which means BS79A>BS34A. As BS79A is 4% more 
fit than BS92A, and BS92A is 3% more fit than BS34A, therefore by using the 
transitive law, it is indicated that BS79A is 7.12% more fit than BS34A.  
 
The competitive fitness between BS79A and BS92A was also determined in the 
presence of tetracycline. In this experiment, tetracycline was added at the 
beginning of the competition experiment. Table 3.3 illustrates the relative fitness of 
BS79A and BS92A, enumerated every 1 h up to 5 h of competition. BS79A is 10% 
more fit than BS92A during the first 1 h, however the fitness is reduced for the next 
2 h of competition. At 4 h, BS79A demonstrated a more fitness effect (3%) than 
BS92A, whereupon it was again decrease at 5 h. 
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Table 3.1 Relative fitness of B. subtilis strains BS92A (BS34AΔamyE) and BS34A (contains 
wild type Tn916). The relative fitness was elucidated using the realised Malthusion 
parameter; m = ln [N(1)/N(0]) and w =m1/m2 where m describing the exponential growth 
of each competitor, N(1) and N(0) are the final and initial cell densities during competition 
and w is the relative fitness of each genotype. The fitness effect (s) is calculated as s = w-1. 
Therefore, in this competition experiment, s = 1.03-1 = 0.03 which imply that strain A 
(BS92A) is 3% more fit than strain B (BS34A). 
 
Strains 
Realised Malthusion parametera Relative 
fitnessa 
w=mA/mB 
Fitness 
effect 
s=w-1 mA=ln 
[A(1)/A(0)] 
mB = ln 
[B(1)/B(0)] 
B. subtilis BS92A 
(A) vs. B. subtilis 
BS34A (B) 
 
2.59 ( 0.03) 
 
2.52 ( 0.05) 
 
1.03 ( 0.11) 
 
0.03  
(3%  1%) 
 
aAverage of 3 independent experiments 
 
 
Table 3.2 Relative fitness of B. subtilis strains BS79A (contains Tn916Δorf12) and BS92A 
(BS34AΔamyE). The relative fitness was elucidated as above. As fitness effect (s) is 
calculated as s = w-1, therefore, in this competition experiment, s = 1.04-1 = 0.04 which 
imply that strain A (BS79A) is 4% more fit than strain B (BS92A). 
 
Strains 
Realised Malthusion parametera Relative 
fitnessa 
w=mA/mB 
Fitness 
effect 
s=w-1 mA=ln 
[A(1)/A(0)] 
mB= ln 
[B(1)/B(0)] 
B. subtilis BS79A 
(A) vs. B. subtilis 
BS92A (B) 
 
2.31 ( 0.14) 
 
2.22 ( 0.16) 
 
1.04 ( 0.02)  
 
0.04  
(4%  2%) 
 
aAverage of 3 independent experiments 
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Table 3.3  Relative fitness of B. subtilis strains BS79A (contains Tn916Δorf12)  and BS92A 
(BS34AΔamyE) in tetracycline containing media. The relative fitness was elucidated as 
previously described. However, in this experiment, N(1) which is the final cell densities 
varies between 1-5 h. N(0) remains the initial cell densities. This experiment demonstrated 
a variation in the fitness effect, with an inconsistent fitness observed for BS79A throughout 
the 5 h competition experiments. 
B. subtilis BS79A (A) vs. 
B. subtilis BS92A (B) 
Realised Malthusion parametera Relative fitnessa 
w=mA/mB 
mA=ln [A(1)/A(0)] mB= ln [B(1)/B(0)] 
1 h 0.64 ( 0.14) 0.58 ( 0.12) 1.10 ( 0.16) 
2 h 1.22 ( 0.22) 1.30 ( 0.19) 0.94 ( 0.26) 
3 h 2.49 ( 0.06) 2.56 ( 0.17) 0.97 ( 0.11) 
4 h 3.25 ( 0.05) 3.15 ( 0.12) 1.03 ( 0.09) 
5 h 0.94 ( 0.14) 1.51 ( 0.25) 0.62 ( 0.17) 
 
aAverage of 3 independent experiments 
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3.3.7  Transfer of Tn916 from B. subtilis BS34A and BS79A to 
C. difficile CD37 
 
This experiment was carried out to investigate the effect of the disruption of the 
start codon of orf12 in the mobility of Tn916. In this filter mating experiment, C. 
difficile CD37 was used as the recipient. The frequency of transfer [ standard 
deviation (SD)] detected for BS34A (contains wild type Tn916) was 1.74 x 10-6 ( 
2.28 x 10-6) per recipient. As for BS79A which contains Tn916Δorf12, the transfer 
frequency detected was 4.14 x 10-6 ( 4.07 x 10-6) per recipient. From these results, 
it was concluded that the transfer of Tn916Δorf12 is not appreciably different to 
that of the wild type Tn916, despite the disruption of the start codon of orf12. The 
presence of Tn916 in C. difficile CD37 was confirmed by PCR amplification of tet(M) 
gene (Figure 3.17). 
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Figure 3.17 PCR amplification of tet(M) gene in C. difficile CD37. Panel A: tet(M) gene in  
CD37 transconjugants (BS34A x CD37). Panel B: tet(M) gene in CD37 transconjugants 
(BS79A x CD37). Lane 1: Hyperladder I; Lane 2: Genomic DNA of B. subtilis BS34A (positive 
control); Lane 3: Genomic DNA of B. subtilis BS79A (positive control); Lanes 4-8: Putative 
transconjugants carrying tet(M) gene; Lane 9: Genomic DNA of C. difficile CD37 (negative 
control); Lane 10: No DNA. 
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3.4 Discussion 
 
 
In this study, an in-depth investigation concerning the role of orf12 and its 
translation in regulating the transcription of Tn916 was carried out using B. subtilis 
construct containing 2 bp mutation disrupting the start codon of orf12. The 
experiments were performed in the presence and absence of tetracycline, which 
was previously shown to be involved in the transcriptional regulation of this 
element (Su et al., 1992; Celli and Trieu-Cuot, 1998). In agreement with previous 
reports, the involvement of tetracycline in the transcriptional regulation of Tn916 
was again highlighted in this study. In growth conditions where tetracycline is 
present (abf-Tc and Tc-Tc), both the wild type (BS34A) and the mutated strain 
[BS79A (contains Tn916Δorf12)] demonstrated a slower growth rate compared to 
their respective tetracycline-free culture (Tc-abf and abf-abf) counterparts, 
especially during the mid-logarithmic phase where cells were rapidly dividing 
(Figure 3.13 and Figure 3.14). It is possible that at this stage, the presence of 
tetracycline has partially inhibited the growth while Tet(M) takes time to protect 
enough ribosomes to allow increased translation of tet(M) gene. As this happens, 
the cells are able to grow normally, indicated by comparable growth rates with 
tetracycline-free cultures towards the end of the logarithmic phase and the start of 
stationary phase. The ability of Tet(M) to protect ribosomes was demonstrated by 
Burdett (1986) although it remains a matter of speculation of the average time 
required to complete the process.  
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Interestingly, results presented also suggests that tetracycline exerted a more 
pronounced effect to the growth profile when added to the cultures during 
monitoring of growth (abf-Tc) rather than exposure at the onset (Tc-Tc). Pre-
exposing the cultures with tetracycline for overnight has assisted the cells to 
maintain the resistance during the second exposure, which led to a higher growth 
rate when compared with the non pre-exposed cells. The significance of pre-
exposing the cells to tetracycline has been highlighted in a number of studies. For 
instance, Nesin et al. (1990) have demonstrated that pre-exposure of cells to 
tetracycline not only increase the tetracycline resistance but also caused an 
increase in the level of mRNA transcripts for tet(M). Pre-exposing the cultures with 
tetracycline has also been shown to enhance conjugal transfer of Tn916 between 
Bacillus species as reported by Showsh and Andrews (1992). 
 
In the presence of tetracycline, BS79A (contains Tn916Δorf12) demonstrated a 
slower growth rate compared to the wild type BS34A (Figure 3.15), which is 
probably due to the defective start codon of orf12. The absence of the start codon 
is expected to permanently stop the translation of orf12, thus led to the maximal 
formation of the transcriptional terminator structures. Therefore minimal read-
through of transcription is expected to occur into tet(M) gene, representing  the 
basal level of transcription through these terminators. This hypothesis is supported 
by previous study by Burdett (1986) who demonstrated that the transcription into 
tet(M) without the translation of the leader peptide is possible as the ribosomes 
could still bind to the tet(M) Shine-Dalgarno site. The model proposed for tet(M) 
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regulation requires a basal level of Tet(M) to be produced in order to protect a few 
of the ribosomes in the cell in case of exposure to tetracycline. This basal level of 
expression is investigated in detail in the next chapter. 
 
As comparison of the exponential growth rates was insufficient to detect any 
biological fitness cost of BS34A (contains wild type Tn916) and BS79A (contains 
Tn916Δorf12), therefore a more sensitive and accurate evaluation was carried out 
using competition experiments. Results suggest that BS79A is 7.12% more fit than 
BS34A in the absence of selective pressure, indicating that the 2 bp mutation at the 
start codon of orf12 does not confer any fitness cost to BS79A in the absence of 
antibiotic. In fact, it appears that there is a slight fitness benefit to this strain in the 
absence of antibiotic. Although the reasons for this remain elusive, we can 
hypothesise that the level of translation of orf12 in the wild type will be more than 
zero, as it will be in BS79A therefore more terminator structures will be destroyed 
in the wild type when compared to BS79A. This means the wild type is likely 
producing a higher basal amount of Tet(M) and other Tn916 proteins.  
 
In the presence of tetracycline, the fitness of BS79A (contains Tn916Δorf12) 
reduced relative to BS92A (BS34AΔamyE) after 2-3 h of growth (Table 3.3). As 
synthesis of Tet(M) is limited in BS79A due to the defective start codon of orf12, 
therefore it is suspected that the ability of the cells to compete is substantially 
reduced especially during mid-logarithmic phase where cells are rapidly dividing, 
this is what we detected in our experiments. 
124 
 
Additionally, it was shown that in the presence of tetracycline, Tn916Δorf12 was 
transferred at a comparable frequency as the wild type Tn916 despite the mutation 
in the start codon. It has been shown previously in this study that BS34A (contains 
wild type Tn916) and BS79A (contains Tn916Δorf12) grow at different rate in the 
mid-exponential phase (Figure 3.16), hence transfer frequency was expected to be 
lower in the mutant, however this does not seems to be the case. The reason that 
contributed to this result are unclear, however it is suspected it could be due to the 
basal level of transcriptional read-through of tet(M) and the downstream genes (xis 
and int) is high enough for the transfer of the mutant Tn916orf12, although this 
needs to be experimentally proven. It also suspected that the concentration of 
tetracycline might affect the frequency of transfer as shown in a number of studies. 
Although in this study tetracycline was used at a concentration of 10 µg ml-1, which 
was previously shown to enhance the transfer of Tn916 (Showsh and Andrews, 
1992), in most cases, tetracycline was used at a sub-inhibitory concentration as 
reported by Doucet-Populaire et al. (1991) and  Ammor et al. (2008). Another 
reason, and probably the correct one, is that the filter-mating experiments are not 
refined enough to detect small differences in the transfer frequency. 
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3.5 Conclusions 
 
In this chapter the 2 bp mutation in the start codon of orf12 of Tn916 has been 
shown to have an effect on the growth of the cells [BS79A (contains Tn916Δorf12)] 
compared to the strain carrying wild type Tn916 (BS34A). However, no appreciable 
difference could be detected in the frequency of transfer to C. difficile CD37. 
Furthermore this is the first demonstration that the basal level of transcription of 
tet(M) and downstream genes is enough to provide resistance to inhibitory 
concentrations of the antibiotic (10 µg ml-1) and enough to allow transfer. 
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4 Quantitative analysis of tet(M) expression using a 
reporter gene system 
4.1 Introduction 
 
Reporter gene systems have been widely used for analysis of gene regulation as it 
offers a rapid and sensitive quantification of gene expression. There are a number 
of reporter genes available including -galactosidase (Helmer et al., 1984), 
luciferase (Slauch and Silhavy, 1991), green fluorescent protein (GFP) (Tsien, 1998) 
and -glucuronidase (Jefferson et al., 1987). The -glucuronidase gene, which 
originated from E. coli, was first used as a reporter gene for transformation of 
plants (Jefferson et al., 1987). -glucuronidase (EC 3.2.1.31) encoded by uidA (Novel 
and Novel, 1973) belongs to the family of hydrolases that catalyses the cleavage of 
a wide variety of -glucuronides. The expression of this enzyme is measured using 
colorimetric assays. 
 
In this chapter, the transcriptional regulation of Tn916 and Tn5397 was investigated 
using the -glucuronidase reporter gene system. The transcriptional activity 
initiated at the promoter upstream of tet(M); Ptet(M) was quantified 
colorimetrically. Ptet(M) is the promoter in Tn916, believed to be at the beginning 
of the regulatory network of Tn916 (Su et al., 1992; Celli and Trieu-Cout, 1998). The 
activity of Ptet(M) has been shown to be regulated by the presence of tetracycline 
(Celli and Trieu-Cout, 1998). This chapter also emphasises the functional roles of 
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the orf12 of Tn916 and the alternative orfs, orf25 and orf26 of Tn5397 in the 
transcriptional regulation of these elements.  
 
4.2 Materials and methods 
 
4.2.1  Bacterial strains and plasmids 
 
E. coli α-select (bronze efficiency) was used for transformation of pUC19-Pcwp2-
GusA and pHCMCO5 (Table 2.2). B. subtilis BS34A (contains wild type Tn916) was 
used as a host for all promoter constructs. E. coli and B. subtilis were grown under 
the conditions described in Section 2.3. 
 
4.2.2  Bacterial transformation 
 
B. subtilis and E. coli transformation was carried out according to the protocol 
described in Section 2.5.10 and 2.5.11, respectively. The E. coli transformants were 
selected on LB agar after 18-24 h incubation at 37oC. Conversely, selection of B. 
subtilis transformants were carried out on BHI agar after 24-48 h incubation at 
37oC. Agar plates were supplemented with ampicillin (100 µg ml-1), tetracycline (10 
µg ml-1) or chloramphenicol (10 µg ml-1) for selection of transformants.  
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4.2.3  Construction of Ptet(M) promoter constructs of Tn916 
and Tn5397  
 
The orf12 of Tn916 and orf25 and orf26 of Tn5397 were amplified using primers 
(Tn916: Ptet(M) For/Rev; Tn5397: Ptet(M) For5397/Rev5397) (Table 2.3) that 
bound upstream of Ptet(M) promoter and tet(M) gene (Figure 4.1 and Figure 4.2). 
The amplified PCR products were cloned into pUC19-Pcwp2-GusA, replacing the 
Pcwp2 using restriction enzymes KpnI and EcoRI (Figure 4.3). The plasmids were 
then transformed into E. coli and transformants were selected on LB agar 
supplemented with ampicillin. After 18-24 h incubation at 37oC, the transformants 
were randomly picked and grown into LB/ampicillin broth. Plasmid extraction 
(Section 2.5.1) was carried out and the purified plasmids were then sequenced. 
These plasmids were used as template in site directed mutagenesis (Section 2.5.15) 
for mutant construction (Figure 4.4). The mutant amplicons were then ligated and 
transformed into E. coli. After 18-24 h incubation, the transformants were selected 
for plasmid extraction. The purified plasmids were then digested with restriction 
enzymes KpnI and BamHI. The GusA-Ptet(M) fragments were cloned into pHCMCO5 
replacing the lacO/Pspac fragment followed by transformation into E. coli. 
Subsequently, plasmid DNA (5 µg) was prepared for transformation into B. subtilis 
BS34A (Section 2.5.9). Transformants were selected on BHI agar supplemented with 
tetracycline and chloramphenicol after 24-48 h incubation at 37oC.  
130 
 
 
Figure 4.1 Amplification of the Ptet(M) of Tn916. Primers Ptet(M) For and Ptet(M) Rev were 
designed to amplify 100 bp upstream of the orf12 and tet(M) gene. The pointed ‘P’ 
indicates the Ptet(M) promoter. The 450 bp amplified PCR product was cloned into the 
pUC19-GusA vector and transformed into E. coli.  
 
Figure 4.2 Amplification of the Ptet(M) of Tn5397. Primers Ptet(M) For5397 and Ptet(M) 
Rev5397 were designed to amplify 100 bp upstream of the orf25/26 and tet(M) gene. The 
pointed ‘P’ indicates the Ptet(M) promoter. The 358 bp amplified PCR product was cloned 
into the pUC19-Pcwp2-GusA vector and transformed into E. coli. 
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Figure 4.3 Construction of the transcriptional reporter construct, pHCMCO5-Ptet(M). The 
Ptet(M) construct was digested with restriction enzymes KpnI and EcoRI. The digested 
fragment was cloned into KpnI and EcoRI-digested pUC19-Pcwp2-GusA and transformed 
into E. coli. The prepared plasmid DNA was then digested with KpnI and BamHI, and the 
GusA-Ptet(M) fragment was cloned into a shuttle vector pHCMCO5, replacing the 
lacO/Pspac. The constructed plasmid was then transformed into E. coli and subsequently 
into B. subtilis BS34A.  
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Figure 4.4 Site directed mutagenesis of Ptet(M) Tn916 and Tn5397. The blue box 
represents the Ptet(M) constructs of Tn916 and Tn5397, green boxes represent orf12 in 
Tn916 and orf25 and orf26 in Tn5397, yellow box represents the gusA gene, grey box 
represents the plasmid backbone, red arrows represent the annealing position of the 
primers and the direction of priming. The pUC19-Ptet(M)-GusA was used as template. Two 
sets of primers (For916 ST and Rev916 ST; For5397 ST and Rev5397 ST) were used to 
introduce 2 bp mutation in the start codon of orf12 and orf26 of Tn916 and Tn5397, 
respectively. Primers For916 PO, Rev916 PO, For5397 PO and Rev5397 PO were used to 
construct the Ptet(M) without the orf12 of Tn916, and orf25 and orf26 of Tn5397. All PCR 
products were ligated and transformed into E. coli.  
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4.2.4 Measurement of reporter gene (gusA) expression 
 
 
The -glucuronidase activity was measured based on the method developed for B. 
subtilis (Belitsky et al., 1995) with slight modifications. The optical density of the 
overnight culture of B. subtilis containing the promoter constructs was measured at 
600 nm using the spectrophotometer. This culture (20 ml) was then harvested by 
centrifugation (3000 x g, 25oC, 10 min). The cell pellets were stored in the freezer   
(-70oC) for 1 h. The pellet was then thawed at room temperature (25oC) prior to 
resuspension in 0.8 ml of Z buffer (60 mM Na2HPO4.7H2O, pH7; 40 mM NaH2PO4 
H2O; 10 mM KCl; 1mM MgSO4.7H2O; 50 mM 2-mercaptoethanol) and 0.8 µl of 
toluene. The mixture was transferred to 1.5 ml tube containing unwashed glass 
beads (150-212-μm-in diameter) and treated in a Ribolyser at setting 6.5 for 25 sec 
to lyse the cells. Treatment was repeated twice. The lysates were cooled on ice for 
1 min and centrifuged (3000 x g, 4oC, 3 min) to remove the glass beads. Next 0.4 ml 
of the supernatant was removed and mixed with 0.4 ml Z buffer in a 
microcentrifuge tube. The mixture was incubated at 37oC for 5 min. The enzyme 
reaction was started by the addition of 0.16 ml of 6 mM -nitrophenyl--D-
glucuronide and incubated for 5 min at 37oC. The enzyme reaction was stopped by 
the addition of 0.4 ml of 1 M Na2CO3 followed by centrifugation (3000 x g, 25
oC, 10 
min) to remove the cell debris. The absorbance was read at 405 nm using the 
spectrophotometer. The -glucuronidase units were calculated using the following 
equation: (A405 x 1000) / [OD600 x time (min) x 1.25 x volume (ml)] (Miller, 1972).  
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4.2.5  Investigating the freezing time in -glucuronidase assay 
 
Freezing at -70oC and thawing at room temperature (Section 4.2.4) are important 
steps in -glucuronidase assay as in theory, it assists the cell lysis via ice crystal 
formation. As we knew the freezing time of some of the samples was likely to vary 
in this study, we therefore investigated the influence of different freezing time on 
the enzyme activity. B. subtilis BS80A harbouring the pHCMCO5/Tn916 Ptet(M) WT 
(wild type) (Table 2.1) and BS83A harbouring pHCMCO5/(-)Ptet(M) (promoterless 
construct) (Table 2.1) were grown in BHI broth for 18 h  under shaking conditions 
(200 rpm).  These cultures were diluted to OD600 ~0.1 using fresh pre-warmed BHI 
broths (100 ml) and left to grow for 5 h. Five ml of each culture was aliquoted into a 
25 ml tube every 1 h intervals. The OD600 was measured followed by centrifugation 
(3000 x g, 25oC, 10 min). The supernatant was discarded and the cell pellets frozen 
at -70oC. The -glucuronidase assay was carried out at the end of the 5 h 
incubation, meaning we had harvested cells incubated at -70oC for varying lengths 
of time.  
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4.2.6  Investigating the freezing time in -glucuronidase assay 
using an exponentially-grown cells at a single time point 
 
As we saw a surprising result in the above assay, we wanted to determine if 
freezing time differences would matter on aliquots of the same cells harvested at 
exponential phase of growth. This culture was grown until OD600 ~0.2. Five ml of the 
culture was aliquoted into 3 separate 25 ml tubes and froze for 1, 3 and 5 h at -70oC 
after centrifugation.  The -glucuronidase assay was subsequently carried out after 
the individual incubation times. This methodology corrected for extended growth. 
The specific activity was calculated using the equation described in Section 4.2.4. 
 
4.2.7  Determination of the basal level expression of -
glucuronidase in Tn916 and Tn5397 wild type constructs 
 
B. subtilis harbouring pHCMC05/Ptet(M) wild type constructs of Tn916 (BS80A) and 
Tn5397 (BS84A) were grown separately in BHI broths containing chloramphenicol 
10 µg ml-1) for 18 h (37oC, 200 rpm). The cultures were diluted to an OD600 of ~0.1 in 
500 ml Erlenmeyer flasks containing 100 ml fresh pre-warmed antibiotic-free BHI 
broths. Cultures were incubated at 37oC under shaking conditions (200 rpm). Five 
ml of samples were collected every 30 min intervals up to 8 h. The OD600 of the 
collected samples were measured prior to harvesting by centrifugation (3000 x g, 
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4oC, 10 min). The pelleted cells were stored at -70oC until used for the enzyme 
assay.  
 
4.2.8  Measurement of the effect of tetracycline on the 
expression of -glucuronidase in Tn916 and Tn5397 Ptet(M) 
wild type constructs 
 
B. subtilis BS80A [Ptet(M) Tn916 (wild type)] and BS84A [Ptet(M) Tn5397 (wild 
type)] were prepared as described previously in Section 4.2.7. However, in this 
experiment tetracycline (10 µg ml-1) was added to the diluted cultures after 2 h 
(mid-logarithmic phase) and 5 h (stationary phase) of growth. Cultures were grown 
for an additional 2 h after the addition of tetracycline. Samples were collected 
every 30 min intervals during that 4 h and 7 h of growth and treated as described 
previously. 
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4.2.9  Measurement of the effect of tetracycline and biocides 
on the expression of -glucuronidase in Tn916 and Tn5397 
Ptet(M) constructs 
 
In experiments to investigate the effect of tetracycline on the expression of -
glucuronidase, all Ptet(M) Tn916 [wild type (BS80A); promoter only (BS81A); start 
codon (BS82A]) and Tn5397 [wild type (BS84A); promoter only (BS85A); start codon 
(BS86A]) constructs were prepared as mentioned in Section 4.2.7. The diluted 
cultures of all Ptet(M) constructs were grown for 4 h at 37oC with shaking (200 
rpm). Tetracycline (10 µg ml-1) was added to the cultures after 2 h of growth. A 
control culture which was not challenged with tetracycline was grown in parallel for 
each construct. The expression detected in this control culture was taken as 100% 
expression for that time point and the expression of the challenged culture was 
compared to it and percentage difference calculated. Samples were collected every 
30 min intervals and treated as previously described.  
 
The effect of biocides on the expression of -glucuronidase was investigated using 
BS80A [Ptet(M) Tn916/wild type)]. The experiment was carried out as above 
however the basal level of expression before challenge was used as the control. 
Biocides (chlorhexidine digluconate (CHX), hydrogen peroxide (HP), sodium 
hypochlorite (SH) and ethanol (EtOH) were added to the cultures after 2 h of 
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growth. All biocides were used at sub-inhibitory concentrations as determined by 
our collaborators from the Technical University of Denmark (MIC/4).  
 
4.2.10 Plasmid stability test 
 
B. subtilis harbouring Ptet(M) promoter constructs of Tn916 and Tn5397 were 
grown separately  in BHI broths supplemented with chloramphenicol (10 µg ml-1) 
for 18 h (37oC, 200 rpm). The grown cultures were diluted to an OD600 of ~0.1 in 50 
ml tube containing 20 ml fresh pre-warmed antibiotic-free BHI broth. Cultures were 
incubated at 37oC under shaking conditions (200 rpm). One hundred µl of the 
cultures were collected every 30 min intervals and diluted into a total of 1 ml (900 
µl of BHI broth + 100 µl culture) to dilution factors of 104, 105 and 106. One hundred 
µl of cultures from each dilution were plated onto antibiotic free-BHI agar and BHI 
agar supplemented with chloramphenicol (10 µg ml-1). Plates were incubated at 
37oC for 18 h. The number of colonies on each plate was counted. Cells that grow 
on antibiotic free-BHI agar represents the total viable cells whereas cells grown on 
BHI agar supplemented with chloramphenicol (10 µg ml-1) represents the number of 
cells that still carry the plasmid.  
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4.3 Results 
 
4.3.1   Generation of Ptet(M) Tn916 promoter fusions  
 
The plasmid-based promoter Ptet(M) constructs of Tn916 were successfully 
transformed into B. subtilis BS34A (contains wild type Tn916). Ptet(M) indicated by -
35 and -10 (Su et al., 1992) which was located upstream of the orf12 was fused with 
the promoterless gusA gene (Novel and Novel, 1973) in the shuttle vector 
pHCMCO5. The constructed gene fusion plasmid allows the expression of the 
reporter gene, initiated at Ptet(M) promoter to be quantitated. The three Ptet(M) 
Tn916 constructs comprise either the entire orf12 [wild type, WT (BS80A)], Δorf12 
with a 2 bp mutation in the start codon of orf12 [start codon, ST (BS82A)] or the 
deletion of the entire orf12 [promoter only, PO (BS81A)] as indicated in Figure 4.5. 
In BS82A construct, the start codon of orf12 (ATG) was mutated to GCG.  
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Figure 4.5  Sequence alignment of Ptet(M) Tn916 constructs. The -35 and -10 sequences of 
Ptet(M) promoter are underlined. The 2 bp start codon mutation of orf12 is shown in red 
box (ATG ---> GCG). The dashed line illustrates the deletion of orf12. The dashed arrows 
represent the inverted repeats 5, 6, 7 and 8. The ribosome binding site (RBS) and the start 
codon of gusA are underlined. BS80A; Ptet(M) Tn916 wild type (WT), BS82A; start codon 
mutant (ST), BS81A; promoter only (PO). 
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4.3.2  Generation of Ptet(M) Tn5397 promoter fusions 
 
The plasmid-based promoter Ptet(M) constructs of Tn5397 were successfully 
transformed into B. subtilis BS34A. In Tn5397, a deletion of 84 bp upstream of 
tet(M) compared to Tn916 has generated alternative orfs; orf26 and orf25. The 
three Ptet(M) constructs of Tn5397 comprise either both orf25 and orf26 [wild 
type, WT (BS84A)], Δorf26 with a 2 bp mutation in the start codon of orf26 [start 
codon, ST (BS86A)] or the deletion of  orf25 and orf26 [promoter only, PO (BS85A)] 
as illustrated in Figure 4.6. 
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Figure 4.6  Sequence alignment of Ptet(M) Tn5397  constructs. The -35 and -10 sequences 
of Ptet(M) promoter are underlined. The 2 bp start codon mutation of orf26 is shown in red 
box (TTG ---> GCG). The dashed line illustrates the deletion of orf25 and orf26. The dashed 
arrows represent the inverted repeats 3, 4, 5 and 6. The ribosome binding site (RBS) and 
the start codon of gusA are underlined. BS84A; Ptet(M) Tn5397 wild type (WT), BS86A; 
start codon mutant (ST), BS85A; promoter only (PO). 
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4.3.3  Effect of freezing time on the activity of -
glucuronidase  
 
In this experiment, the effect of freezing time on the activity of -glucuronidase was 
investigated on cells which were frozen for 1-5 h at -70oC. This was carried out as 
we predicted there may be differences in the freezing times of the samples 
harvested throughout the experiments. As illustrated in Figure 4.7, the highest -
glucuronidase activity (1419.69  108.90 Miller Unit) was detected when B. subtilis 
BS80A [Ptet(M) Tn916 (wild type)] was frozen for 5 h. The enzyme activity 
decreased gradually with the decrease of freezing time. B. subtilis BS83A 
(promoterless construct) which was included as the control demonstrated a 
constant enzyme activity despite the differences in the freezing time. This led us to 
believe there may be a relationship with expression from this promoter and growth 
of the cells. 
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Figure 4.7  Enzymatic activity as a function of freezing time at -70oC. The B. subtilis strains 
BS80A [Ptet(M) Tn916 (wild type)] and BS83A (promoterless construct) were grown for 5 h 
in BHI broth. Samples were taken every 1 h intervals and froze for 1-5 h prior to enzyme 
assay. The bars represent the enzyme activity whereas the lines represent the growth rates 
of both strains. Error bars indicate the standard deviation of three independent 
experiments.  
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Therefore, another enzymatic assay was carried out to investigate if the -
glucuronidase activity we observed was growth-dependent. In this experiment, B. 
subtilis BS80A [Ptet(M) Tn916 (wild type)] and BS83A (promoterless construct) were 
left to grow for 2 h (OD600 ~ 0.2) prior to being frozen at -70
oC for 1, 3 and 5 h. 
Assays were carried out after each of the different incubation periods were finished 
(i.e. at 1 h, at 3 h and at 5 h). Results are illustrated in Figure 4.8. Although frozen 
for different lengths of time, the enzyme activity was comparable. These results 
suggest that the -glucuronidase activity is growth-dependent and is not affected 
by the length of freezing time during the assay.  
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Figure 4.8  Relationship between freezing time and -glucuronidase activity. B. subtilis 
strains BS80A [Ptet(M) Tn916 (wild type)] and BS83A (promoterless construct) were grown 
to 2 h prior freezing at -70oC for 1, 3 and 5 h.  Enzyme assay was subsequently carried out. 
Error bars indicate the standard deviation of three independent experiments.  
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4.3.4  Basal level expression of -glucuronidase in Tn916 and 
Tn5397 promoter constructs 
 
In this experiment, the basal expression of -glucuronidase by Ptet(M) Tn916 and 
Tn5397 wild type constructs was investigated as the previous experiments had 
indicated that this may in fact change during the growth phase of the bacteria host. 
B. subtilis BS80A [Ptet(M) Tn916 (wild type)] and BS84A [Ptet(M) Tn5397 (wild 
type)] were grown up to 8 h, and the enzyme activity was quantified. High 
expression level of -glucuronidase were observed in both constructs during lag 
and exponential phases (Figure 4.9). The highest activity recorded for BS80A and 
BS84A was at mid-exponential phase (4.5 h) before it reduced at 5 h and was 
generally constant thereafter. The enzyme activity profile observed for BS80A and 
BS84A confirmed that the expression of -glucuronidase initiated at Ptet(M) 
promoter of Tn916 and Tn5397 is growth-dependent. 
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Figure 4.9 -glucuronidase activity of B. subtilis BS80A [Ptet(M) Tn916 (wild type)] and B. 
subtilis BS84A [Ptet(M) Tn5397 (wild type)]. The bars represent the enzyme activity 
whereas the lines represent the growth of the two constructs. BS80A and BS84A were 
grown for 8 h prior to the enzyme assay. Error bars indicate the standard deviation of three 
independent experiments. 
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4.3.5  Effect of tetracycline on the expression of -
glucuronidase by Ptet(M) Tn916 and Tn5397 constructs  
 
 
The effect of tetracycline on the activity of -glucuronidase was investigated at 2 
growth points; one in exponential and one in stationary. This experiment was 
carried out using B. subtilis BS80A [Ptet(M) Tn916 (wild type)] and BS84A [Ptet(M) 
Tn5397 (wild type)]. In the exponential phase, both strains were grown up to 2 h 
prior to addition of an inhibitory concentration of tetracycline (10 µg ml-1). BS80A 
demonstrated an increase in the enzyme activity (62%  21%) after 1 h of exposure 
to tetracycline, and activity was maintained up to 2 h after exposure (Figure 4.10).  
 
In contrast, no significant increase in the enzyme activity of BS84A was detected 
when cells were challenged with tetracycline (Figure 4.11). This result suggests that 
the enzyme activity initiated from Ptet(M) of Tn5397 was not upregulated by 
tetracycline as observed for Ptet(M) of Tn916.  
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Figure 4.10 -glucuronidase activity of the Ptet(M) Tn916 construct at exponential phase 
compared to an unchallenged culture. The black arrow shows the time point where B. 
subtilis BS80A [Ptet(M) Tn916 (wild type)] was exposed to tetracycline. Results presented 
are the average of three independent experiments. 
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Figure 4.11 -glucuronidase activity of the Ptet(M) Tn5397 construct at exponential phase. 
The black arrow shows the time point where B. subtilis BS84A [Ptet(M) Tn5397 (wild type)] 
was exposed to tetracycline. Results presented are the average of three independent 
experiments. 
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In the stationary phase, BS80A [Ptet(M) Tn916 (wild type)] were grown for 5 h 
before being exposed to tetracycline. The effect of tetracycline to the expression of 
-glucuronidase was measured up to 2 h after exposure. The tetracycline 
downregulated the transcriptional activity of Ptet(M) Tn916 after 1 h of exposure. A 
slight increase in enzyme activity was later observed (Figure 4.12). As we do not 
observe any upregulation in the expression of -glucuronidase during the stationary 
phase for BS80A, therefore expression of BS84A [Ptet(M) Tn5397 (wild type)] at this 
phase is not tested.  
 
An increase in the enzyme activity during exponential phase and not during the 
stationary phase revealed that the tetracycline-based transcriptional regulation at 
Ptet(M) of Tn916 is growth phase-dependent. 
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Figure 4.12 -glucuronidase activity of the Ptet(M) Tn916 construct at stationary phase. 
The black arrow shows the time point where B. subtilis BS80A [Ptet(M) Tn916 (wild type)] 
was exposed to tetracycline. Results presented are the average of three independent 
experiments. 
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4.3.6  The functional role of orf12 and orf26 in the regulation 
of Tn916 and Tn5397 
 
The involvement of orf12 and orf26 in the regulation of Tn916 and Tn5397, 
respectively was further investigated. In this experiment, a total of 3 Ptet(M) 
promoter constructs for each conjugative transposons were tested;  
 
Tn916: BS80A [Ptet(M) Tn916 (wild type)]; BS82A, with a 2 bp mutation in the start 
codon of orf12 [Ptet(M) Tn916 (start codon)]; BS81A, with the deletion of the entire 
orf12 [Ptet(M) Tn916 (promoter only)], and  
Tn5397: BS84A, consists of orf25 and orf26 [Ptet(M) Tn5397 (wild type)]; BS86A, 
with a 2 bp mutation in the start codon of orf26 [Ptet(M) Tn5397 (start codon)] and 
BS85A, with the deletion of orf25 and orf26 [Ptet(M) Tn5397 (promoter only)]. 
 
All constructs were grown for 4 h with an exposure to tetracycline at 2 h. Figure 
4.13 illustrates the enzyme activity observed for Ptet(M) Tn916 constructs. All 
constructs demonstrated highest enzyme activities during the first 1 h of growth, 
before the activities decline by 1.5 h. A marked increase in the activity of BS80A 
[Ptet(M) Tn916 (wild type)] and BS81A [Ptet(M) Tn916 (promoter only)] was 
observed when tetracycline was added to the culture. However, BS82A [Ptet(M) 
Tn916 (start codon)] show an indistinguishable activity. 
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Figure 4.13 The -glucuronidase activity of the Ptet(M) Tn916 promoter constructs. The 
bars represent the enzyme activity whereas the lines represent the growth rates of the 
three constructs. The B. subtilis constructs were grown up to 4 h with exposure to 
tetracycline (shown in black arrow) at mid-exponential phase (2 h). Error bars indicate the 
standard deviation of three independent experiments. 
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Figure 4.14 show the enzyme activity observed for Ptet(M) constructs of Tn5397. In 
BS85A [Ptet(M) Tn5397 (promoter only)], highest enzyme activity was observed 
during the first 1 h of growth before it went down thereafter despite the presence 
of tetracycline at 2 h. In contrast, the enzyme activities observed for BS84A [Ptet(M) 
Tn5397 (wild type)] and BS86A [Ptet(M) Tn5397 (start codon)] are generally 
constant throughout the 4 h growth and the presence of tetracycline does not seem 
to upregulate the expression of -glucuronidase in these constructs. At this point, it 
is difficult to interpret the result. Therefore, a plasmid stability test was carried out 
to investigate if the instability of plasmid has led to the results we observed.  
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Figure 4.14 The -glucuronidase activity of the Ptet(M) Tn5397 promoter constructs. The 
bars represent the enzyme activity whereas the lines represent the growth rates of the 
three constructs. The B. subtilis constructs were grown up to 4 h with exposure to 
tetracycline (shown in black arrow) at mid-exponential phase (2 h). Error bars indicate the 
standard deviation of three independent experiments. BS84A [Ptet(M) Tn5397 (wild type)]; 
BS85A: [Ptet(M) Tn5397 (promoter only)]; BS86A [Ptet(M) Tn5397 (start codon)]. 
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4.3.7  Plasmid stability of Ptet(M) promoter constructs 
 
Plasmid stability test was carried out on all Ptet(M) constructs of Tn916 and 
Tn5397, mainly to determine if the instabilities of plasmid, pHCMCO5 which carries 
the promoter constructs has resulted to a low enzyme activity observed . Based on 
the results (raw data is included in Appendix A), it can be concluded that pHCMCO5 
carrying Tn916 promoter constructs are stable throughout the first 2 h growth 
hence the low activity observed is not due to the plasmid instability. However, each 
construct in the Tn916 group showed instability after this time and therefore the 
data was corrected for this instability and is presented in Figure 4.15. The Tn5397 
construct were stable throughout the experiment. 
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Figure 4.15 The corrected data of -glucuronidase activity of the Ptet(M) Tn916 promoter 
constructs based on plasmid stability. Panel A shows the original data whereas Panel B 
shows the corrected data.  
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4.3.8 Biocides upregulate the expression of -glucuronidase 
 
 
This experiment was carried out to test the hypothesis that the regulation of Tn916 
is dependent on the rate of transcription (charged tRNA level) rather than the 
presence of tetracycline (Roberts and Mullany, 2009). In this collaborative work 
between our laboratory and the Research group for Microbial Genomics and 
Antimicrobial Resistance, Technical University of Denmark, the effect of biocides on 
the expression of -glucuronidase of BS80A [Ptet(M) Tn916 (wild type)] was 
investigated. Four biocides; ethanol (EtOH), hydrogen peroxide (HP), chlorhexidine 
digluconate (CHX) and sodium hypochlorite (SH) at sub-lethal concentrations 
(MIC/4) were tested. Cultures were grown up to 4 h, and exposed to the tested 
compounds after 2 h of incubation. EtoH upregulated the expression of -
glucuronidase after 2 h of exposure, with 46-54% increase in transcription 
compared to the basal level before exposure. This is somewhat different to the 
other three biocides, where the activity increases as early as 1 h after exposure. The 
highest activity recorded for HP was 42%, as compared to the CHX and SH with 15% 
and 24%, respectively (Figure 4.16). All enzyme activities were standardised to the 
control sample (non-exposed sample) to adjust for the basal level expression.  
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Figure 4.16 Effect of biocides on the activity of -glucuronidase of the Ptet(M) Tn916 
promoter construct. The construct, designated BS80A [Ptet(M) Tn916 (wild type)] was 
grown up to 4 h, with exposure to sub-lethal concentrations of biocides after 2 h of growth. 
Four biocides were tested; panel A represents the ethanol, panel B represents the 
hydrogen peroxide, panel C represents the chlorhexidine digluconate and panel D 
represents the sodium hypochlorite. The Y-axis represents the enzyme activity (Miller Unit) 
whereas the X-axis indicates the time in hours after exposure to biocides. Data presented 
with permission by Seier-Petersen, M. A. 
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4.4 Discussion 
 
This study was designed to gain an insight into the functional role of orf12 and 
orf26 in the transcriptional regulation of Tn916 and Tn5397, respectively. In order 
to do this, a -glucuronidase gene was used as a reporter gene system to 
quantitatively measure the read-through activity of orf12 and orf26 under the 
control of Ptet(M) promoter. Expression of -glucuronidase is measured using 
fluorometric assay for B. subtilis which was developed by Belitsky et al. (1995). As 
this assay involves a freezing step at -70oC, which was identified to assist the cell 
lysis, therefore an investigation into the effect of different freezing time to the 
enzyme activity was carried out. This was essential considering that throughout the 
experiments, samples are taken and frozen at different time points prior to enzyme 
assay at the end. Although the results suggested that the enzyme activity increased 
as the length of freezing time increased (Figure 4.7), it was unclear, however, 
whether the increase in the activity was due to the freezing time or the continuing 
growth of the cells. To verify this, another enzymatic assay was carried out on cells 
grown for 2 h and frozen for different times (1, 3 and 5 h). Interestingly, the enzyme 
activity observed were indistinguishable despite the variation in their freezing time, 
which strongly implies that the activity of -glucuronidase is growth-dependent and 
is not affected by the length of freezing time during the assay. This is a novel finding 
as it shows, for the first time, that expression from the Ptet(M) is growth-
dependent.  
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Further to this, an experiment to measure the basal level expression of -
glucuronidase was carried out, mainly to investigate if the growth-dependent 
enzyme activity previously observed in the initial experiments described above is 
reproducible. Generally, basal level expression is a minimum expression of a gene 
ensuring that there is always a minimal amount of protein present in the cell in the 
absence of an inducer (Krebs et al., 2010). In this experiment, the enzyme activity of 
B. subtilis strains BS80A [Ptet(M) Tn916 (wild type)] and BS84A [Ptet(M) Tn5397 
(wild type)] which were grown for 8 h was quantified. Our finding that the enzyme 
activities are maximal during the lag and mid-exponential phases reinforces our 
previous data that the enzyme activity is growth-dependent. It is postulated that 
during the lag phase, the rate of protein translation increases in response to the 
adaption of the cells to the new environment (fresh growth media). Additionally the 
cells are likely to have high levels of tRNA, having previously been in stationary 
phase. This would conceivably allow them to react quickly in the presence of 
nutrients. However, as the protein translation continues, the amount of charged 
tRNA (especially the rare ones in the leader peptide) in the cells become limited, 
thus led to the reduction of protein translation. The activity appears to remain low 
during exponential phase, presumably due to the low amount of tRNA, as a result 
of high protein translation. In stationary phase, the activity increase and this may 
be due to the fact that as nutrients are becoming limited protein production is 
slowing down and therefore tRNA pool is increasing allowing the ribosome to once 
again catch up with the RNA polymerase leading to expression of the reporter. As 
the amount of charged tRNA decreases through stationary phase, a lowering of the 
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enzyme activity is observed. At this phase, however, it is also possible that the low 
activity observed is due to the dying cells and consequent degradation of proteins. 
For a mobile genetic element to be able to detect when nutrients are running out in 
the environment of its host cell would be advantageous as it would be a good time 
for it to transfer. Upon entering stationary phase the host cells are also at high 
density (at least in the laboratory culture) and this may provide better opportunity 
for the element to gain access to a suitable recipient. It is possible that this situation 
may also occur in nature e.g. in the gut.  
 
A number of studies illustrated a growth phase-associated gene expression 
(Wanner et al., 1977; Liang et al., 1999) which shows variations in the expression 
profile in response to growth-phases. For instance, the expression of the excision 
genes from the Bacteroides mobilisable transposon NBU1 is constant at the early 
growth-phase, and increase at the beginning of the late exponential phase (Song et 
al., 2009). Conversely, enterotoxin (cpe)-gusA expression in C. perfringens was 
undetectable throughout the exponential phase but is shown to increase by 3-fold 
at the beginning of the stationary phase (Mellville et al., 1994).  
 
Further investigation was done by measuring the expression level of -
glucuronidase in the presence of tetracycline using BS80A [Ptet(M) Tn916 (wild 
type)] and BS84A [Ptet(M) Tn5397 (wild type)] constructs. BS80A demonstrated an 
increase in the expression level after 1 h of exposure to tetracycline (Figure 4.10). In 
the presence of tetracycline, most ribosomes are inactivated, which resulted in a 
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build up of charged tRNA molecules. As there are a few ribosomes that are 
protected by Tet(M) these ribosomes start translating the orf12 using the 
accumulated tRNAs. A rapid translation of orf12 prevents the formation of the 
terminators within the orf12 and leads to a high expression level of the reporter 
gene located downstream of orf12. This data highlights the central role of the orf12 
region in the transcriptional response of Tn916 to tetracycline, and is therefore 
consistent with the previously proposed transcriptional attenuation model by Su et 
al. (1992). The expression level of -glucuronidase in the presence of tetracycline 
was also tested at stationary phase, however there is no increase in the enzyme 
activity observed. These results imply that the enzyme activity is not only 
upregulated in the presence of tetracycline, but it is also a growth-dependent.  The 
expression level of BS84A (Tn5397 WT construct) does not show the same increase 
in the presence of tetracycline as observed for the Tn916 construct. This result is in 
contrast to the reported data by Roberts (2001) which demonstrated an inducible 
expression of this element by comparative growth curve and reverse transcriptase 
PCR, however this was not quantified so the actual level of increase in transcription 
is not known. At 1 h after addition of tetracycline the Tn5397 reporter construct 
gave high expression compared to the control, however this high level of expression 
compared to the control was also seen before addition of tetracycline. It is difficult 
to interpret this data but there is a feature in the sequence of the terminator in 
Tn5397 which is described in the following chapter. 
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To further understand the system, therefore Ptet(M) promoter mutants were 
constructed which was described in Section 4.3.1 and Section 4.3.2. These 
constructs consist of a 2 bp mutation in the start codon of orf12 (BS82A) and orf26 
(BS86A), and a deletion of the entire orf12 (BS81A) and orf25 and orf26 (BS85A). 
The expression level of all promoter mutants were quantitated and compared to 
the wild type constructs (BS80A and BS84A). As all the constructs were plasmids, 
we also wanted to ensure that the stability of the plasmids did not affect the 
expression levels that we observed. Therefore, dilutions were plated out from each 
time point onto antibiotic free and chloramphenicol containing agar plates. The 
percentage growing on chloramphenicol compared to the total cell count on the 
antibiotic free was taken as the percentage stability. It was noticed that in the 
Tn916 constructs the stability of the plasmids reduced after 2 h and therefore the 
data presented in Figure 4.13 was corrected e.g. at time point x, if culture A had 
50% plasmid containing cells and gave a reading of 500 Miller Units this would be 
correct to 1000 Miller Units (assuming a 100% plasmid maintenance). This data is 
presented in Figure 4.15. The wild type expression levels (BS80A) reduced as the 
culture progressed through exponential phase as expected from the data from the 
previous chapter. Following addition of tetracycline at 2 h, we observed an increase 
in the expression until 1 h following addition of tetracycline. Then the expression 
levels go down, presumably as the pool of charged tRNAs are being used up.  
 
The construct containing the start codon mutation (BS82A) show a similar level 
before addition of tetracycline, again representing the basal level of expression. 
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However when tetracycline was added it showed an increase. This could be due to 
the fact that the B. subtilis host BS34A contains a copy of Tn916 in its chromosome 
(required as we were challenging with tetracycline). Therefore the ribosomes of the 
cell are likely to become protected by Tet(M) which will lead to an increase in 
overall gene expression. This will include our reporter construct. Again, as the levels 
of tRNA are expected to reduce a reduction is seen in the expression of BS82A 
[Ptet(M) Tn916 (start codon)]. Therefore, we can say that the effect seen in BS80A 
[Ptet(M) Tn916 (wild type)] is due to the attenuation system located within orf12 
and the profile seen with BS82A most likely represents the background expression 
pattern for rest of the chromosome which is being actively transcribed. 
 
The promoter only construct (BS81A) shows an unexpected profile in that it is not 
constant as we could predict. It is higher in expression compared to the wild type 
and the start codon mutation which strongly suggests that the predicted 
terminators in this region are actively terminating transcription. This is investigated 
fully in the next chapter. It does reduce during growth of the culture which again 
suggests that the activity of this promoter is growth phase dependant. This is in 
agreement with the experiments in Chapter 3. Following addition of tetracycline 
the is an unexpected increase in activity, however this is due to the correction we 
have applied for the low stability of this plasmid. It could be that the plasmid is 
simply too unstable because it contains such a strong promoter and therefore when 
the tRNA levels are high (after exposure to tetracycline) its activity increases 
dramatically, which may also explain its instability.  
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Although Tn916 and Tn5397 are closely related, results presented in this study 
revealed that the presence of tetracycline does not upregulate the expression of -
glucuronidase initiated at Ptet(M) of all Tn5397 constructs. It is interesting to note 
that the plasmid constructs were all 100% stable throughout the experiment 
(Appendix A). The wild type expression (BS84A) gradually decreases with 
exponential growth, however upon exposure to tetracycline there is a modest 
increase. This could simply be due to the protected ribosomes resulting from the 
expression of Tet(M) from the chromosomal copy of Tn916. This is different to what 
we expected and an explanation is put forward to explain this in the next chapter. 
 
The orf26 start codon mutant (BS86A) showed no real change throughout the 
experiment. This was as expected and most likely represents the basal level of 
expression through the predicted terminators. The promoter only construct 
(BS85A) shows relatively high levels of expression compared to the other two 
constructs and decrease with the growth of the cells again suggesting this promoter 
is a growth phase-dependant promoter. It is possible that a specific sigma factor is 
produced during the early stages of growth and this is responsible for the 
differential expression of the terminator. 
 
 In a collaborative work between our laboratory and the Research group for 
Microbial Genomics and Antimicrobial Resistance, Technical University of Denmark, 
the effect of biocides on the transcriptional regulation of Tn916 was investigated 
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using the reporter system constructed here. Results showed that the exposure of 
cells to biocides has upregulated the expression of -glucuronidase, which is 
observed at an average of 1.5-2 h after exposure. As biocides are known for their 
ability to cause multiple damages to the biological system of bacteria (McDonnell 
and Russell, 1999), therefore it is suspected that this damage could result in the 
accumulation of charged tRNA molecules in the cells, due to the disruption of 
protein synthesis, which in turn results in the upregulation of -glucuronidase 
expression. This result supports the hypothesis that the regulation of Tn916 does 
not necessarily depend on the presence of tetracycline, but any event or process 
that could possibly increase the amount of charged tRNA molecules (Roberts and 
Mullany, 2009). This makes evolutionary sense as it will benefit the element if it can 
detect multiple stresses on the host which lead to transfer. 
 
4.5 Conclusion 
 
This study highlights the role of the leader peptide orf12 in the transcriptional 
regulation of Tn916. More work will be necessary to determine the functional role 
of orf26 in the transcriptional regulation of Tn5397 as the response, if any, was 
weaker. The data in this chapter also supports the theory that the promoter is 
differentially expressed with high expression in the early growth phase. The work 
with the biocides shows that multiple stresses can affect the expression from the 
Ptet(M) of Tn916. 
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5 Investigation into the efficiency of terminators located 
upstream of tet(M) in Tn916  
5.1 Introduction 
 
Regulation of gene expression at the level of transcription in bacteria involves four 
identifiable steps; promoter recognition, initiation of transcription, transcript 
elongation and transcription termination (Turner et al., 2000). The efficiency of 
regulation of gene expression at this level is associated with the efficacy of the 
system in promoting as well as terminating the transcriptional processes. A 
terminator consists of two complementary sequences, capped by a short loop and 
followed by thymidine (T)-rich stretches. Studies have shown that the 
transcriptional terminators can be located within as well as at the end of an operon 
(Yanofsky, 1981). Over the years, many studies have been carried out focusing on 
the prediction of the transcriptional terminators in bacterial genomes (Hess and 
Graham, 1990; d’ Aubenton Carafa et al., 1990). Further work has focused on 
evaluating the efficiency of the terminators in terminating the transcription process 
using an algorithm (d’ Aubenton Carafa et al., 1990; Ermolaeva et al., 2000).  
 
In this study, the efficiency of the terminators located within orf12 of Tn916 were 
evaluated using the gusA reporter system employed in Chapter 4. There are two 
terminators within this regulatory region; one large which will be known as the 
large terminator (LT) and one smaller which will be known as the small 
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terminator(ST). These terminators consists of two complementary sequences 
separated by 4-6 bases and followed by 4-5 T residues (Figure 5.1). Having a 
common structural similarity with the reported terminators, the transcriptional 
termination in this region of Tn916 is therefore expected to occur according to the 
established model by Farnham and Platt (1980); the RNA stem loop that forms 
induces the RNA polymerase to pause, and the unstable rU-dA hybrid (Martin and 
Tinoco, 1980) between the nascent RNA and the transcribed DNA strand releases 
the transcript and leads to the dissociation of the RNA polymerase from the DNA 
and terminates the transcription process. In this study, various terminator 
constructs were designed to allow the efficiency of each terminator to be evaluated 
individually. Following the in vitro enzymatic reporter assays, an analysis of the 
predicted termination efficiency was carried out using algorithms developed by d’ 
Aubenton Carafa et al. (1990) and these were compared to the experimental data.  
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Figure 5.1 The predicted stem loop structures and terminator sequences in the mRNA of 
orf12 of Tn916. The red-shaded area represents the orf12. The free-energy values (ΔG) of 
each structure are shown in kcal mol-1. The run of U residues are underlined and the 
terminator structures are labeled LT (large terminator) and ST (small terminator). (Taken 
from Roberts and Mullany, 2009) 
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5.2 Materials and methods 
 
5.2.1  Bacterial strains and plasmid 
 
E. coli α-select (bronze efficiency) was used for transformation of pHCMCO5 (Table 
2.2) containing the terminator constructs. This plasmid was subsequently 
transformed into B. subtilis BS34A (contains wild type Tn916). E. coli and B. subtilis 
were grown under the conditions described in Section 2.3. 
 
5.2.2  Bacterial transformation 
 
E. coli and B. subtilis transformation were carried out according to the protocol 
described in Section 2.5.11 and 2.5.10, respectively. The E. coli transformants were 
selected on LB agar after 18-24 h incubation at 37oC. Selection of B. subtilis 
transformants was carried out on BHI agar after 24-48 h incubation at 37oC. Agar 
plates were supplemented with ampicillin (100 µg ml-1), tetracycline (10 µg ml-1) or 
chloramphenicol (10 µg ml-1) for selection of transformants.  
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5.2.3  Construction of Tn916 terminator constructs  
 
The efficiency of the transcriptional terminators within orf12 of Tn916 was 
investigated using two sets of plasmid-based terminator constructs, which were 
constructed using the site directed mutagenesis approach described in detail in 
Chapter 4. Primers used to amplify all terminator constructs are listed in Table 2.3.  
In both sets, the terminators were fused with the reporter gene, gusA encoding for 
-glucuronidase. The efficiency of the terminators was determined using the -
glucuronidase assay.  
 
5.2.3.1 Construction of terminator construct set I 
 
In the first set of terminator constructs (referred to as terminator construct set I), 
the upstream and the downstream sequences of the terminators were deleted, 
leaving the test terminator structure alone as shown in Figure 5.2. This construct 
allows the termination efficiency of each terminator to be tested while eliminating 
the background effect of the other terminator.  
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Terminator Construct Set I 
 
A.  Wild type (WT) 
 
B.  Large terminator (LT) 
 
 
  
 
  
 
C. Small terminator (ST) 
 
D. Promoter only (PO) 
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Figure 5.2 Schematic diagram of the transcriptional terminator constructs set I. All constructs were cloned into pHCMCO5 and transformed into B. 
subtilis BS34A. The pointed ‘P’ indicates the Ptet(M) promoter. The red-shaded area represents orf12 of Tn916. The free-energy values (ΔG) of 
each structure are shown in kcal mol-1. The green box represents the reporter gene gusA. In wild type construct (WT), both terminators are 
present. In constructs with the large (LT) and small (ST) terminators, the upstream and downstream sequences were deleted, thus leaving only the 
test terminator alone. Both terminators were absent in promoter only (PO) construct. 
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5.2.3.2 Construction of terminator construct set II  
 
In another set of terminator constructs (referred to as terminator construct set II), 
the T residues downstream of the stem loop structure were mutated into a series of 
G and C residues as illustrated in Figure 5.3. The GC nucleotides that substitute the 
poly-T residues is expected to overcome the weak interaction between the nascent 
RNA transcript and the DNA strand (rU-dA) that leads to the dissociation of the RNA 
polymerase and thus terminates the transcription.  
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Terminator Construct  Set II 
 
A. Wild type (WT) 
 
B. Large terminator (LT) 
 
 
 
 
 
 
 
    
 
 
C. Small terminator (ST) 
 
D. Large and small terminator (LTST) 
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Figure 5.3 Schematic diagram of the transcriptional terminator constructs set II. All constructs were cloned into pHCMCO5 and transformed into B. 
subtilis BS34A. The pointed ‘P’ indicates the Ptet(M) promoter. The red-shaded area represents orf12 of Tn916. The free-energy values (ΔG) of 
each structure are shown in kcal mol-1. The green box represents the reporter gene gusA. In wild type construct (WT), both terminators are 
present. In large (LT), small (ST) as well as large and small (LTST) terminator constructs, the underlined T residues were mutated into GC 
nucleotides as shown in brackets. 
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5.2.4  Prediction of the termination efficiency using an 
algorithm 
 
An algorithm developed by d’ Aubenton Carafa et al. (1990) was used to predict the 
termination efficiency of the transcription terminators located in orf12 of Tn916. 
This algorithm was constructed based on two parameters that defined the putative 
terminator structures. The first parameter is nT, defined as the total counts of the 
stretch of T residues, following the double stranded stem of the terminator. The 
calculations are as follows: 
n = n-1 x 0.9  if the nth nucleotide is a T 
n = n-1 x 0.6  if the nth nucleotide is other than T 
 
The value for the first T is:  1 = 0.9, and n is calculated as the sum of the T residues only, 
therefore;               
                   
Equation 5.1 nT =  n    for all T residues in the terminator. 
 
For example, in hexanucleotide TTATTT, the nT is calculated as follows: 
 
T:      0.9 
T:      0.9 x 0.9 = 0.81 
A:      0.81 x 0.6 = 0.486 
T:      0.486 x 0.9 = 0.437 
T:      0.437 x 0.9 = 0.394 
T:      0.394 x 0.9 = 0.354 
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Therefore nT = 0.9 + 0.81 + 0.437 + 0.394 + 0.354 = 2.895 (nT counts only the T residues). 
The value 0.2895 is considered as the minimum value possible for the stretch of T residues 
of a real terminator and values less than 2.895 are therefore rejected (d’ Aubenton Carafa 
et al., 1990). 
 
The second parameter for the algorithm is the Y value, which is the function of the 
Gibbs free energy (ΔG) against the number of nucleotides between the 5’ end of 
the stem and the first U in the stretch (LH). Y value is calculated as follows: 
 
 Equation 5.2  Y = (-ΔG)/LH  
 
By using the value from the defined parameters nT and Y, d’ Aubenton Carafa et al. 
(1990) has plotted a two dimensional diagram to distinguish the real transcriptional 
terminators from intracistronic or random structures. Line D was drawn to obtain 
the best separation between the two structures (Figure 5.4). From the diagram, the 
distance between a point (a structure) and the line D was indicated. Based on the 
computational analysis, the following equation was derived; 
 
Equation 5.3   d = nT x 18.16 + Y x 96.59 – 116.87, where condition d>0 is applied to all 
terminator structures. 
 
The correlation between the d value (Equation 5.3) and the percentage of the 
termination efficiency was empirically estimated and is shown in Figure 5.5 (d’ 
Aubenton Carafa et al., 1990).  
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Figure 5.4 A two dimensional diagram showing the separation of the real transcriptional 
terminators from the intracistronic or random structures in E. coli.  (●) represents the real 
transcriptional terminators whereas (○) represents either the intracistronic or random 
structures. The nT and Y (-ΔG)/LH) values for each structure were plotted on abscissa (x-
coordinate) and on ordinate (y-coordinate), respectively. A best separation between the 
two structures was obtained using line D. The distance between a point (a structure) and 
the line D was indicated. (Taken from d’ Aubenton Carafa et al., 1991) 
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Figure 5.5  The correlation between the score d and the percentage of the termination 
efficiency of some rho-independent terminators in E. coli. The terminators are named 
based on the preceding gene or operon: (□) rrnB T1, bacteriophage T7 Te; (▲) ampL 
attenuator and ampL35A mutant; (○) infC, pheS attenuator, his attenuator, trpt and 
trpC301 and trpC302 mutants, bacteriophage T3 Te; (Δ) tonB (both directions), rplT; (●) trp 
attenuator, trp a1419 and trp a135 mutants, trpL77, trpL78, trpL80, trpL153 mutants; (■) 
thr attenuator and T2, T3, T4, T5, T6, T8 mutants in the poly (U) stretch; (□) thr attenuator 
stem mutants L135U, L138U, L139U, L140A, L151A, L151U,  L153A, L153U, L153 + G, L153 –
G, L156U;  (X) rnpB; (+) intracistronic signals in cca. (Taken from d’ Aubenton Carafa et 
al., 1991) 
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5.3 Results 
 
5.3.1  Generations of Tn916 terminator constructs 
 
Construction of set I and set II terminator constructs was carried out as described in 
Sections 5.3.2.1 and 5.3.2.2, and this was verified by DNA sequencing. As shown in 
Figure 5.6, set I constructs constitute only the desired terminator regions. In the 
wild type construct (BS80A), the large and small terminators are both present. In 
the following two constructs (BS87A and BS88A), either the large or small 
terminator is present. Conversely, both terminators are absent in the BS81A 
construct. All constructs were fused with the reporter gene gusA which encodes for 
-glucuronidase. 
 
Set II constructs contain the entire orf12 sequence as illustrated in Figure 5.7. 
However, other than the wild type (BS80A), the T residues downstream of the stem 
loop structure of all constructs were substituted with a series of G and C residues. 
In BS89A and BS90A constructs, the T residues were mutated to CGGTC and CGGC, 
respectively. Conversely, no terminator is present in BS91A construct as both of the 
poly-T residues are mutated. 
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Figure 5.6 Sequence alignment of the Ptet(M) Tn916 terminator constructs set I. The -35 
and -10 of the Ptet(M) promoter are underlined. The start codon of orf12 is labeled and 
underlined. The dotted arrows represent the large (LT) and small (ST) terminators. The 
dashed line illustrates the deletion of the terminator in each constructs. The ribosome 
binding site (RBS) and the start codon of gusA are underlined. BS80A; wild type, BS87A; Δ 
small terminator, BS88A; Δ large terminator, BS81A; Δ large and small terminators. 
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Figure 5.7 Sequence alignment of the Ptet(M) Tn916 terminator constructs set II. The -35 
and -10 of the Ptet(M) promoter are underlined. The start codon of orf12 is labeled and 
underlined. The dotted arrows represent the large (LT) and small (ST) terminators. The 
mutated T residues are shown in red boxes. The ribosome binding site (RBS) and the start 
codon of gusA are underlined. BS80A; wild type, BS89A; Δ small terminator, BS90A; Δ large 
terminator, BS91A; Δ large and small terminators. 
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5.3.2  Estimation of the termination efficiency of the 
terminators using an in vitro reporter gene assay  
 
The efficiency of the Tn916 terminators in terminating the transcription was 
investigated using -glucuronidase assay. Figure 5.8 illustrates the enzyme activity 
observed for the terminator constructs in set I. In the absence of the small 
terminator (BS87A), the enzyme activity increased up to 53% as compared to the 
wild type (BS80A). The enzyme activity is more pronounced (77%) when the large 
terminator (BS88A) is absent. As the enzyme activity is considered reciprocal to the 
termination efficiency, these results suggest that the large terminator is more 
efficient than the small terminator in terminating the transcription initiated at the 
Ptet(M) of Tn916. Surprisingly the construct without either terminator (BS81A) 
demonstrated a lower activity when compared to BS87A (Δ small terminator) and 
BS88A (Δ large terminator) although it is expected that the absence of these 
terminators will result in the highest enzyme activity due to it having the lowest 
(presumably zero) termination efficiency.  
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Figure 5.8 -glucuronidase activity of the Tn916 terminator constructs in set I. The enzyme 
activity was measured after 2 h of growth. Error bars indicate the standard deviation of 
three independent experiments.  
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We hypothesised that we may have altered the secondary structures by carrying 
out deletions in these constructs. Therefore, in order to make sure that no 
alternative secondary structures had formed in the RNA, the terminator constructs 
set I were re-designed by restoring the sequences located  upstream of the stem 
loop and  downstream of the T residues. Similarly, the termination efficiency of the 
terminators in these constructs (set II) was determined using -glucuronidase assay. 
As shown in Figure 5.9, BS90A (Δ large terminator) which comprises the mutated T 
residues following the large stem loop structure demonstrated an increase in the 
enzyme activity as compared to the wild type (BS80A). On the contrary, a reduction 
in the enzyme activities was observed for BS89A (Δ small terminator) and BS91A (Δ 
small and large terminators).  
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Figure 5.9  -glucuronidase activity of the Tn916 terminator constructs II. The enzyme 
activity was measured after 2 h of growth. Error bars indicate the standard deviation of 
three independent experiments. 
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5.3.3  Mfold analysis of the terminator structures in set II 
 
 
The mfold program developed by Zuker (2003) is a web server that uses 
computational approach to predict the RNA secondary structure. This program was 
applied in this study to investigate the predicted RNA structure of the terminator 
constructs in set II as we found it difficult to interpret the results.  This step was 
performed mainly to observe if the Shine-Dalgarno sequence of the reporter gene is 
occluded which would lead to a decrease enzyme activity of the terminator 
constructs [BS89A (Δ small terminator) and BS91A (Δ small and large terminators)]. 
Results presented suggest that although the RBS and the start codon of -
glucuronidase did appear to be  occluded in the most energetically favourable folds 
(Figure 5.10), the RNA structures of the terminator constructs in set II are all 
conserved despite an extra binding region following the large terminator in two of 
the constructs (BS90A and BS91A). However, it is not certain if this has an effect. 
There is nothing specific to BS89A and BS91A in terms of predicted folding 
compared to the other constructs, therefore, the unexpected low activities 
observed are not likely to be due to the changes in the RNA secondary structure. 
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Figure 5.10 Structure of terminator constructs set II as predicted by mfold. The expected 
stem loop structures were visible in the predicted folds in all constructs despite the 
mutated T residues (shown in blue boxes). The start codon and the ribosome binding site 
(RBS) of -glucuronidase are shown in red boxes. Black arrows show the extra binding 
regions following the large terminator. Panel A represents the wild type (BS80A), panel B 
represents the mutated small terminator (BS89A), panel C represents the mutated large 
terminator (BS90A) and panel D represents the mutated large and small terminators 
(BS91A).  (Zuker, 2003) 
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5.3.4 Estimation of the termination efficiency of the 
terminators using an algorithm 
 
The termination efficiency of the terminators in Tn916 was estimated using an 
algorithm developed previously by d’ Aubenton Carafa et al. (1990) (Section 5.2.4). 
The calculations are as follows; 
 
As the nT =  n   and the large terminator are pentanucleotides TTTTT, therefore: 
     T:      0.9 
     T:      0.9 x 0.9 = 0.81 
     T:      0.81 x 0.9 = 0.729 
     T:      0.729 x 0.9 = 0.656 
     T:      0.656 x 0.9 = 0.590 
 
Therefore nT = 0.9 + 0.81 + 0.729 + 0.656 + 0.590 = 3.685, and as 
 
 
     Y = (-ΔG)/LH, therefore 
 
     Y = 20.6/30 
 
     Y = 0.69 
 
      
d value of the large terminator therefore equals:  
 
     d = nT x 18.16 + Y x 96.59 – 116.87 
     d = 3.685 x 18.16 + 0.69 x 96.59 – 116.87  
     d = 16.7 
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On the other hand, as the small terminator are tetranucleotides TTTT, therefore: 
      T:      0.9 
      T:      0.9 x 0.9 = 0.81 
      T:      0.81 x 0.9 = 0.729 
      T:      0.729 x 0.9 = 0.656 
 
Therefore nT = 0.9 + 0.81 + 0.729 + 0.656 = 3.095, and as Y value is calculated as: 
 
 
       Y = 8/12 
       Y = 0.67 
 
d value of the small terminator is therefore equals to:  
 
       d = nT x 18.16 + Y x 96.59 – 116.87 
       d = 3.095 x 18.16 + 0.67 x 96.59 – 116.87  
       d = 4.05 
 
Using the defined parameters, the d scores were plotted on the diagram in Figure 
5.11 to estimate the termination efficiency of the terminators. The correlated 
termination efficiencies estimated for the large and small terminators are 58% and 
28%, respectively. The estimation of the termination efficiency was then compared 
with the results of the in vitro assays of the terminator constructs in set I (Figure 
5.12). Having termination efficiencies of 47% (18) (large terminator) and 23% 
(15) (small terminator), these results are therefore in good agreement with the 
measured efficiencies using an algorithm.  
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Figure 5.11 Correlation between the score d of some rho-independent terminators and 
their efficiency in vitro (d’ Aubenton Carafa et al., 1990). The d values of the large 
terminator (16.7) and the small terminator (4.05) were plotted on the x-axis and correlated 
with 58% (red dotted line) and 28% (blue dotted line) of termination efficiencies, 
respectively.   
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Figure 5.12 The termination efficiency of the large (BS87A) and small (BS88A) terminators 
set I. The termination efficiencies were determined by in vitro assays (blue) and an 
algorithm (red).  
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5.4 Discussion 
 
The two terminators located within orf12 of Tn916 are shown to satisfy the minimal 
conditions of a rho-independent transcription terminator; GC rich stem (Sugimoto 
et al., 1987; Tuerk et al., 1988), small loop ( 6 nucleotides) (Gralla and Crothers, 
1973; Groebe and Uhlenbeck, 1988) followed by a series of uridine residues 
(Stroynowski et al., 1983; Lynn et al., 1988) in the RNA. Having a variation in the 
number of GC content as well as the number of U residues, both terminators are 
expected to demonstrate different termination efficiencies. Results presented in 
this study demonstrated that the large terminator is more efficient than the small 
terminator and this result is consistent with the predicted in silico termination 
efficiency (experimental value is 91% of the predicted value). This result is highly 
expected as the large terminator consists of more GC content as well as the U 
residues than the small terminator. The preference of the GC nucleotides as the 
most energetically favorable base pair for the formation of a stable RNA stem loop 
and its association with the T residues, which are responsible for the efficiency of 
the termination process have been reported in a number of studies (Christie et al., 
1981; Stroynowski et al., 1983; Tuerk et al., 1988). In fact, it was suggested that 
high GC content (>75%) is necessary for the formation of RNA stem loop and a rapid 
disruption of the RNA-DNA duplex during the termination process (d’ Aubenton 
Carafa et al., 1990). Additionally, studies by Jeng et al. (1997) indicated that the 
termination efficiency increases by the number of T residues. 
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In a system where both terminators are present, it is predicted that the 
transcription could be efficiently reduced by up to 69.76%. This value corresponds 
to ~30% of transcriptional read-through, therefore when both terminators are 
absent, it is estimated that the transcriptional read-through could lead to as high as 
11646 units of enzyme activity. The experimental data seen in Chapter 4 does show 
high levels of activity for the promoter only construct (Figure 4.13 and Figure 4.14). 
The predicted value suggests that Ptet(M) is an exceptionally strong promoter and 
needs to be controlled as rapid transcription from this promoter would likely be 
deleterious for both the element as well as the host therefore it is not surprising 
that this regulatory system is conserved. Also in this study, it has been shown that 
the small terminator can independently cause termination without the synergistic 
presence of the large terminator. This result appears to contradict the previous 
hypothesis by Hippel and Yager (1991), which according to their kinetic and 
thermodynamic analyses, the small terminator with a free energy value of -8 kcal 
mol-1 is considered as a weak terminator and not normally capable of causing 
termination on its own. 
 
Although the large terminator constitutes more GC content and T residues than the 
small terminator, these characteristics are not the only factors that contribute to 
the measured efficiencies. In some terminators, the sequences of the promoter 
regions can strongly affect the termination efficiency (Golliger et al., 1989) by 
allowing substantial read-through of strong termination signals in a phenomenon 
known as factor-independent antitermination (Telesnitsky and Chamberlin, 1989). 
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Additionally, d’Aubenton Carafa and co-workers (1991) suggested that various 
protein factors might contribute to the efficiency of terminators, which is in fact a 
restriction to the constructed algorithm which is unable to correlate the sensitivity 
of the terminators to these proteins. They also suggested that the sequences 
situated upstream to the stem loop structure and downstream of the stretch of T 
residues might play a role in determining the efficiency of the terminators, although 
the mechanism remains elusive. This prediction is relevant to our results which 
indicate that the restoration of the upstream and downstream sequence 
(terminator construct set II) may have led to different termination efficiencies as 
compared to the terminator constructs in set I. Interestingly, the enzyme activities 
of BS89A (Δ small terminator) and BS91A (Δ small and large terminators) decrease 
as compared to the wild type (BS80A) when the U residues following the small 
terminator are mutated. It is unclear if the mutation introduced in this region has 
led to the reduced enzyme activity considering that the predicted secondary 
structures of both constructs are consistent with the wild type. Further 
investigation is therefore necessary particularly to understand the significant of 
these T residues in the transcriptional termination of Tn916. 
 
Although Tn916 and Tn5397 have an almost identical terminator structure, despite 
those two nucleotides different in the large stem (Roberts and Mullany, 2009), the 
termination efficiency of the large terminator in Tn5397 cannot be estimated using 
an algorithm as the minimal value of the parameter (nT) is not fulfilled. This is 
because there is a single base (A residue) separation between the 3’-end of the 
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stem and the poly-T residues which led to the rejected nT value (<2.895). However, 
the small terminator in Tn5397 has been estimated to share the same termination 
efficiency (28%) with the small terminator in Tn916. This may explain the lack of 
differential transcriptional activity we have seen in Chapter 4 for Tn5397. If the 
predicted large terminator does not actually function as a terminator, we would not 
see a very large change in expression due to the presence of tetracycline, or indeed 
at the beginning of the growth phase as 72% of transcripts would be predicted to 
read-through the attenuator. However, the efficiency of the large terminator in 
Tn5397 requires experimental verification. 
 
5.5 Conclusion 
 
The efficiency of the terminators within the orf12 of Tn916 was successfully 
predicted using an algorithm and validated using the in vitro reporter assays. The 
large terminator is more efficient than the small terminator as indicated by both 
analyses. This is also the first demonstration that the small terminator can act 
alone. 
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6 Transfer of Tn5397 between C. difficile and E. faecalis 
 
6.1 Introduction 
 
E. faecalis and C. difficile are the leading pathogens of nosocomial infections in 
humans in which they inhabit the same niche (Poduval et al., 2000; Donskey et al., 
2003). For the last ten years, the emergence of vancomycin resistant enterococci 
(VRE) as nosocomial pathogens has caused considerable public concern as it leads 
to multiple infections that cause serious or life threatening illnesses (Mundy et al., 
2000). However, the greatest concern is the co-infection of C. difficile in patients 
with VRE (Donskey et al., 2003) where the possible genetic exchanges between the 
two pathogens could possibly disseminate the vancomycin resistant determinants, 
vanA and vanB (Arthur et al., 1996) to C. difficile. This might cause major challenges 
in the treatment of C. difficile infections (CDI) as metronidazole and vancomycin are 
the conventional treatments of CDI despite the newly introduced antibiotic 
fidaxomicin (Cornely et al., 2012). 
 
In this chapter, transfer of the conjugative transposon Tn5397 conferring 
tetracycline resistance gene tet(M) from C. difficile 630 to E. faecalis JH2-2 was 
investigated. This experiment was carried out to investigate if there is a barrier to 
genetic exchange between C. difficile and E. faecalis. This observation is crucial as it 
highlights the need for continual monitoring of emerging resistances in both C. 
difficile and E. faecalis. 
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6.2 Materials and methods 
 
6.2.1 Bacterial strains 
 
In filter mating experiments, C. difficile 630 and E. faecalis EF20A were used as the 
donor strains of Tn5397, whereas the recipient strains were E. faecalis JH2-2 and C. 
difficile R20291. The characteristics of each strain are listed in Table 2.1.  All strains 
were grown under the conditions described in Section 2.3.  
 
6.2.2 Transfer experiments and transconjugants selection 
 
Transfer of Tn5397 between C. difficile and E. faecalis was demonstrated by filter 
mating (Section 2.6). The E. faecalis transconjugants were selected on BHI agar 
supplemented with tetracycline (10 µg ml-1), fusidic acid (5 µg ml-1) and rifampicin 
(25 µg ml-1) after 24 h of incubation at 37oC. In contrast, the C. difficile 
transconjugants were selected on BHI agar supplemented with tetracycline (10 µg 
ml-1) and erythromycin (10 µg ml-1) after 24-48 h incubation at 37oC in an anaerobic 
atmosphere (80% N2, 10% H2 and 10% CO2).    
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6.2.3  Electrophoresis and Southern blotting 
 
The genomic DNA (3 µg) of E. faecalis transconjugants from 5 independent 
experiments was digested with a 6 bp cutter restriction enzyme, XmnI. Digestion 
was carried out for 12 h at 37oC. The digested genomic DNA was then 
electrophoresed on 1% (w/v) agarose gel in 1X TAE buffer for 1 h at 50 V. The 
insertion profile and the copy number of Tn5397 in E. faecalis transconjugants was 
subsequently determined using Southern blot analysis (Section 2.7). A 300 bp probe 
derived from tndX gene was used for hybridisation (Figure 6.1). 
 
6.2.4  Single specific primer PCR (SSP-PCR) 
 
SSP-PCR was used to determine the integration site of Tn5397 in E. faecalis EF20A. 
Genomic DNA of E. faecalis (3 µg) and pUC19 (0.1 µg) were digested with either 
EcoRI or BamHI at 37oC for 2 h. The digested DNA and the dephosphorylated pUC19 
were purified using QIAprep Spin Miniprep column. Ligations were carried out at 
4oC for 18 h with T4 DNA ligase. The ligation mixture (approximately 0.2 ng l-1) was 
used as template in PCR. Amplification was carried out using Tn5397 specific 
primers (LEO or REO) and either M13 For or M13 Rev primers (situated in pUC19). 
Sequences of each primer were listed in Table 2.3. The schematic representation of 
SSP-PCR is shown in Figure 6.2. 
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Figure 6.1 A schematic representation of Tn5397. Arrow represents the location of the 300 
bp probe derived from tndX gene which was used for hybridisation. (Adapted from Roberts 
and Mullany, 2009) 
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Figure 6.2 Schematic representation of SSP-PCR. E. faecalis genome was restricted with 
EcoRI and BamHI prior to ligation with the dephosphorylated pUC19. The ligated products 
which consist of non-specific and specific fragments were used as template in PCR using 
primers M13 For and M13 Rev (Table 2.3). Dashed arrows represent the primers and the 
direction of priming. Template that consists of specific fragments are amplified in the PCR 
reaction. 
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6.3 Results 
 
6.3.1 Transfer of Tn5397 from C. difficile 630 to E. faecalis 
JH2-2 
 
Transfer of Tn5397 from C. difficile 630 to E. faecalis JH2-2 was demonstrated. The 
mean transfer frequency [ standard deviation (SD)] was 8.85 x 10-8 ( 2.14 x 10-7) 
transconjugants per recipient (average of 5 independent filter mating experiments). 
The presence of this element in E. faecalis transconjugants was confirmed by PCR 
amplification of tndX gene with the expected products of 1.6 kb (Figure 6.3). DNA 
from the donor strain (C. difficile 630) was included as positive control for the PCR. 
All transconjugants analysed were generated independently from different filter 
mating experiments to exclude the possibility of analysing siblings. Sequence 
analysis showed that all the amplified PCR products are tndX (accession no. 
AF333235). One transconjugant was chosen for further study and was designated 
EF20A. 
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Figure 6.3 Amplification of tndX gene in E. faecalis transconjugants. Lane 1: HyperLadder I; 
Lane 2: Genomic DNA of C. difficile 630 (positive control); Lanes 3-7: Genomic DNA of E. 
faecalis transconjugants from 5 independent filter mating experiments; Lane 8: Genomic 
DNA of E. faecalis JH2-2 (negative control); Lane 9: No DNA.  
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6.3.2  Transfer of Tn5397 from E. faecalis EF20A to C. difficile 
R20291  
 
This experiment was carried out to investigate if Tn5397 can be transferred from E. 
faecalis back to C. difficile, hence demonstrate a two-way genetic exchange 
between these two bacteria.  Results show that Tn5397 was transferred from E. 
faecalis EF20A to C. difficile R20291 with a transfer frequency [ standard deviation 
(SD)] of 4.44 x 10-6 ( 1.15 x 10-6) transconjugants per recipient or 6.15 x 10-8 ( 1.27 
x 10-8) transconjugants per donor (average of 3 independent filter mating 
experiments). Tn5397 has been shown to occupy 2 target sites in C. difficile R20291 
(Hussain et al., unpublished data), namely fic1 and fic2 (filamentation induced by 
cAMP) genes. PCR amplification was carried out using combination of primers that 
flanked both target sites to confirm the presence as well as the orientation of 
Tn5397 in C. difficile R20291 (Figure 6.4). C. difficile R20291 (recipient) was included 
as a negative control. PCR amplification and sequencing results confirmed the 
presence of Tn5397 in these two sites (Figure 6.5). These results confirmed the 
reciprocal genetic exchange between E. faecalis and C. difficile. 
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Figure 6.4 Schematic diagram showing the position of the primers used to amplify the 2 
target sites of Tn5397 in the C. difficile R20291 genome. PCR amplification was carried out 
using combinations of primers (Fic1 For and LEO; Fic2 For and LEO; Fic1 Rev and REO; Fic2 
Rev and REO) (Table 2.3) flanking the insertion sites and the transposon. Red boxes 
represent the Fic1/Fic2 regions. Green boxes represent the C. difficile genome.  Dashed 
arrows represent the primers and the direction of priming. 
 
 
 
 
Figure 6.5  PCR results showing the presence of Tn5397 in two sites of C. difficile R20291. 
panel A: Amplification of the first target site, Fic1: Lane 1: HyperLadder I; Lane 2: Fic1 For + 
Leo (transconjugant); Lane 3:  Fic1 For + Leo (negative control); Lane 4: Fic1 For + Reo 
(transconjugant); Lane 5: Fic1 For + Reo (negative control); Lane 6: Fic1 Rev + Leo 
(transconjugant); Lane 7: Fic1 Rev + Leo (negative control); Lane 8: Fic1 Rev + Reo 
(transconjugant); Lane 9: Fic1 Rev + Reo (negative control). Panel B: Amplification of the 
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second target site, Fic2: Lane 1: HyperLadder I; Lane 2: Fic2 For + Leo (transconjugant); 
Lane 3:  Fic2 For + Leo (negative control); Lane 4: Fic2 For + Reo (transconjugant); Lane 5: 
Fic2 For + Reo (negative control); Lane 6: Fic2 Rev + Leo (transconjugant); Lane 7: Fic2 Rev + 
Leo (negative control); Lane 8: Fic2 Rev + Reo (transconjugant); Lane 9: Fic2 Rev + Reo 
(negative control). The negative control for this PCR reaction was C. difficile strain R20291 
(recipient). 
 
 
6.3.3 Determination of the number of copies of Tn5397 in E. 
faecalis transconjugants 
 
Southern hybridisation was carried out to determine the number of copies of 
Tn5397 in E. faecalis. Genomic DNA of E. faecalis JH2-2 and E. faecalis EF20A from 5 
independent experiments were digested with XmnI and probed with a 300 bp 
amplicon of tndX. The cutting sites of XmnI in the tndX sequence were mapped and 
the presence of a single band (approximately 1300 bp) in all transconjugants after 
the Southern blotting suggests that a single copy of Tn5397 has integrated into the 
genome of all the E. faecalis transconjugants at a single conserved site (Figure 6.6 
and Figure 6.7).  
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Figure 6.6 Southern blot analysis using tndX probe. Insertion profile of Tn5397 in E. 
faecalis. Panel A shows the genomic DNA digested with XmnI and electrophoresed on 1% 
agarose gel. Panel B shows the Southern blotting performed on this gel. The single 
hybridizing band for each transconjugant is shown (30 min exposure). Lane 1: 1 kb DNA 
ladder; Lanes 2-6: XmnI-digested genomic DNA of transconjugants; Lane 7: E. faecalis JH2-2 
(negative control); Lane 8: HyperLadder I; Lane 9: tndX fragment.  
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Figure 6.7 Cutting sites of XmnI within tndX gene and E. faecalis genome. Panel A 
represents Tn5397, with tndX gene circled. Panel B represents the cutting sites of XmnI 
(black arrows) within tndX gene (red arrowed box) and E. faecalis genome (black bar). The 
black dotted arrow represents the location of the probe used for hybridisation. A product 
of 1300 bp, which consists of tndX gene and E. faecalis genome (black bar), was observed 
on the blot (red dotted arrow).  
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6.3.4  Determination of the target site of Tn5397 in E. faecalis  
 
The nucleotide sequence of the target site of Tn5397 in E. faecalis was determined 
using SSP-PCR (Figure 6.8A). Amplicons were cloned into pGEM-T Easy and after 
transformation into E. coli, plasmids which contained different sizes of inserts were 
sequenced (Figure 6.8B). Analysis of the sequence showed that Tn5397 has inserted 
within the chromosome at a region which is identical to an open reading frame 
from E. faecalis V583 encoding the IIA component of a mannose/sorbose specific 
sugar phosphotransferase system (Accession number: NP_814245) involved in the 
uptake and phosphorylation of carbohydrates. 
 
Based on the sequence of PTS system IIA component of E. faecalis V583, 
amplification of the genome:transposon junction was carried out using primers (PTS 
For and PTS Rev) flanking the insertion site (Figure 6.9). The sequencing results 
showed the presence of a GA dinucleotide flanking both the genome:transposon  
junctions (Figure 6.10).  
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Figure 6.8 Characterization of the target sites of Tn5397 in E. faecalis. Panel A: Visualization 
of amplified products from SSP-PCR. Lane 1: HyperLadder I; Lanes 2 and 7: Leo + M13 For; 
Lanes 3 and 8: Reo + M13 For; Lanes 4 and 9: Leo + M13 Rev; Lane 5: Reo + M13 Rev. PCR 
products from Leo + M13 For (Lanes 2 and 7) were chosen and cloned into pGEM-T Easy. 
Panel B: XmnI-digested plasmids containing different sizes of inserts. The inserts from the 
plasmids in Lanes 2-5 (arrows) were sequenced.  
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Figure 6.9 Schematic diagram showing the position of the primers used to amplify the 
target site of Tn5397 in the E. faecalis genome. PCR amplification was carried out using 
combination of primers (PTS For and LEO; PTS Rev and REO) (Table 2.3) flanking the 
insertion site and the transposon. Red boxes represent the PTS IIA component gene. Green 
boxes represent the flanking E. faecalis genome. Dashed arrows represent the primers and 
the direction of priming.  
 
 
 
 
 
Figure 6.10 DNA sequence of the target site-transposon junctions. The GA dinucleotide that 
flanks Tn5397 is shown in boldface. The target site in C. difficile 630 was included as 
reference comparison. The conserved hexamer TGATTT was observed in both target site of 
E. faecalis JH2-2 and C. difficile 630 (underlined). 
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6.3.5  PCR amplification for the joint of the circular form of 
Tn5397 in E. faecalis 
 
Circularisation of the conjugative transposon Tn5397 was first demonstrated by 
Wang et al. (2000). PCR amplification was carried out using outward firing primers, 
LEO and REO (Figure 6.11). A PCR product of 280 bp is expected if the left and right 
ends of the transposon were ligated together following excision from the 
chromosome. Figure 6.12 shows the amplified products from both the C. difficile 
630 (donor) and the E. faecalis transconjugants. No products were observed for E. 
faecalis JH2-2 (recipient) (negative control).  
 
6.3.6  Effect of acquisition of Tn5397 on the growth of E. 
faecalis  
 
The effect of the acquisition of Tn5397 to the growth of the E. faecalis EF20A was 
investigated using comparative growth curve. Results demonstrate that the 
acquisition of Tn5397 had caused a small fitness burden to E. faecalis EF20A, which is 
presented by a delayed growth rate compared to the wild type E. faecalis JH2-2 
(Figure 6.13).  
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Figure 6.11 Circularisation of Tn5397. Primers LEO and REO (Table 2.3) are designed to bind 
to the sequence of Tn5397 in an outward position. These primers are able to amplify the 
region in Tn5397 if this element excises and form a circular intermediate prior to 
integration. 
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Figure 6.12 PCR results revealing the presence of circular form of Tn5397 in E. faecalis 
transconjugants. Lane 1: HyperLadder I; Lane 2: Genomic DNA of C. difficile 630 as template 
(positive control); Lanes 3-7: Genomic DNA of E. faecalis as template (transconjugants from 
five independent experiments); Lane 8: Genomic DNA of E. faecalis JH2-2 as template 
(negative control); Lane 9: No DNA. 
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Figure 6.13 Comparison of the growth kinetics of E. faecalis JH2-2 and EF20A. Error bars 
indicate the standard deviation of three independent experiments.  
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6.4 Discussion 
 
The conjugative transposon Tn5397 was shown to transfer from C. difficile 630 to E. 
faecalis JH2-2, and from this host to C. difficile R20291 ribotype 027. This is the first 
report on the intergeneric transfer of Tn5397 between these two bacteria although 
previous studies have indicated the transfer of this element from C. difficile strains 
to and from B. subtilis and between C. difficile strains (Mullany et al., 1990; Roberts 
et al., 1999). Studies by Launay et al. (2006) have shown that although intergeneric 
transfer of Tn1549 between C. symbiosum and E. faecalis and E. faecium occurs 
both in vitro and in vivo, however higher number of transfers were obtained in in 
vitro. Although the transfer of Tn5397 between E. faecalis and C. difficile occurs in 
the laboratory, which is different from the usual environment of the bacteria but 
the active movement of this element demonstrates that there is no obvious barrier 
for the exchange of conjugative elements. Therefore, the fact that we have not yet 
seen vancomycin resistant C. difficile may be due to either host factors or 
expression problems of the vancomycin proteins. 
 
In addition, the transfer of Tn5397 between C. difficile and E. faecalis does not 
appear to be restricted. The mean transfer frequency detected in this study concurs 
with the previous work by Agersø and co-workers (2006) who demonstrated the 
transfer of Tn5397 between E. faecium strains, with the transfer frequency of 7 x 
10-8 transconjugants per donor. In previously mentioned study by Launay et al. 
(2006), the intergeneric transfer of Tn1549 between C. symbiosum and E. faecalis 
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and E. faecium was demonstrated to occur between 10-8 and 10-9 transconjugants 
per recipient. Launay and co-workers also suggested that the efficiency of transfer 
between Clostridium sp. and Enterococcus sp. appears to be both donor and 
recipient dependent, where the most efficient donor and recipient strains of C. 
symbiosum and E. faecalis used in their study have been identified.  
 
Tn5397 has been shown to integrate the genome of E. faecalis at a single site, 
based on the Southern blot analysis. This site is identified within an open reading 
frame that was predicted to encode a phosphotransferase (PTS) IIA component 
(locus_tag: EF_0461). The PTS IIA component is a major carbohydrate transport 
system in bacteria, involves in uptake and metabolism of sugars (Postma et al., 
1993). The integration of Tn5397 within this region probably due to the presence of 
TGATTT hexamer, which was also observed in both target sites of C. difficile 630 and 
E. faecalis JH2-2 suggested that this could be a preferred region for TndX binding to 
catalyse the insertion of this element. 
 
Although Tn5397 has been shown to integrate into a single specific site in E. 
faecalis, there is a possibility that different E. faecalis strains will have multiple 
insertion site as reported in B. subtilis. Studies by Wang et al. (2006) have shown 
that Tn5397 has a preferred target site in C. difficile, attBCd. In C. difficile 630, 
Tn5397 integrated into one preferred site (Wang et al., 2006), whereas in C. difficile 
R20291 ribotype 027, this element inserts into two target sites. These target sites 
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are used by Tn5397 and can be occupied at the same time (Hussain et al., 
unpublished data). The integrated Tn5397 in E. faecalis has also been shown to be 
flanked by the GA dinucleotides. Excision of Tn5397 involves a 2 bp staggered cuts 
at 3‘ ends of the directly repeated GA dinucleotides at each end of the transposon. 
These sticky ends form the joint of a circular intermediate which is essential for 
conjugal transfer and transposition of this element (Wang et al., 2006). In this 
study, the circular intermediate of Tn5397 was observed in all E. faecalis 
transconjugants as demonstrated by PCR amplification results hence provides an 
evident that this element is transferable from E. faecalis host. 
 
Preliminary study on the effect on growth of acquiring Tn5397 was carried out by 
comparative growth curves of E. faecalis JH2-2 and E. faecalis EF20A. Results 
suggest that the acquisition of Tn5397 by E. faecalis and its integration within the 
orf encoding a IIA component, may show a small fitness burden. In order to 
determine the effect empirically a competitive assay should be used as we used in 
Chapter 3. Previous studies have evaluated the fitness cost associated with 
antibiotic resistance genes carried by transposons. Enne et al. (2005) have shown 
that acquisition of Tn1 and Tn7 which carry ampicillin and trimethoprim resistance 
genes, respectively had no cost on the fitness of E. coli. In another study by 
Foucault et al. (2010), it was demonstrated that Tn1549 conferring vancomycin 
resistance genes carriage had no cost for the E. faecalis and E. faecium under 
noninduced state. However, a reduced fitness was observed when the expression 
of the resistance genes was induced. Fitness cost has also been shown to be 
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associated with the integration site of the transposons. Studies by Elena et al. 
(1998) illustrate a fitness cost of Tn10 insertional mutants which was related to the 
insertion locus rather than to expression of tetracycline resistance. It has also been 
shown that the integration of Tn1549 in the coding sequence of Enterococci is not 
costly, compared to the integration in the non-coding sequence (Foucault et al., 
2010). It maybe that Tn5397 has evolved to have a very low burden upon its host. 
This would make sense as it would therefore be more stable within the genome. 
 
6.5 Conclusion 
 
The reciprocal genetic exchange between C. difficile and E. faecalis was 
demonstrated. A single copy of Tn5397 has integrated the E. faecalis genome 
within an open reading frame encoding a phosphotransferase (PTS) IIA component. 
Acquisition of Tn5397 has caused a small fitness burden to E. faecalis EF20A. 
 
 
 
 
 
 
 
 
223 
 
 
 
 
 
 
 
 
Chapter 7.0 
Final Conclusions and Future Work 
 
 
 
 
224 
 
7 Final Conclusions and Future Work 
 
 
The work presented in this study was carried out in order to investigate the detailed 
molecular mechanisms of regulation that have evolved in the conjugative 
transposons Tn916 and Tn5397.  In the first results chapter (Chapter 3), a defined 
mutation was constructed in the start codon of orf12, the gene immediately 
upstream of tet(M) in Tn916. This mutant showed a delayed growth when 
challenged with tetracycline, presumably because the formation of the terminator 
structures upstream of tet(M) were always formed because the translation of orf12 
cannot occur due to the absence of a start codon. Therefore limited Tet(M) 
production will mean not as many ribosomes will be protected and the growth in 
tetracycline will be slower. This provides evidence that orf12, is involved in the 
transcriptional regulation of this element. As orf12 consists of five rare amino acid 
residues among the aminoacyl-tRNA pool (cysteine, methionine and histidine) and 
the paucity of these amino acids could limit the translation rate of this region, 
therefore future work on this subject should aim to determine the significant level 
of each amino acid and its effect in the translation rate of orf12. 
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Furthermore, the relative fitness was compared between a differentially marked 
BS34A (contains wild type Tn916) strain and BS79A (contains Tn916Δorf12). 
Without antibiotics, BS79A was 4% more fit than the BS92A (BS34AΔamyE) strain. 
Following treatment with tetracycline a large decrease in fitness was seen at 5 h 
post-challenge (38% less fit than BS92A). Again this fitness cost can be attributed to 
the mutation in the start codon of orf12 in BS79A for the same reasons as described 
above.   
 
Next, the expression of the reporter gene (gusA) was measured in constructs 
containing the promoter upstream of orf12, with and without orf12. It was 
discovered that the expression of the reporter gene located downstream of the 
wild type promoter of Tn916 was growth phase-dependent. The highest expression 
was seen in the lag phase culture, most likely due to a high amount of tRNA in the 
cell (as they had been in stationary phase overnight). Then the expression 
decreased as the log phase progressed. This can be attributed to the tRNAs being 
used up by the fast growing cells. This is the first time this pattern of basal level of 
expression has been seen with this system.  Next, the expression levels were 
measured before and after exposure to tetracycline. It was found that the 
expression level of BS80A [Ptet(M) Tn916 (wild type)] increased after 1 h of 
exposure to tetracycline. This is in agreement with the hypothesis being tested. 
Lower levels of expression were seen in BS82A ([Ptet(M) Tn916 (start codon)], again 
as predicted, however a small increase was seen following exposure to tetracycline. 
It is thought this is due to the wild type copy of Tn916 in the chromosome 
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protecting the ribosomes leading to increased basal levels of expression. In both 
the Tn5397 wild type (BS84A) and the orf26 start codon mutant (BS86A) constructs, 
no response was seen following the addition of tetracycline. This is discussed later.  
 
Further experiments with biocides demonstrated that the regulation of Tn916 does 
not necessarily depend on the presence of tetracycline. It has been hypothesised 
that the amount of charged tRNA molecules is the necessary trigger for the 
regulatory mechanism of Tn916 (Roberts and Mullany, 2009). The expression of the 
reporter gene is upregulated upon exposure to the biocides; ethanol, hydrogen 
peroxide, chlorhexidine digluconate and sodium hypochlorite, all of which damage 
the cell in multiple ways. This data support the above hypothesis and suggest that 
any damage caused to the biological systems of bacteria, which affect translation 
could result in the accumulation of charged tRNA molecules in the cells. Upon 
sensing this stress condition, the element responsed by upregulating its 
transcriptional activity. This new knowledge is incorporated with the previous 
hypothesis and reviewed in Figure 7.1. As the translation of orf12 is associated with 
the amount of charged tRNA, therefore future work on this subject should aim to 
determine the amount of the accumulated charged tRNA that leads to the faster 
translation of orf12.  
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Figure 7.1 Regulation of tet(M) in Tn916 (current view). Regulation of tet(M) resistance 
gene in Tn916 involved the short open reading frame, orf12 and  is associated with several 
external factors that determine whether the expression of Tet(M) is upregulated or 
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downregulated. Malfunctioned caused to the biological systems of bacteria due to the 
presence of tetracycline or biocides, as well as when the cell is under stress condition leads 
to the slower growth and decrease in protein synthesis. As this happened the amount of 
charged tRNA in the system increases enabling a more rapid translation of orf12 by the 
Tet(M)-protected ribosomes. The ribosomes are predicted to catch up the transcribing RNA 
polymerase and prevent the formation, or destroy the terminator structures. At this stage, 
the transcription of tet(M) is predicted to be approximately 100%. High level of protein 
translation leads to low level of charged tRNA in the system. Limited amount of charged 
tRNA eventually decreases the translation rate, and cause terminator structures to form. In 
contrast, when the amounts of nutrients in the cells are abundant, the bacteria grow faster 
and lead to high protein synthesis. This will lead to the shortage of tRNA molecules in the 
cells concurrently decreases the translation rate. As this happened, the ribosomes lags 
behind the extending RNA polymerase allowing the terminators to form. At this stage, the 
transcription of tet(M) is predicted to be approximately 30% [large and small terminators 
reduce transcription by up to 47% ( 18%) and 23% ( 15%), respectively. When all of the 
ribosomes are protected by Tet(M), the expression level will return to the basal level, which 
is growth-dependent.  
 
The ability of mobile genetic elements to evacuate the dying host under stress 
condition has been highlighted in a number of studies including the SXT integrative 
conjugative element (Beaber et al., 2004) and the temperate phages (Penades et 
al., 2005). SXT, which is derived from Vibrio cholerae O139, encodes genes that 
confer resistance to chloramphenicol, sulphamethoxazole, trimethoprim and 
streptomycin (Waldor et al., 1996). This element responds to a variety of stress 
conditions i.e. environmental factors and antibiotics by upregulating the the 
expression of genes necessary for SXT transfer (Beaber et al., 2004). The temperate 
phages respond to stress condition by entering the lytic pathway that causes the 
host cell to lyse. Under this condition, the phage-encoded repressor protein that 
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controls the lytic pathway is repressed, thus inducing the prophage and lead to the 
production of new virions and lysis of the host cell (Madigan et al., 2000).  
 
In Chapter 5, the efficiency of the terminators located in the regulatory region of 
Tn916 was investigated using reporter constructs and using an algorithm designed 
to predict terminator efficiency in E. coli. In both analysis it was seen that the large 
terminator is more efficient (47% experimentally vs. 58% predicted by the 
algorithm) than the small terminator (23% experimentally vs. 28% predicted by the 
algorithm). This is the first time the efficiency has been reported for these 
terminators and again, supports the hypothesis. Prediction of the termination 
efficiency for the large Tn5397 terminator could not be done as it does not fulfill 
one of the required parameters. This is due to the presence of an A residue 
between the stretch of T’s and the base of the stem loop. This may in fact explain 
why no response was seen to tetracycline in the above experiments with 
tetracycline. The small terminator in Tn5397 is identical to that in Tn916. Therefore, 
future work on this subject should focus on constructing the large terminator 
reporter plasmid of Tn5397 so that the efficiency of this terminator can be 
determined experimentally. This could not be completed in the time available for 
this study. 
 
Finally, the first reciprocal genetic transfer between E. faecalis and C. difficile was 
demonstrated in this study. Tn5397 has been shown to integrate into the genome 
of E. faecalis at a preferred site, flanked by 5’ GA dinucleotides as previously 
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suggested by Wang et al. (2006). The acquisition of this element has caused a small 
fitness burden to E. faecalis as determined by comparative growth curve. 
Competitive studies are required to determine the fitness effect relative to the 
recipient strain. 
 
As conjugative transposons such as Tn916 and Tn5397 are responsible for the 
spread of antibiotic resistance genes, the continued research on the molecular basis 
of regulation of these conjugative transposons is essential, as it will provide an 
insight into the event, or events, that lead to the dissemination of the antibiotic 
resistance genes. If we fully understand the regulatory mechanism, then we may be 
able to come up with strategies, such as drug design, to control the spread. 
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Appendix A: Raw data of plasmid stability test  
Plasmid stability of pHCMCO5/Ptet (M) Tn916  constructs
0.5 h 2.5 h
BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM
x 10-5 65 73 80 68 72 72 x 10-5 271 89 285 177 TNTC 212
x 10-6 7 8 9 6 9 14 x 10-6 39 14 40 23 55 32
x 10-6 2 1 1 1 2 2 x 10-6 5 1 6 2 5 2
1.0 h 3.0 h
BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM
x 10-5 60 62 87 85 75 77 x 10-5 168 41 TNTC 73 69 31
x 10-6 9 5 10 6 9 15 x 10-6 29 10 73 10 69 31
x 10-6 0 1 2 1 1 0 x 10-6 2 1 8 1 6 3
1.5 h 3.5 h
BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM
x 10-5 92 92 97 111 113 111 x 10-5 TNTC 57 80 66 TNTC 227
x 10-6 7 6 12 16 11 12 x 10-6 129 27 80 10 104 45
x 10-6 1 1 0 2 0 3 x 10-6 7 3 9 3 15 4
2.0 h 4.0 h
BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM
x 10-5 130 133 160 146 180 181 x 10-5 TNTC 120 TNTC 144 TNTC 106
x 10-6 14 21 26 18 25 23 x 10-6 131 39 219 35 183 82
x 10-6 3 2 2 1 3 4 x 10-6 18 8 29 6 25 9
WT PO ST
WT PO ST
WT PO ST
WT PO ST
WT PO ST
WT PO ST
WT PO ST
WT PO ST
*TNTC: Too numerous to count 
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Plasmid stability of pHCMCO5/Ptet (M) Tn5397  constructs
0.5 h 2.5 h
BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM
x 10-5 91 69 72 72 75 66 x 10-5 TNTC 187 TNTC TNTC 147 98
x 10-6 9 13 7 7 7 9 x 10-6 66 57 65 52 40 29
x 10-6 0 0 1 0 1 0 x 10-6 7 7 5 7 6 5
1.0 h 3.0 h
BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM
x 10-5 93 103 85 78 67 73 x 10-5 TNTC 130 TNTC 136 233 201
x 10-6 9 9 11 12 11 11 x 10-6 118 77 113 74 75 40
x 10-6 2 1 0 0 1 1 x 10-6 14 8 13 10 7 5
1.5 h 3.5 h
BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM
x 10-5 98 116 89 98 113 99 x 10-5 TNTC TNTC TNTC TNTC TNTC TNTC
x 10-6 14 16 14 9 14 14 x 10-6 208 164 191 218 108 94
x 10-6 2 1 0 1 1 2 x 10-6 27 23 25 16 16 12
2.0 h 4.0 h
BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM BHI BHI/CM
x 10-5 194 200 209 208 133 174 x 10-5 TNTC TNTC TNTC TNTC TNTC TNTC
x 10-6 35 23 27 23 29 26 x 10-6 180 147 216 209 160 136
x 10-6 9 4 5 3 2 4 x 10-6 45 32 44 35 29 31
WT PO ST WT PO ST
WT PO ST WT PO ST
WT PO ST WT PO ST
WT PO ST WT PO ST
 
*TNTC: Too numerous to count 
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Appendix B: Composition of media and solutions 
 
Media/solutions Composition 
Luria-Bertani (LB) agar g l-1: 10.0 tryptone, 10.0 sodium chloride, 5.0 yeast 
extract and 15.0 agar (pH 7.0) 
Luria-Bertani (LB) broth g l-1: 10.0 tryptone, 10.0 sodium chloride and 5.0 yeast 
extract (pH 7.0) 
Brain heart infusion (BHI) 
agar 
 
g L-1: 12.5 brain infusion solids, 5.0 beef heart infusion 
solids, 10.0 proteose peptone, 5.0 sodium chloride, 2.5 
disodium phosphate, 2.0 glucose, and 10.0 agar (pH 
7.4) 
Brain heart infusion (BHI) 
broth 
g l-1: 12.5 brain infusion solids, 5.0 beef heart infusion 
solids, 10.0 proteose peptone, 5.0 sodium chloride, 2.5 
disodium phosphate and 2.0 glucose (pH 7.4) 
Starch agar 
 
g l-1: 12.5 brain infusion solids, 5.0 beef heart infusion 
solids, 10.0 peptone, 5.0 sodium chloride, 2.5 disodium 
phosphate and 2.0 glucose, 4.0 starch and 10.0 agar 
(pH 7.4) 
SP4X  
 
g l-1: 56.0 dipotassium phosphate, 24.0 potassium 
phosphate, 8.0 ammonium sulphate, 4.0 trisodium 
citrate dihydrate, 0.8 magnesium sulphate 
heptahydrate, 4.0 casamino acids and 4.0 yeast extract 
(pH 7.2) 
SPI v/v: 25 SP4X, 2.5 glucose (20%), 2.86 thymine (35 mg 
ml-1), 5.0 amino acids solution [histidine, threonine and 
methionine (1 mg ml-1)], and 64.6 distilled water 
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Media/solutions Composition 
SPII ml 90 ml-1: 22.5 SP4X, 2.25 glucose (20%), 2.6 thymine 
(35 mg ml-1) and 62.65 distilled water 
SOC 10 ml: 2% tryptone, 0.5% yeast extract, 10 mM sodium 
chloride, 2.5 mM potassium chloride, 10 mM 
magnesium chloride, 10 mM magnesium sulphate and 
20 mM glucose  
Z buffer 
 
1 L: 60 mM disodium hydrogen phosphate, 40 mM 
sodium dihydrogen phosphate, 10 mM potassium 
chloride, 1 mM magnesium sulphate heptahydrate and 
50 mM 2-mercaptoethanol 
Hybridisation buffer w/v: 2.92 sodium chloride and 5.0 milk powder   
 
20 x SSC 1L: 0.3 M trisodium citrate (pH 7.0) and 3 M sodium 
chloride 
Primary wash buffer 1 L: 6 M urea, 0.4% SDS and 0.5X SSC 
Depurination solution 1 L: 250 mM hydrochloric acid 
Denaturation solution 1 L: 1.5 M sodium chloride and 0.5 M sodium 
hydroxide 
Neutralisation solution 1 L: 1.5 M sodium chloride and 0.5 M Tris-HCl, pH 7.5 
Loading buffer 
 
v/v: 0.25% bromophenol blue, 0.25% xylene cyanol FF 
and 40% sucrose in sterile distilled water 
 
 
267 
 
Appendix C: Publications  
1. Jasni, A. S., Mullany, P., Hussain, H., Roberts, A. P. (2010). Demonstration of 
conjugative transposon (Tn5397)-mediated horizontal gene transfer between 
Clostridium difficile and Enterococcus faecalis. Antimicrobial Agents and 
Chemotherapy 54(11), 4924-4926. 
 
2. Ciric, L., Jasni, A., de Vries, L. E., Agersø, Y, Mullany, P. and Roberts, A. P. (2011) 
‘The Tn916/Tn1545 Family of Conjugative Transposons’ in Roberts, A. P. and 
Mullany, P. (ed.) Landes Bioscience and Springer Science+Business Media. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
